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Hydrogen sulfide (H2S) has recently emerged as an important biological signaling 
molecule involved in a number of key physiological processes. These observations have 
generated interest in harnessing H2S as a potential therapeutic agent to treat disease states 
and chronic conditions associated with H2S-based signaling. A mechanistic analysis of 
these physiological processes reveals the prevalence of H2S and other reactive sulfur 
species including sulfane sulfur and persulfides. To better understand the biological 
properties of these reactive sulfur species, chemical tools which provide methods of 
generating these fleeting species under controlled reaction conditions are needed. 
Chapter I is a comprehensive review discussing the large library of small molecule 
H2S donors reported to date and their respective mechanisms of activation. Chapter II 
describes the discovery of a highly efficient, chemoselective reaction between free cysteine 
and thionoesters to generate H2S at physiological pH. Chapter III builds upon the findings 
of Chapter II to provide a tunable method of H2S generation upon treatment of 
functionalized dithioesters with free cysteine. Chapter IV demonstrates the validity of 
using synthetic organic polysulfides in the presence of biological thiols to generate H2S 
through the intermediate formation of persulfides. Chapter V reports the effect of varying 
sulfane sulfur content in benzyl polysulfides on thiol-mediated H2S release and the 
v  
biological activity of these compounds. Chapter VI highlights the use of dithiasuccinoyl 
protecting groups to improve current methods of H2S generation which function through 
the intermediate generation of carbonyl sulfide (COS) in the presence of carbonic 
anhydrase. Building upon growing interest in the potential biological activity of COS, 
Chapter VII demonstrates the use of a benzobisimidazolium salt for selective detection of 
COS by UV-Vis and fluorescent spectroscopy. 
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ACTIVATABLE SMALL-MOLECULE HYDROGEN SULFIDE DONORS 
 
 
This chapter includes previously published and co-authored material from Levinn, C.M.; 
Cerda, M.M.; Pluth, M.D. Activatable Small-Molecule Hydrogen Sulfide Donors. 
Antioxid. Redox Signal. 2020, 32 (2), 96-109. This review was co-written by Carolyn M. 





Hydrogen sulfide (H2S), historically dismissed as a toxic and malodorous gas, has 
emerged in the scientific community as an important biological signaling molecule.1 The 
physicochemical properties of H2S have been studied extensively, and we refer the 
interested reader to recent reviews that cover this area in depth.2 Since its initial recognition 
as a relevant biomolecule, diverse scientific communities ranging from chemists to 
physiologists have focused on investigating the role of H2S in various biological systems. 
H2S is produced endogenously in mammals predominantly from cysteine through the 
action of three main enzymes. Cystathionine--synthase is primarily localized in the 
nervous system, brain, and liver; cystathionine--lyase produces H2S primarily in the 
cardiovascular system; and 3-mercaptopyruvate sulfurtransferase is localized in the 
mitochondria.1a, 3 Investigations into the  biological  roles  of  H2S  have  established 
its critical roles in different disease states and pathologies in almost every human organ 







Figure 1.1 Selected roles of H2S in major organ systems. 
 
 
As brief examples, H2S plays important roles in the central nervous system, participates in 
neurotransmission, and has been shown to have neuroprotective effects, specifically in 
mouse models of Parkinson’s disease.5 In addition, H2S upregulates glutathione (GSH) 
production in the brain during periods of high oxidative stress and contributes to regulating 
key sodium channels in neuronal cells.5c In the respiratory system, H2S plays roles in 
different conditions, including chronic obstructive pulmonary disease, pulmonary fibrosis, 
and hypoxia-induced pulmonary hypertension.6 In the cardiovascular system, H2S 
mitigates oxidative stress and reduces myocardial injury related to ischemia–reperfusion 
events.7 Moreover, lower circulating H2S levels are found in experimental models of heart 
3  
failure, and CSE-deficient mice exhibit greater cardiac dysfunction after transverse aortic 
constriction, both of which suggest additional roles of H2S in heart failure.8 
More broadly, H2S interacts through several signaling pathways, such as the KATP 
channels, and promotes angiogenesis by the protein kinase B and phosphatidylinositol 3- 
kinase pathways. Low levels of H2S have been demonstrated to promote cell proliferation 
and migration.9 Importantly, the activity of administered H2S often shows a stark 
concentration dependence, with low versus high concentrations frequently producing 
contrasting effects. More recently, a study of psoriasis patients demonstrated lower serum 
H2S levels than healthy patients, underscoring the potential role that H2S plays in skin 
protection and repair.10 As a whole, the established pathophysiological targets of H2S are 
incredibly diverse, and they include activities as an established antiapoptotic,11 anti- 
inflammatory,12 and antioxidative agent,13 as well as contributing to many other processes. 
With such a broad range of biological targets and activities, significant effort has 
focused on investigating and understanding the direct effects of H2S on specific systems 
with a long-term goal of leveraging these insights to deliver H2S-related therapeutic 
interventions. Much of the preliminary work in this area relied on direct inhalation of H2S 
or administration of inorganic sulfide salts, such as sodium hydrosulfide and sodium sulfide 
(Na2S). Although highly efficient, these systems often release an instantaneous bolus of 
H2S and fail to mimic the more gradual rates or distributions of endogenous H2S 
production.14 This discrepancy, as well as other significant limitations, has driven the 
development of small-molecule “donors” that are capable of releasing H2S under 
physiologically-relevant conditions and in response to specific stimuli. 
4  
Many reported H2S donor systems respond to specific exogenous or biocompatible 
stimuli to release H2S.2b, 2f, 15 Such activation profiles allow for donor activities to be tuned 
to respond to specific activators and stimuli present in a given system. Although there is 
no single universal “ideal donor,” certain donor classes provide distinct advantages and 
useful properties. For example, donors should have readily accessible control compounds 
that can be used to clearly delineate observed biological activities and outcomes associated 
with H2S from those of donor byproducts. Similarly, donors that respond to specific stimuli 
enable experiments in which H2S delivery can be controlled or triggered by specific 
activators. Coincident with these primary needs, significant advances in the development 
of activatable H2S donors have occurred in the past 5 years, with key examples including 
donors activated by light, various pH regimes, enzymes, biological thiols, and hydrogen 
peroxide (H2O2). 
In developing activatable H2S-releasing donors, a number of primary strategies have 
emerged, which are summarized briefly in this section but are expanded on in various 
sections of this review (Figure 1.2). The first commonly used strategy is to replace an 
oxygen atom in a molecule with a sulfur, such that hydrolysis releases H2S. A second 
common strategy is to develop systems that generate an intermediate persulfide, which can 
be subsequently cleaved by thiols, such as reduced glutathione (GSH) or cysteine, to 
generate H2S and a disulfide. A third strategy is to develop systems that release carbonyl 
sulfide (COS) as an intermediate, which can be quickly converted to H2S, the ubiquitous 
mammalian enzyme carbonic anhydrase (CA).16 These three general approaches are 
summarized in Figure 1.2 and will be discussed briefly throughout the review. Rather than 
focus on the mechanistic details of each structure in this review, we refer interested readers 
5  
to the Supplementary Appendix, which includes the activation mechanism of different 





Figure 1.2 General classes of H2S release from small-molecule donors 
 
 
1.2 Enzyme-Activated Donors 
 
Because H2S has myriad biological targets, disentangling the effects of sulfide delivery 
in specific environments can be challenging. One approach to overcome this difficulty is 
to incorporate an enzymatically cleaved trigger on a sulfide donor. This approach allows 
for donors to be developed that are stable until the activating group is cleaved or modified 
by the target enzyme to release H2S or an H2S equivalent, such as COS. This strategy has 
the benefit of being readily tuned to specific triggering groups and enzyme pairs. In 
6  
addition, utilizing an enzyme to carry out the donor activation event does not consume 
cellular nucleophiles or thiols, which could otherwise perturb the redox balance of related 
reactive sulfur species – an inherent challenge with many thiol-triggered H2S donors 






Figure 1.3 Enzyme-activated donors and associated enzymes. (a) Structures of 




In this system, esterase-mediated cleavage of an acyl-protecting group on the donor motif 
was used to generate an unstable phenolic intermediate that subsequently underwent an 
intramolecular lactonization with a pendant thioacid to release H2S.17 Esterases are 
expressed in most tissue types and are involved in the activation or metabolism of ~10% 
of drugs (Figure 1.3b).18 One benefit of this design is that the rate of H2S release could be 
tuned by varying the identity of the ester triggering group or by modifying the geminal- 
dimethyl substitution in the “trimethyl lock” backbone to facilitate lactonization. Notably, 
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the authors were able to conjugate this sulfide-donating scaffold to the nonsteroidal anti- 
inflammatory drug naproxen, forming an activatable H2S-drug hybrid. 
In 2017, both Chauhan et al.19 and our group20 independently reported esterase- 
 
activated donors that functioned through the intermediacy of COS release. In these 
approaches, self-immolative thiocarbamates or thiocarbonates functionalized with ester 
motifs were enzymatically activated to release COS, which is rapidly metabolized to H2S 
by CA, rather than H2S directly. In this context, “self-immolation” refers to the 
spontaneous cascade reaction of a molecular linker after a chemical triggering event that 
results in release of a desired payload. 
Chauhan et al.19 utilized a tert-butyl ester trigger with an extended methylenedioxy 
 
linker to connect the donor motif to the core amine scaffold. These donors, such as 
Esterase-TCM-SA, encompassed both aryl and benzyl amine terminating S-alkyl 
thiocarbamates, as well as S-alkyl thiocarbonates (Figure 1.3a). The different scaffolds 
exhibited different release rates based on the identity of the parent amine, and different 
toxicity profiles toward MCF-7 (human breast cancer) cells. Our group also reported tert- 
butyl ester triggered motifs, including the donor compound Esterase-TCM-OA, as well as 
the analogous triggerless and sulfide-depleted carbamate control compounds (Figure 
1.3a).20 The COS/H2S donors showed significant cytotoxicity in BEAS 2B human lung 
epithelial cells when compared with the carbamate and triggerless control compounds or 
with equivalent concentrations of the H2S sources/donors Na2S, AP39, or GYY4137. 
Further investigations using bioenergetics assays revealed that the esterase- 
activated thiocarbamate donors inhibited mitochondrial respiration, whereas exogenous 
H2S or the triggerless and sulfur-depleted control compounds did not. Building from the 
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hypothesis that the observed cytotoxicity could be due to a buildup of COS in the 
mitochondria, due to faster rates of ester cleavage and self-immolation than COS 
hydrolysis by CA, we prepared a suite of esterase-triggered self-immolative 
thiocarbamates with esters of varying steric bulk. These esters displayed different rates of 
COS release, which correlated inversely with cytotoxicity in HeLa (human cervical cancer) 
cells. Again, the triggerless control and sulfur-depleted control compounds failed to show 
significant cytotoxicity, showing the utility of having readily accessible control 
compounds. These results support the hypothesis that COS may function as more than a 
simple H2S shuttle in certain circumstances; however, these observations do not account 
for differences in subcellular localization of different donors or differential activities of 
various CA isoforms toward COS.21 We do note that as a whole, most developed COS- 
releasing compounds appear to function as H2S donors, with activities directly attributable 
to the release of H2S. 
Shukla et al.22  further expanded work on enzyme- triggered donor platforms to 
 
develop donors activated by bacterial nitroreductase (NTR) (Figure 1.3b). NTRs are 
frequently found in bacteria and are also upregulated under hypoxic conditions in different 
cell types.23 The NTR-mediated reduction of the electron-withdrawing nitro groups on 
NTR-H2S to the corresponding aniline, with the nitrogen lone pair now free to resonate 
through to release the (imino)quinone methide, was used to reveal a geminal-dithiol 
intermediate that hydrolyzes in buffer to generate H2S (Figure 1.3a). H2S release was 
confirmed and measured in these systems by using monobromobimane and fluorescence 
assays. These  donors have  been used to study the  role  of H2S in the  intracellular redox 
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balance and the development of antibiotic resistance in bacteria, specifically Escherichia 
coli.22 
 
1.3 Reactive Oxygen Species-Activated Donors 
 
H2S exhibits anti-inflammatory activities and protective effects against reactive oxygen 
species (ROS), which has motivated a number of groups to develop H2S donors that are 
activated in the presence of ROS, such as H2O2. The cellular localization and levels of these 
ROS can vary in response to different stress states. In 2016, our group reported a caged 
thiocarbamate equipped with a pinacol boronate ester, Peroxy-TCM-OA, that self- 
immolates on exposure to H2O2 to release COS (Figure 1.4).24 
 
 
Figure 1.4 H2O2-activated COS donor scaffolds. 
 
 
These thiocarbamate donors are stable toward aqueous hydrolysis, but respond to H2O2, 
and to a lesser extent to superoxide and peroxynitrite, to release H2S. In these studies, H2S 
release was measured by using an H2S-responsive electrode, and fluorescence imaging in 
HeLa cells confirmed that the thiocarbamate donor could be activated in a biological 
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environment with either exogenous H2O2 or endogenous ROS. Cytotoxicity experiments 
showed that the donor provided cytoprotection against exogenous H2O2 treatment. The 
sulfur-depleted control compounds showed modest cytoprotection, due to H2O2 
consumption by the boronate moiety, whereas the triggerless control compounds failed to 
provide protection against H2O2 as expected. These experiments underscore the importance 
of having high fidelity control compounds to fully understand the mechanism of action of 
donor molecules. 
Expanding from this initial report, we reported experimental and computational 
investigations of all the COS-releasing isomers of boronate-functionalized thiocarbamates 
and thiocarbonates.25 We found that S-alkyl thiocarbamates, Peroxy-TCM-SA, released 
H2S slower than the analogous S-alkyl thiocarbonates, and that S-alkyl dithiocarbonate 
released H2S faster and more efficiently than the other S-alkyl derivatives. Further 
contributing to the understanding of COS/H2S release profiles, Chauhan et al.26 employed 
related S-alkyl boronate-functionalized thiocarbamates to demonstrate that the rate of 
H2O2-triggered COS release can additionally be tuned by the basicity of the amine payload. 
These investigations also demonstrated that alkyl amine payload, such as a propylamine, 
significantly reduced the rate of H2S release when compared with aryl amine payloads. 
More recently, Hu et al.27 further leveraged the boronate-functionalized self- 
immolative thiocarbamates to access the turn-on fluorescent H2S donor Peroxy-FL (Figure 
1.4). Exchanging the amine payload with the 3-amino-N-butyl-1,8-naphthalimide 
fluorophore allowed for the fluorescence of this system that is modulated by cleavage of 
the thiocarbamate motif to generate the parent aryl amine on the naphthalimide 
fluorophore. H2S generation was confirmed by using the methylene blue assay, and the 
11  
fluorescence response was demonstrated in both HeLa and RAW 264.7 (murine 
macrophage) cells. These donors released H2S in response to both exogenous and 
endogenous H2O2, as demonstrated in cell culture experiments. 
 
 
1.4 Hydrolysis-Based and pH-Sensitive Donors 
 
Numerous H2S donors are activated by hydrolysis mechanisms, and most of these 
respond through acid-mediated pathways. Figure 1.5 shows the structures of these donors 
and the pH value or ranges at which the compounds have been reported to release H2S. 
This class of H2S donors provides the unique opportunity to target specific diseases, cells, 
and/or organelles in which acidic microenvironments are present. As a simple example, 
thioacetamide can function as a pH–activated H2S donor in extremely acidic environments 
(pH 1.0) and was initially used for the precipitation of dissolved metals as metal sulfides 
from acidic solutions for qualitative analysis.28 We note that the inherent toxicity of 
thioacetamide has severely limited the use of this H2S donor in biological studies. 
As interest in the chemical biology of H2S has grown, the use of related thioamides 
as H2S donors has expanded to include various aryl thioamides, which are highlighted in a 
separate review.29 Other simple small molecules have also been reported as pH–activated 
H2S donors. For example, both thioglycine and thiovaline release H2S in the presence of 
bicarbonate (HCO3–) at physiological pH.30 Both of these thioamino acids were 
demonstrated to increase intracellular cyclic guanosine monophosphate levels and promote 
vasorelaxation in mouse aortic rings, with both being more efficacious and potent than 
GYY4137. 
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One of the most commonly used, GYY4137, is a water-soluble H2S donor that 
draws inspiration from Lawesson’s Reagent,31 which is traditionally used in organic 
synthesis to prepare various organosulfur compounds.32 The release of H2S from GYY4137 
occurs slowly at physiological pH, but it can be accelerated under acidic conditions (pH 
<3.0).33 Relative to other pH-sensitive H2S donors, the biological activities of GYY4137 
 
Figure 1.5 Hydrolysis-activated H2S donors. The pH windows shown represent specific 
pH values or pH windows in which H2S release was reported or in which H2S release was 
reported to be optimal. 
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have been studied extensively and are highlighted in a separate review.34 To tune the rate 
of pH-dependent H2S release from P=S motifs related to GYY4137, Park et al.35 
investigated the use of analogous phosphorodithioates as H2S donors. The inclusion of 
phenolic groups was found to enhance the rates of H2S release at physiological pH, whereas 
alkyl alcohols decreased the efficiency of H2S production consistent with the enhanced 
leaving group ability of phenols relative to alkyl alcohols. Moreover, pretreatment of H9c2 
mouse cardiomyocytes with these H2S donors provided significant cytoprotection against 
H2O2-induced oxidative damage. Interestingly, analogous experiments with GYY4137 
failed to provide similar results due to the inherent cytotoxicity of this donor at higher 
concentrations. 
In a follow-up study of phosphorodithioate-based H2S donors by Feng et al.,36 they 
prepared a library of derivative compounds and examined the H2S-releasing properties of 
these compounds. The cyclized derivative FW1256 displayed relatively high levels of H2S 
release and potent cytotoxicity against MCF7 breast cancer cells. In 2016, this concept was 
revisited by Kang et al.,37 leading to the design of GYY4137 derivatives, including JK-2, 
that bear a pendant nucleophile that can participate in an intramolecular cyclization to 
generate H2S.37 H2S release was demonstrated within a range of pH 5.0 to 8.0, with 
significant enhancements in releasing efficiency more than GYY4137. Moreover, 
treatment with JK-2 resulted in significant reductions in infarction size in a myocardial 
ischemia–reperfusion injury mouse model. 
In an alternative approach, our group recently reported pH-sensitive - 
ketothiocarbamate donors, including -KetoTCM-1, that function through intermediate 
COS release. This system was inspired by the use of 4-hydroxy-2-butanone esters to 
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prepare self-immolative carbamate polymers that undergo b-elimination to generate carbon 
dioxide as a function of pH.38 The release of H2S from -KetoTCM-1 was measured over 
a range of pH values (6.0–8.0), with increasing rates in more basic solution. The H2S 
release half-life could be modified by structural tuning, and the donors provided anti- 
inflammatory activity in RAW 264.7 cells.39 More recently, we reported a self-immolative 
thiocarbamate (S-pHTCM) with a pendant aryl imine trigger as a pH-sensitive donor that 
releases COS/H2S.40 Notably, this triggering motif was designed to be activated within a 
specific acidic pH window and showed optimal cleavage rates between pH 4.3 and 7.3. 
 
 
1.5 Thiol-Activated Donors 
 
Compounds activated by biological thiols, including cysteine and reduced GSH, 
represent the largest class of small-molecule H2S donors (Figure 1.6). The activation of 
many of these compounds proceed through persulfide intermediates, although others 
function through poorly understood mechanisms. The fundamental role and abundance of 
biological thiols, especially GSH, allows researchers to use these nucleophiles to probe the 
effects of H2S donor administration. 
Expanding from thioacetamide, many aryl thioamides have been reported as H2S 
donors. These compounds are stable at physiological pH and exhibit a cysteine-dependent 
H2S release, yet the mechanism of H2S release is unclear.29 The use of structurally related 
iminothioethers as cysteine-activated H2S donors was reported by Barresi et al.41 H2S 
release from these donors was evaluated in buffer containing 4 mM cysteine, and releasing 
efficiencies were dependent on donor derivatization. In isolated rat hearts, two donors were 




Figure 1.6 Structures of donor compounds activated in the presence of biological thiols. 
(a) H2S donors activated in the presence of cysteine. (b) H2S donors activated in the 
presence of cysteine and GSH. 
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flow, and studies on human aortic smooth muscle cells showed that these donors exhibited 
membrane hyperpolarizing effects. The mechanism of cysteine-mediated H2S release from 
iminothioethers remains unclear. 
Aryl isothiocyanates were first reported as cysteine-activated H2S donors in 2014 
by Martelli et al.42 Although release efficiency from these compounds was relatively low 
and required millimolar levels of cysteine for release, the isothiocyanates were found to 
cause membrane hyperpolarization of vascular smooth muscle cells and vasorelaxation in 
coronary arteries, both of which are consistent with H2S release. In 2019, Lin et al.43 
investigated the mechanism of H2S release from aryl isothiocyanates, and their data suggest 
that H2S release proceeds through a native chemical ligation-type mechanism after initial 
attack on the isothiocyanate by the cysteine sulfhydryl group. 
Also building from a native chemical ligation mechanistic approach,44 our group 
 
reported in 2018 that thionoesters, which are structural isomers of thioesters commonly 
used in native chemical ligation, respond selectively to cysteine over other thiols to release 
H2S with >80% efficiency.45 Mechanistic investigations demonstrated that the N-to-S acyl 
transfer step was the rate-limiting step of this reaction. We later expanded this approach to 
demonstrate that dithioesters, which are more synthetically diversifiable than thionoesters, 
release H2S selectively in the presence of cysteine.46 This approach has also been extended 
to provide fluorescent H2S donors activated in the presence of cysteine (CysP-1).47 
Proceeding through a key N-to-S acyl transfer step, Zhao et al.48 showed that acyl-protected 
geminal dithiols react selectively to release H2S in the presence of cysteine, through 
generation of an unstable geminal dithiol intermediate. Expanding to bioactive thioketone 
derivatives, Zhu et al.49  demonstrated during an investigation into the metabolism of 
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clopidogrel (Plavix) that an intermediate metabolite containing a thioenol motif releases 
H2S efficiently at physiological pH, suggesting possible future application of these and 
related compounds as H2S donor motifs. 
Also building from a native chemical ligation mechanistic approach,44 our group 
 
reported in 2018 that thionoesters, which are structural isomers of thioesters commonly 
used in native chemical ligation, respond selectively to cysteine over other thiols to release 
H2S with >80% efficiency.45 Mechanistic investigations demonstrated that the N-to-S acyl 
transfer step was the rate-limiting step of this reaction. We later expanded this approach to 
demonstrate that dithioesters, which are more synthetically diversifiable than thionoesters, 
release H2S selectively in the presence of cysteine.46 This approach has also been extended 
to provide fluorescent H2S donors activated in the presence of cysteine (CysP-1).47 
Proceeding through a key N-to-S acyl transfer step, Zhao et al.48 showed that acyl-protected 
geminal dithiols react selectively to release H2S in the presence of cysteine, through 
generation of an unstable geminal dithiol intermediate. Expanding to bioactive thioketone 
derivatives, Zhu et al.49 demonstrated during an investigation into the metabolism of 
clopidogrel (Plavix) that an intermediate metabolite containing a thioenol motif releases 
H2S efficiently at physiological pH, suggesting possible future application of these and 
related compounds as H2S donor motifs. 
Inspired by the unique reactivity of S–N motifs present in S-nitrosothiols, Zhao et 
al.50 developed a series of compounds termed “N-mercapto donors” and demonstrated H2S 
release in the presence of cysteine. The mechanism of H2S release from these donors 
proceeds through the N-acylation of cysteine and generation of cysteine persulfide as the 
key H2S-releasing intermediate. This class of donors was later expanded on in the 
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development of NHSD-2, which exhibited significant cardioprotective effects in a murine 
model of myocardial–ischemia reperfusion injury.51 Also leveraging the generation of 
intermediate persulfide motifs, Zhao et al.52 investigated the use of protected cysteine and 
penicillamine persulfide derivatives as H2S donors in the presence of cysteine and GSH. 
These compounds function by initial attack on the donor by cysteine to generate a cysteine 
persulfide, which undergoes subsequent reaction with thiols to generate H2S. These donors 
also provided H2S-related protection against in vivo murine models of myocardial 
ischemia–reperfusion injury. 
In a related approach, Foster et al.53 reported the related S-aroylthiooxime class of 
compounds, which release H2S in the presence of cysteine and can be tuned predictably by 
simple electronic modulation. H2S release from these compounds likely proceeds by initial 
attack by cysteine on the donor to release an iminothiol intermediate, which further reacts 
with cysteine to generate a cysteine persulfide intermediate en route to H2S release. More 
recently, the intermediate persulfide generation from S–X hybrid systems was further 
leveraged by Kang et al.54 to develop a series of cyclic sulfur–selenium compounds and by 
Hamsath et al.55 to develop acyclic sulfur–selenium compounds, which generate H2S- 
releasing persulfides and analogous selenylsulfides in the presence of cysteine. In an 
alternative approach, Roger et al.56 reported that dithioperoxyanhydrides also function as 
H2S donors through the intermediate generation of persulfides in the presence of GSH and 
cysteine. These compounds were demonstrated to induce vasorelaxation in isolated rat 
aortic rings. In general, the use of persulfides as H2S-releasing species has been of 
particular interest because a number of H2S signaling mechanisms involve persulfidation 
of cysteine residues. In parallel to these developments, different methods of direct 
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persulfide generation in water are of significant interest and advances in this area will be 
highlighted elsewhere.57 
An often overlooked yet uncontrolled method of generating H2S from persulfide 
intermediates is by treatment of organic polysulfides with thiols.58 The most widely used 
organic polysulfide, diallyl trisulfide (DATS), is a simple organosulfur compound readily 
isolated from alliums, including garlic.59 In the presence of thiols, DATS is reduced to 
generate allyl persulfide, which is further reduced by thiols to generate H2S. We note that 
although diallyl disulfide (DADS) is often used in the literature as an H2S donor, its 
apparent H2S-releasing activity has been demonstrated to be a result of a DATS 
impurities.60 Both experimental and computational results support the lack of direct H2S 
release from DADS in the presence of thiols, except for a minor, slow pathway involving 
attack at the -carbon by a thiol to generate an allyl persulfide intermediate.61 Consistent 
with this slow release, the generation of H2S from thioester donors reported by Yao et al.62 
is likely due to the intermediate release of allyl thiol and subsequent oxidation to form 
DADS, which results in slow H2S donation. 
Expanding investigations into H2S from organic polysulfides, our group recently 
reported bis(aryl) and bis(alkyl)tetrasulfides as H2S donors and demonstrated that 
tetrasulfides release more H2S than trisulfides, as expected.63 In comparing a series of 
benzyl di-, tri-, and tetra-sulfides,64 we confirmed cysteine and GSH-mediated H2S release 
occurs exclusively from dibenzyl trisulfide and dibenzyl tetrasulfide, which is consistent 
with the presence of sulfane sulfur.65 A related study by Ercole et al.66 highlighted the 
efficient release of H2S from polysulfide-based donors built around polyethylene 
glycol/trisulfide/cholesterol conjugates that assemble into supramolecular macrostructures. 
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COS-based H2S donors that are activated by thiols have also been reported. In 2018, 
we reported a small library of sulfenyl thiocarbonate motifs, including FLD-1 that 
undergoes thiol-mediated decomposition to generate COS.67 By using a fluorophore as a 
payload that is released upon COS/H2S donation, these donors provide a fluorescent 
response that correlates linearly with COS/H2S release and allows for spatiotemporal 
resolution of cellular COS/H2S release in live cell imaging. We also reported cysteine- 
selective COS-based H2S donors, such as OA-CysTCM-1, which utilized a cysteine- 
mediated cyclization to activate a self-immolative donor motif.68 A large library of 1,2,4- 
thiadiazolidine-3,5-diones was reported by Severino et al.69 that was demonstrated to 
release H2S in the presence of cysteine. We note that the proposed mechanism of donor 
activation in this system proceeds through an anionic thiocarbamate intermediate, which 
likely results in the direct release of COS with concomitant hydrolysis to H2S. 
 
 
1.6 Photoactivated Donors 
 
The ability to control H2S donation using external bio-orthogonal stimuli that 
selectively activate the desired compound in the presence of diverse biological functional 
groups is a powerful method that has garnered significant interest. Of such strategies, 
photoactivatable donors offer the potential for high spatiotemporal control of H2S release 
(Figure 1.7). Photocaged species react on exposure to specific wavelengths of light to 
cleave a protecting group and reveal, in these cases, an H2S-releasing moiety. This 
approach allows for noninvasive triggering of H2S release in cells in vitro and the potential 

















Figure 1.7 Structures and excitation wavelengths of selected photoactivable H2S donors. 
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The first photoactivated H2S donor Photo-gem-dithiol was reported by Devarie-Baez et 
al.,71 in which a bis-orthonitrobenzyl protected geminal-dithiol undergoes a Norrish type 
II rearrangement on irradiation (irr = 365 nm) to unmask an unstable gem-dithiol 
intermediate that is subsequently hydrolyzed to release H2S. Sulfide release was con- 
firmed by using the methylene blue assay, as well as through fluorescence imaging with 
HeLa cells. Moreover, these donors displayed pH-dependent H2S release, consistent with 
other donors involving hydrolysis of gem-dithiols, an acid-mediated process. Similar 
photocleavable gem-dithiol scaffolds (irr = 365 nm) have since been incorporated into 
water-soluble polymers and block copolymer nanoparticles,72 as well as upconverting 
nanoparticles, which absorb low-energy near- infrared light (irr = 980 nm) and emit 
ultraviolet to visible light, that can trigger H2S release.73 
An alternative photocontrollable H2S donor was reported by Fukushima et al.,74 
which centers around a functionalized thioether that releases H2S directly after photo- 
cleavage of the protecting groups, rather than relying on a subsequent hydrolysis step. 
Initially employing 2-nitrobenzyl photoactivatable groups, this approach was expanded to 
incorporate ketoprofenate photocages to avoid the production of the potentially deleterious 
2-nitrosobenzaldehyde byproduct. These donors were further adapted to function by 
photoexcitation (irr = 325–385 nm) of xanthone chromophores.75 Photocaged 
thiobenzaldehydes have also been used as light-activated H2S donors. In these systems, 
irradiation (irr = 355 nm) reveals a thiobenzaldehyde intermediate that requires a 
subsequent nucleophilic attack by an amine to liberate the H2S.76 Such donors have been 
incorporated into both water-soluble H2S releasing polymers and hydrogels. One benefit 
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of this approach is that the byproduct of photolysis is simply acetophenone, which is a 
benign and Food and Drug Administration-approved excipient. 
Expanding to visible light photoexcitation, Yi et al.77 harnessed the 
 
photogeneration of singlet oxygen to trigger H2S release. Irradition (irr = 500–550 nm) of 
a photosensitizer in the presence of ambient oxygen and 1,3-diphenylisobenzothiophene 
generated an unstable endoperoxide intermediate, which undergoes rapid fragmentation to 
generate 2-benzoylbenzophenone and H2S.77 This system was incorporated into artificial 
vesicles or polymersomes, which enabled H2S generation in water. An interesting 
advantage of this system is that the photoirradiation wavelengths are dictated by the choice 
of photosensitizer rather than the donor itself, which allows for a broad range of 
wavelengths to be used (ex = 380–550 nm demonstrated). 
A number of photoactivatable COS-based H2S donors have also been reported. In 
2017, our group reported the first light-activated COS-based H2S donor, PhotoTCM-1, in 
which an o-nitrobenzyl protecting group masked a caged thiocarbamate, which was 
cleaved on irradiation (irr = 365 nm) to release COS.78 PhotoTCM-1 was also shown 
through a series of selectivity studies to be stable to relevant biological thiols and 
nucleophiles, releasing COS only on photoirradiation. This strategy was later expanded by 
Sharma et al.79 with a BODIPY-based photolabile group protecting an S-alkyl 
thiocarbamate that releases COS under irradiation at a more biocompatible wavelength (irr 
= 470nm) (BODIPY-TCM- 1). More recently, efforts in this area have been focused on 
developing light-activated donors that function within a “tissue-transparent” window, the 
bounds of which are set by the absorbance of hemoglobin below 600 nm and of water 
above 900 nm.80 This goal was accomplished by Stacko et al.81 using a COS-based delivery 
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approach coupled to a modified BODIPY core protecting an S-alkyl thiocarbamate. COS 
release from BODIPY-TCM-2 was accomplished with longer wavelength irradiation (irr 
= 700 nm), which is a significant improvement over prior COS donors. 
 
In a hybrid system, Woods et al.82 reported a red-light activated complex of GYY- 
4137 and a common ruthenium photocage (Ru-GYY) that releases H2S on irradiation (irr 
= 626nm). Interestingly, although GYY-4137 is known to spontaneously hydrolyze in 
aqueous systems, complexation to the ruthenium metal center suppresses this H2S release. 
The authors were thus able to demonstrate controlled H2S release from this donor, as well 
as its activity against a model of ischemia–reperfusion injury in H9c2 heart myoblast cells. 
The Singh lab recently reported a novel optical-readout-based phototriggered H2S donor. 
Harnessing excited-state intramolecular proton transfer, which had been previously applied 
to monitoring nitric oxide donation83 among other analytes, they developed a p- 
hydroxyphenacyl triggered donor that releases H2S under irradiation (irr = 410 nm), while 
simultaneously shifting the fluorescence of the donor.84 This change in fluorescence 
allowed for H2S release to be monitored, and it was demonstrated to function in HeLa cells. 
 
 
1.7 Miscellaneous Activatable Donors 
 
In addition to the compounds described earlier in this review, a number of H2S 
donors that are triggered by specific stimuli have been reported and do not correspond to 
the categories outlined earlier (Figure 1.8). For example, our group reported the initial 
demonstration of leveraging intermediate COS release to access H2S donors by developing 
self-immolative thiocarbamates, which we incorporated into analyte replacement 
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fluorescent probes (Figure 1.8a).16 This donor serves as an analyte-replacement probe, as 
it regenerates the consumed H2S during the mechanism of release. 
 
 
Figure 1.8 Structures of COS-based donor compounds activated by miscellaneous 
activators. (a) H2S-activated analyte replacement probe. (b) “Click and release” 
bioorthogonal COS-based H2S donor. (c) Activation of N-thiocarboxyanhydride by glycine 
to generate H2S. 
 
 
In a bioorthogonal delivery approach, we also demonstrated that self-immolative 
thiocarbamates bearing a trans-cyclooctene moiety can be utilized as “click and release” 
COS-based H2S donors in the presence of tetrazines undergoing an inverse-electron 
demand Diels–Alder reaction (Figure 1.8b).85 Such bioorthogonal approaches leverage the 
bimolecular reaction between two specific components to form a chemical bond while 
remaining inert to common reactive functional groups present in the surrounding biological 
milieu.86 The development of N-thiocarboxyanhydrides (NTA) by Powell et al.87 provides 
an alternative to self-immolative thiocarbamates (Figure 1.8c). This donor scaffold was 
demonstrated to release COS and generate a peptide byproduct in the presence of glycine 
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and has recently been leveraged to develop a number of macromolecular H2S donors,88 
which is the topic of another review.89 One benefit of the NTA-based approach is that donor 
activation does not release electrophilic byproducts such as a p-quinone methide, which 
are often found in other self-immolative COS-based donors. 
 
 
1.8 Conclusions and Outlook 
 
The development of activatable small-molecule H2S donors has been one of the most 
significant advances in the field of H2S chemical biology over the past 5 to 10 years. This 
palette of activatable H2S donors provides researchers with a toolbox to better probe the 
biological activities of H2S. The range of activators for controlled H2S release has grown 
significantly in the past 5 years, and it is poised to enable new types of biological 
investigations that are not feasible with simple sulfide salts. Key needs include broader 
comparisons of different classes of donors in specific biological contexts to better delineate 
the bioavailability and localized release of H2S from different donor constructs. Moreover, 
H2S-releasing dynamics measured in vitro are likely to be perturbed in a biological system 
and may significantly alter the biological viability of these donors. As the chemistry that 
enables triggered release of H2S and related reactive sulfur species from synthetic donors 
continues to evolve, the development of donors that respond to molecular stimuli up- 
regulated during specific disease states is likely to provide new tools to harness the 
therapeutic potential of H2S, alongside more finely tuned organelle or cell-type specific 
targeted donors. Overall, the rapid expansion of chemistry that enables small-molecule H2S 
donors is poised to advance the field and help elucidate the inherent complexities of 
reactive sulfur species in biology. 
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In parallel to the growing number of physiological processes involving H2S-based 
signaling, the development of small molecule H2S donors as chemical tools to better 
understand the biological effects H2S and related reactive sulfur species has rapidly 
expanded. The research discussed in this dissertation highlights contributions to thiol- 
activated, small molecules capable of generating H2S directly and through the intermediate 
generation of COS or persulfides (Chapters II through VI). In the interest of investigating 
the potential signaling role of COS independent of H2S, Chapter VII discusses the 
development of a fluorescent probe selective for COS detection. Chapters I through VI 






THIONOESTERS: A NATIVE-CHEMICAL LIGATION INSPIRED APPROACH 
TO CYSTEINE-TRIGGERED H2S DONORS 
 
 
This chapter includes previously published and coauthored material from Cerda, M.M.; 
Zhao, Y.; Pluth, M.D. Thionoesters: A Native Chemical Ligation Inspired Approach to 
Cysteine-Triggered H2S Donors. J. Am. Chem. Soc. 2018, 140 (39), 12574-12579. This 
manuscript was written by Matthew M. Cerda with editorial assistance from Professor 
Michael D. Pluth. The project in this chapter was conceived by Matthew M. Cerda with 
insight from Dr. Yu Zhao. The experimental work in this chapter was performed by 





Hydrogen sulfide (H2S) is now recognized as an important biological signaling 
molecule90 that is produced endogenously, cell membrane permeable, and reactive toward 
cellular and/or molecular targets.1c The endogenous production of H2S stems primarily 
from catabolism of cysteine and homocysteine by cystathionine β-synthase (CBS), 
cystathionine γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3-MST).91 
Recently, increasing interest has focused on harnessing H2S as a potential therapeutic 
agent92 based on its role in vasodilation,93 neurotransmission,94 and angiogenesis.95 
Although the majority of prior reports have used sodium hydrosulfide (NaSH) or sodium 
sulfide (Na2S) as sources of H2S, the addition of these salts to a buffer leads to an almost 
29  
instantaneous increase in H2S concentration, which is in stark contrast to the slow, gradual 
endogenous production of H2S.96 In efforts to provide more physiologically relevant rates 
of H2S release, researchers have developed different types of H2S-releasing molecules 
(Figure 2.1a).2f, 15d, 15f 
 
 
Figure 2.1 (a) Representative examples of common synthetic, small molecule H2S donors; 
(b) selected small molecule, thiol-triggered H2S donors. 
 
 
For example, Lawesson’s Reagent and related derivatives33, 37 have been used as 
hydrolysis-activated H2S donors that function at physiological pH, and dithiolethiones, 
such as ADT–OH, have been conjugated to nonsteroidal anti-inflammatory drugs 
(NSAIDs) to access H2S prodrug conjugates.12b More recently, “triggered-release” 
scaffolds have also been reported, including those activated by light71 and enzymatic 
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activation.17 In addition, recent work has demonstrated that carbonyl sulfide (COS)- 
releasing scaffolds can also function as H2S donors via the rapid conversion of the released 
COS to H2S by carbonic anhydrase.16 
Drawing parallels to the enzymatic conversion of cysteine or homocysteine to H2S, 
a number of H2S donor motifs have been developed that are activated by thiols, such as 
cysteine and reduced glutathione (GSH) (Figure 2.1b). Polysulfides, such as the commonly 
used diallyl trisulfide (DATS)59 or more recently reported synthetic trisulfides66 and 
tetrasulfides63 release H2S in the presence of thiols via an intermediate persulfide. Building 
in complexity, Xian and co-workers have reported thiol-triggered H2S donors based on 
protected N-mercaptan51 or persulfide52 platforms. Similarly, Matson and co-workers 
reported S-aroylthiooxime compounds,53 which generate a thiol-reactive intermediate 
thiooxime. Thiol-mediated H2S release from arylthioamides29 and aryl isothiocyanates42 
has also been reported, although the mechanisms of H2S release remains uninvestigated 
and low releasing efficiencies (∼2% and 3%, respectively) are observed. To the best of our 
knowledge, the only reported cysteine-selective H2S donor utilizes the established 
reactivity of acrylate Michael acceptors toward cysteine,97 to subsequently trigger the 
generation of COS, which is quickly converted to H2S by carbonic anhydrase.68 
To further the development of thiol-triggered H2S donors, we were inspired by the 
well-established chemistry of native chemical ligation due to the high biological 
compatibility and presence of a sulfur atom. Native chemical ligation is the chemoselective 
reaction between a thioester and an N-terminal cysteine residue to generate a new amide 
bond.44 This reaction has been applied extensively in the field of protein synthesis, 
including in the semisynthesis of a potassium channel protein.98 The mechanism of this 
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important ligation reaction begins by the nucleophilic addition of a cysteine sulfhydryl 
group to form an intermediate thioester, which then undergoes a rapid S to N acyl transfer 




Figure 2.2 Generalized reaction scheme for native chemical ligation and release of H2S 
upon addition of cysteine to a bis(phenyl) thionoester. 
 
 
Despite the broad use of thioesters as activated coupling partners for native chemical 
ligation, to the best of our knowledge there have not been investigations into similar 
reactions with thionoesters, which are a constitutional isomer of thioesters. Building from 
our interest in the chemistry of reactive sulfur species,2b, 58, 100 we hypothesized that 
thionoesters would undergo a similar reaction pathway in the presence of cysteine, but 
would also generate H2S during the S to N acyl transfer step of the reaction. Such reactivity 
would not only provide access to new H2S-releasing motifs but also provide insights into 
new mechanisms of chemical ligation that could be accessed by simple interchange of 
oxygen and sulfur atoms in a reactive electrophile. Additionally, such platforms are also 
attractive because they mimic the enzymatic conversion of cysteine to H2S. Herein, we 
present a mechanistic and kinetic investigation of thionoesters with cysteine and related 
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species and also demonstrate that thionoesters function as cysteine-selective H2S donors 
that proceed through a native chemical ligation-type mechanism. 
 
 
2.2 Results and Discussion 
 
To prepare a model thionoester system, we treated phenyl chlorothionoformate 
with phenylmagnesium bromide at −78 °C in anhydrous THF to yield O-phenyl 
benzothioate (DPTE).101 Despite previous reports,102 we found that treatment of phenyl 
benzoate with Lawesson’s reagent required extended reaction times and afforded 
undesirable yields, which is consistent with the predicted decrease in reactivity of esters 
toward Lawesson’s reagent.103 The structure and purity of DPTE were confirmed by NMR 
spectroscopy and HPLC (Appendix B). To determine whether thionoesters are a viable 
platform for H2S release, we added 25 μM DPTE to buffered aqueous solutions (10 mM 
PBS, pH 7.4) containing varying concentrations of cysteine (25–500 μM) and monitored 
H2S generation using the spectrophotometric methylene blue assay (Figure 2.3a).104 
Consistent with our design hypothesis, we observed an increase in H2S release from DPTE 
at higher cysteine concentrations, suggesting that thionoesters are a viable platform for 
cysteine-triggered H2S donation. 
To assess the H2S-releasing efficiency from thionoesters, we used a methylene blue 
calibration curve to quantify the H2S release (Figure B.8). We measured that 20 μM of H2S 
was released from a 25 μM solution of DPTE in the presence of 500 μM cysteine (20 
equiv.), which corresponds to a releasing efficiency of 80%. In addition to the thionoester 
system, we also investigated H2S release from structurally related diphenyl ester (2) and 
diphenyl thioester (3) compounds under our conditions (Figure 2.3b). As expected, neither 
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of these compounds released H2S when treated with excess cysteine. Similarly, a 
representative secondary thioamide (4) failed to release H2S in the presence of cysteine, 
suggesting the release of H2S occurs exclusively from the thionoester moiety in the 
presence of cysteine. 
 
Figure 2.3 (a) Release of H2S from DPTE in the presence of increasing cysteine 
concentrations (25, 125, 250, and 500 M) in 10 mM PBS (pH 7.4) at 25 °C. (b) Lack of 
H2S release from structurally related compounds (25 M) in the presence of cysteine (500 
mM, 20 equiv.). 
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To further investigate the selectivity of H2S release from thionoesters, we treated 
 
DPTE with other biologically relevant nucleophiles (Figure 2.4).105 
 
 
Figure 2.4 Selectivity of H2S release from DPTE in the presence of different analytes. Data 
were acquired at 1, 5, 10, 15, 30, 45, and 60 min. Methylene blue absorbance values are 
relative to the maximum absorbance value obtained from H2S release in the presence of 
cysteine (1). Analytes: H2O/PBS buffer (2), serine (3), lysine (4), L-homocysteine (5), DL- 
penicillamine (6), L-cysteine methyl ester hydrochloride (7), N-acetyl-L-cysteine (8), N- 
acetyl-L-cysteine methyl ester (9), S-methyl-L-cysteine (10), GSH (11), cysteine + GSH 
(12), cysteine + lysine (13), PLE (1.0 U/mL) (14). 
 
 
In the absence of any added nucleophiles, no hydrolysis-mediated H2S release was 
observed from DPTE at physiological pH, although we note prior reports show that 
thionoesters are hydrolyzed under basic conditions to afford the corresponding thioacid 
and alcohol.106 Treatment of DPTE with serine or lysine, chosen as representative alcohol- 
and amine-based nucleophiles respectively, did not result in H2S release, although prior 
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reports suggest that amines can react with thionoesters to yield thioamides via displacement 
of the corresponding alcohols.107 To investigate this potential side reactivity, cysteine- 
triggered (500 μM) H2S release from DPTE (25 μM) was measured in the presence of 
lysine (500 μM) and we observed no change in H2S-releasing efficiency. We also 
investigated the reactivity of DPTE with thiol-based nucleophiles. Treatment of DPTE 
with homocysteine also resulted in H2S release, although at a slower rate than from 
treatment with cysteine. This observation is consistent with a larger, less favorable 
transition state required for an intramolecular S to N acyl transfer in the homocysteine 
system in comparison with the cysteine system. Alternatively, the reduced rate may be 
reflective of the significant pKa difference between cysteine (pKa ≈ 8.5) and homocysteine 
(pKa ≈ 10),108 meaning that, under physiological conditions, the effective concentration of 
cysteine thiolate is much greater than homocysteine thiolate (∼10% vs ∼0.03%). 
Surprisingly, treatment of DPTE with penicillamine did not result in H2S release. We 
anticipated that geminal methyl groups would help to preorganize the intermediate 
dithioester generated after nucleophilic attack and would result in faster H2S release.109 
However, the geminal methyl groups also likely significantly reduce the nucleophilicity of 
the thiol moiety due to steric congestion, which would subsequently disfavor the initial 
nucleophilic attack on the thionoester. 
We also investigated whether different cysteine derivatives could generate H2S 
release from DPTE to further understand the requirements for H2S release from 
thionoesters. Treatment of DPTE with cysteine methyl ester did not affect H2S production, 
suggesting that the carboxylic acid is not required for H2S generation. By contrast, 
treatment of DPTE with N-acetylcysteine, N-acetylcysteine methyl ester, or S- 
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methylcysteine completely abolished H2S release, highlighting the requirement of a 2- 
aminoethanethiol moiety for productive H2S release. Consistent with these results, 
treatment of DPTE with GSH, the most abundant biological thiol, did not generate H2S, 
which is consistent with the requirement of a pendant amine to generate H2S release. 
Despite the lack of H2S release, we anticipated that GSH would still attack DPTE to form 
an intermediate dithioester, which should still be sufficiently electrophilic to react with 
cysteine to generate H2S. To test this hypothesis, we treated DPTE (25 μM) with GSH (1 
mM) and cysteine (500 μM) and observed a reduced rate of H2S release. These results 
suggest that the competitive, nonproductive, addition of GSH to the thionoester is 
reversible, and that the thionoester moiety can still react with Cys in the presence of GSH 
to release H2S. Adding to the selectivity investigations, treatment of DPTE with porcine 
liver esterase (PLE) failed to generate H2S; however, we cannot rule out consumption of 
the thionoester moiety by PLE or other native enzymes. Taken together, these results 
demonstrate the high selectivity of the thionoester moiety toward cysteine and 
homocysteine for H2S release. 
Building from the selectivity studies, as well as from the established mechanism of 
native chemical ligation, we proposed a mechanism for cysteine-mediated H2S release 
from thionoesters (Scheme 2.1). Initial nucleophilic addition by cysteine on 1 generates 
tetrahedral intermediate 5, which collapses to form dithioester intermediate 6 and extrude 
1 equiv. of phenol. Similar to native chemical ligation, subsequent nucleophilic attack by 
the pendant amine on the thiocarbonyl leads to the formation of substituted thiazolidine 7. 
Loss of H2S, by either direct extrusion of HS– or solvent-assisted extrusion of H2S, results 
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Scheme 2.1 Proposed mechanism of H2S release from DPTE in the presence of cysteine 
As a first step toward investigating our proposed mechanism, we determined the 
 
reaction order in cysteine by treating DPTE (25 μM) with varying concentrations of 
cysteine under pseudo-first-order conditions at 25 °C and measuring H2S release using the 
methylene blue assay (Figure 2.5). As expected, we observed that increased cysteine 
concentrations led to increased rates of H2S production. The resultant releasing curves were 
fit to obtain pseudo-first-order rate constants (kobs), and plotting log[Cys] versus log[kobs] 
confirmed a first-order dependence in cysteine, which is consistent with our proposed 
mechanism. Additionally, the obtained kobs values were plotted against Cys concentrations 
to obtain a second-order rate constant of 9.1 ± 0.3 M–1 s–1 for the reaction. In comparison 
to other known reactivities, the rate of cysteine-triggered H2S release from DPTE is 
comparable to the rate (10–100 M–1 s–1) of copper(I)-catalyzed azide–alkyne 
cycloadditions (CuAAC), a classic example of a “click reaction”.110 
To further evaluate our proposed mechanism, we sought to identify the rate- 
determining step in cysteine-triggered release of H2S from thionoesters. In native chemical 
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ligation, the initial nucleophilic attack by thiols to form intermediate thioesters is reversible 
and has been utilized to enhance the reactivity of alkyl thioesters for native chemical 
ligation. However, in the presence of cysteine, the transthioesterification resulting from 
 
Figure 2.5 (a) H2S release by DPTE in the presence of increasing cysteine concentrations 
(250, 500, 1000, and 1250 μM). (b) Plot of log(kobs) vs log([Cys]) for DPTE. (c) Plot     
of kobs vs [Cys]. 
 
 
nucleophilic attack of the sulfhydryl group on the thioester is thought to be rate-limiting 
due to the rapid and irreversible subsequent S to N acyl transfer to form the more 
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thermodynamically stable amide bond.99 In the thionoester system, the initial attack by a 
thiol on DPTE results in extrusion of phenol, which is a much weaker nucleophile than a 
thiol and should not attack the generated dithioester intermediate. If other thiols are present 
in solution, then it is likely that they could attack the dithioester intermediate in a 
transdithioesterification reaction. This thiol exchange is supported by the observed reduced 
rate of H2S generation from DPTE in the presence of competing thiols, suggesting that the 
initial nucleophilic attack on dithioesters is reversible. 
Using similar pseudo-first-order conditions as those used for the cysteine order 
dependence investigations (25 μM DPTE, 500 μM cysteine), we performed an Eyring 
analysis to determine the activation parameters for the reaction in an effort to further 
understand the amount of disorder in the rate-limiting transition state for the reaction 
(Figure 2.6). Our expectation was that if initial thiol addition is the rate-limiting step, then 
 
 
Figure 2.6 (a) Effect of temperature on rate of H2S release from DPTE (25 μM) in the 
presence of cysteine (500 μM, 20 equiv). (b) Eyring analysis of H2S release from DPTE. 
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we would observe a negative entropy of activation (ΔS‡) of approximately −20 eu, which 
is typical for a bimolecular reaction. In contrast, if the intramolecular S to N thioacyl 
transfer to form the substituted thiazolidine is the rate-limiting step, then we would expect 
a larger, more negative ΔS‡ due to the highly ordered structure required for the 
intramolecular cyclization. Under our experimental conditions, we observed ΔS‡ = −38 ± 
3 eu, which is most consistent with intramolecular cyclization being the rate-determining 
step of the reaction. 
As a final step of characterizing the proposed mechanism, we performed a 
preparative scale reaction and isolated the reaction products. In addition to recovered 
starting material, we isolated a cysteine-derived dihydrothiazole (CysDHT) rather than N- 
benzoyl-L-cysteine as the major product of the reaction (Figure 2.7). These results suggest 
that the dihydrothiazole is stable under aqueous conditions and is not further hydrolyzed to 
N-benzoyl-L-cysteine. To further confirm the formation of CysDHT from DPTE, we 
synthesized an authentic sample of CysDHT and used HPLC to monitor the reaction 
progress. We treated a 100 μM solution of DPTE with 20 equiv. of L-cysteine methyl ester 
and observed nearly complete conversion to phenol and CysDHT within 1 h. Using known 
concentrations of phenol and CysDHT to construct an HPLC calibration curve, we 
measured that the concentrations of phenol and CysDHT after 1 h were approximately 76 
μM and 64 μM, respectively, which supports the high H2S-releasing efficiency of 
thionoesters. Although we were initially surprised by the inherent stability of the 
dihydrothiazole product, we note that biological formation of the dihydrothiazole moiety 
is a known post-translation modification of cysteine residues in bacteria.111 For example, 
the cyclodehydration of internal cysteine residues results in formation of Fe(III)- 
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coordinating dihydrothiazole, which is commonly found in sideophores,112 such as 
yersiniabactin113 and pyochelin.114 Additionally, adjacent dihydrothiazole moieties can be 
oxidized to a bis(thiazole), and the planarity of this motif allows for intercalation of DNA 
as seen in bleomycin.115 Taken together, these observations highlight the biological 
significance of the dihydrothiazole motif and provides new areas of investigation using this 
established reactivity. 
 
Figure 2.7 (a) Reaction conditions; (b) 100 μM DPTE in 10 mM PBS (pH 7.4) with 10% 
THF; (c) 100 μM PhOH in 10 mM PBS (pH 7.4) with 10% THF; (d) 100 μM CysDHT in 




By investigating the reactivity of DPTE with cysteine, we not only demonstrated 
the inherent reactivity of thionoesters toward cysteine in a native chemical ligation-type 
mechanism but also demonstrated that this functional group provides a novel platform for 
highly efficient H2S donation. We demonstrated that this reaction occurs at rates similar to 
those for the commonly used Cu(II)-mediated azide/alkyne click reaction, with a second- 
order rate constant of 9.1 ± 0.3 M–1 s–1. Our mechanistic investigations suggest that, in 
comparison to native chemical ligation, the rate-determining step has been shunted from 
the addition of cysteine to the intramolecular S to N thioacyl transfer. Taken together, these 
investigations demonstrate that thionoesters are a novel, cysteine-triggered H2S releasing 
scaffold. Additionally, the high selectivity of DPTE toward cysteine warrants future 
exploration into the thionoester functional group for cysteine-selective reactive probes. 
The chemistry and established reactivity of DPTE in the presence of cysteine 
provided a platform for efficient, thiol-activated H2S release from a simple donor scaffold. 
However, the ability to tune the rate of H2S release from thionoesters is limited by the lack 
of synthetic accessibility to structurally diverse thionoesters. A critical analysis of the 
proposed H2S-releasing mechanism from DPTE revealed the intermediate formation of a 
dithioester, a well-established structural motif in the field of polymer chemistry. Given the 
structural similarity between thionoesters and dithioesters, we hypothesized dithioesters 
would provide similar reactivity to generate H2S in the presence of cysteine and could 
readily be tuned by structural modifications. Chapter III discusses the use of dithioesters 
as cysteine-activated H2S donors and ability to tune H2S release by simple alkyl 
functionalization. 
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2.4 Experimental Details 
 
2.4.1 Materials and Methods 
 
Reagents were purchased from Sigma-Aldrich, Tokyo Chemical Industry (TCI) or VWR 
and used directly as received. S-Phenyl benzothioate was synthesized according to a 
previous report.116 N-phenylthiobenzamide was synthesized according to a previous 
report.117 Methyl 2-phenyl-4,5-dihydrothiazole-4-carboxylate (CysDHT) was synthesized 
according to a previous report.118 Deuterated solvents were purchased from Cambridge 
Isotope Laboratories and used as received. 1H and 13C{1H} NMR spectra were recorded on 
a Bruker 500 MHz instrument. Chemical shifts are reported relative to residual protic 
solvent resonances. Silica gel (SiliaFlash F60, Silicycle, 230-400 mesh) was used for 
column chromatography. All air-free manipulations were performed under an inert 
atmosphere using standard Schlenk technique or an Innovative Atmospheres N2- filled 
glove box. UV-Vis spectra were acquired on an Agilent Cary 60 UV-Vis 
spectrophotometer equipped with a Quantum Northwest TC-1 temperature controller at 25 
°C ± 0.05 °C. 
 
 
H2S Detection Materials and Methods 
 
Phosphate buffered saline (PBS) tablets (1X, CalBioChem) were used to prepare buffered 
solutions (140 mM NaCl, 3 mM KCl, 10 mM phosphate, pH 7.4) in deionized water. Buffer 
solutions were sparged with N2 to remove dissolved oxygen and stored in an N2-filled 
glovebox. Donor stock solutions (in DMSO) were prepared inside an N2-filled glovebox 
and stored at -25 °C until immediately before use. Trigger stock solutions (in PBS) were 
freshly prepared in an N2-filled glovebox immediately before use. 
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High Performance Liquid Chromatography (HPLC) Analysis 
 
HPLC analysis was performed on an Agilent 1260 HPLC instrument with a Poroshell 120 
EC-C18 4.6x100 mm column and monitored at 280 nm. Solvent A: 95% H2O, 5% MeOH, 
Solvent B: 100% MeCN. Gradient: 35% Solvent A/65% Solvent B for 2 min. Change to 
100% Solvent B over 4 min and hold for 6.5 min. Change to 35% Solvent A/65% Solvent 
B over 0.5 min and hold for 4.5 min. Flow Rate: 0.5 mL/min, 2 L injection. 
 
General Procedure for Measuring H2S Release via Methylene Blue Assay (MBA) 
Scintillation vials containing 20 mL of PBS were prepared in an N2-filled glovebox. To 
these solutions, 20 L of 500 mM analyte stock solution (in PBS) was added for a final 
concentration of 500 M. While stirring, the solutions were allowed to thermally 
equilibrate in heating block at the desired temperature for approximately 20-30 min. 
Immediately prior to donor addition, 0.5 mL solution of the methylene blue cocktail were 
prepared in disposable 1.5 mL cuvettes. The methylene blue cocktail solution contained: 
200 L of 30 mM FeCl3 in 1.2 M HCl, 200 L of 20 mM N,N-dimethyl-p-phenylene 
diamine in 7.2 M HCl, and 100 L of 1% (w/v) Zn(OAc)2. To begin an experiment, 20 L 
of 25 mM donor stock solution (in DMSO) was added for a final concentration of 25 M. 
At set time points after the addition of donor, 500 L reaction aliquots were added to the 
methylene blue cocktail solutions and incubated for 1 h at room temperature shielded from 
light. Absorbance values at 670 nm were measured 1 h after addition of reaction aliquot. 
Each experiment was performed in quadruplicate unless stated otherwise. 
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MBA Calibration Curve 
 
Solutions containing 0.5 mL of the methylene blue cocktail and 0.5 mL PBS containing 
500 M cysteine were freshly prepared in disposable cuvettes (1.5 mL). Under inert 
conditions, a 10 mM stock solution of NaSH (Strem Chemicals) in PBS was prepared and 
diluted to 1 mM. Immediately after dilution, 1 mM NaSH was added to 1.0 mL solutions 
for final concentrations of 10, 20, 30, 40, and 50 M. Solutions were mixed thoroughly, 
incubated at room temperature for 1 h, and shielded from light. Absorbance values at 670 
nm were measured after 1 h. (Figure B.7) 
 
 




Scheme 2.2 Preparative scale synthesis of CysDHT from DPTE 
 
 
DPTE (0.39 mmol, 1.0 equiv.) was dissolved in 15 mL of 2:1 THF/PBS (10 mM, pH 7.4). 
L-cysteine methyl ester hydrochloride (1.17 mmol, 3.0 equiv.) was added in a single 
portion and stirred at room temperature for 2 h. The reaction mixture was diluted with 
deionized H2O (~20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic 
extracts were washed with brine and dried over MgSO4. After filtration, the solvent was 
removed under reduced pressure, and the purified by preparative thin layer 
chromatography (1:1 CH2Cl2 in hexanes). DPTE Rf = 0.75 (63.6 mg, 76%) and CysDHT 
Rf = 0.03 (11.0 mg, 13%) were isolated and characterized by 1H and 13C{1H} NMR 
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spectroscopy. The significant recovery of DPTE is likely due to the lack of buffering 
capacity in the preparative-scale reaction. 
 
 




Scheme 2.3 Synthesis of CysDHT from DPTE for reaction product analysis by HPLC 
 
 
To a 20 mL solution of 10% THF in PBS (10 mM, pH 7.4) containing 2 mM L-cysteine 
methyl ester (20 equiv.), 20 L of 100 mM DPTE in THF was added and stirred at room 
temperature. After 1 h, a 1 mL reaction aliquot was analyzed by HPLC. HPLC analysis 
was performed on an Agilent 1260 HPLC instrument with a Poroshell 120 EC-C18 4.6x100 
mm column and monitored at 280 nm. Solvent A: 95% H2O, 5% MeOH, Solvent B: 100% 
MeCN. Gradient: 35% Solvent A/65% Solvent B for 2 min. Change to 100% Solvent B 
over 4 min and hold for 6.5 min. Change to 35% Solvent A/65% Solvent B over 0.5 min 
and hold for 4.5 min. Flow Rate: 0.5 mL/min, 4 L injection. The concentration of 
CysDHT and phenol present at the end of the reaction were determined by measurement 






Scheme 2.4 Synthesis of O-phenyl benzothioate (DPTE) 
 
 
O-Phenyl benzothioate (DPTE) was synthesized using a slightly-modified procedure.116 
Phenyl chlorothionoformate (14.8 mmol, 1.1 equiv.) was added to anhydrous THF (20 mL) 
at -78 °C under N2. While stirring, phenylmagnesium bromide (12.8 mmol, 1.0 M in THF, 
1.0 equiv.) was added dropwise, and the reaction solution was stirred for 1 h at -78 °C. 
After 1 h, the reaction solution was allowed to warm to room temperature and stirred for 
an additional 2 h. The reaction was then quenched by addition of deionized H2O (30 mL) 
and extracted with CH2Cl2 (3 x 30 mL). The combined organic extractions were washed 
with brine (30 mL) and dried over MgSO4. After filtration, the solvent was removed under 
reduced pressure, and the desired product purified by column chromatography (10% 
CH2Cl2 in hexanes, Rf = 0.33). The resultant product was isolated as a bright orange- 
yellow liquid. 938 mg (34%). H NMR (500 MHz, CDCl3) δ: 8.37 (d, J = 7.3 Hz, 2 H), 7.63 
(t, J = 7.5 Hz, 1 H), 7.48 (q, J = 7.2 Hz, 4 H), 7.33 (t, J = 7.4 Hz, 1 H), 7.14 (d, J = 7.5 Hz, 
2 H). 13C{1H} NMR (126 MHz, CDCl3) δ: 211.22, 155.03, 138.11, 133.46, 129.76, 129.44, 






DITHIOESTERS: SIMPLE, TUNABLE, CYSTEINE-SELECTIVE H2S DONORS 
 
 
This chapter includes previously published and coauthored material from Cerda, M.M.; 
Newton, T.D.; Zhao, Y.; Collins, B.K.; Hendon, C.H.; Pluth, M.D. Dithioesters: Simple, 
Tunable, Cysteine-Selective H2S Donors. Chem. Sci. 2019, 10 (6), 1773-1779. This 
manuscript was written by Matthew M. Cerda with editorial assistance from Professor 
Michael D. Pluth. The project in this chapter was conceived by Matthew M. Cerda with 
insight from Dr. Yu Zhao. The experimental work in this chapter was performed by 
Matthew M. Cerda and Turner D. Newton. The computational work in this chapter was 





Prevalent in the field of polymer chemistry, dithioesters are utilized as chain 
transfer agents in reversible addition-fragmentation chain transfer (RAFT) 
polymerizations.119 Arising from the ability to readily react with propagating radical 
monomers, the design of thiocarbonyl-containing motifs such as dithioesters, 
trithiocarbonates, and dithiocarbamates has been well studied to enhance the RAFT 
polymerization of various monomers.120 In Chapter II, we demonstrated that related 
thionoesters, which are structural isomers of thioesters bearing a thiocarbonyl motif, 
undergo a chemoselective reaction with cysteine to generate a dihydrothiazole and 
hydrogen sulfide (H2S).121 Despite recent advancements in the synthesis of thionoesters,122 
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the ability to prepare a diverse library of thionoester-based H2S donors is limited by the 
availability of stable, readily-accessible starting materials. However, based on structural 
similarities between thionoesters and dithioesters, we hypothesized that dithioesters could 
provide similar reactivity in the presence of cysteine and allow for the development of 
tunable H2S donors with precise control over H2S release rates and efficiencies. 
Complementing carbon monoxide and nitric oxide, H2S is now classified as an 
important biological signaling molecule.123 Commonly referred to as gasotransmitters, 
these small, gaseous molecules are produced endogenously, readily permeate cell 
membranes, and exert physiological responses upon binding to or reacting with cellular 
and/or molecular targets.124 The involvement of H2S-mediated signaling has been observed 
in a variety of physiological processes such as vasodilation,93 angiogenesis,125 and 
scavenging of reactive oxygen species.126 In recent years, researchers have become 
increasingly interested in utilizing H2S donors for the development of both important 
research tools and novel therapeutics.127 Towards this goal, researchers have relied heavily 
on the use of sodium hydrosulfide (NaSH), which is a water-soluble source of H2S, for 
preliminary studies. However, a comparison between H2S production from native enzymes 
including cystathionine-β-synthase and cystathionine-γ-lyase against exogenous 
administration of H2S (via NaSH) has revealed stark differences which should be taken 
into consideration.128 The dissolution of NaSH in buffered solutions leads to a rapid, almost 
spontaneous increase in local H2S concentration,129 whereas endogenous H2S production 
occurs at a slower, at a slower rate. To address this issue, researchers have developed 
synthetic H2S donors, which release H2S either passively via hydrolysis or in the presence 




Figure 3.1 Selected examples of synthetic H2S donors 
 
Drawing parallels to the dissolution of NaSH, small molecules derived from 
dithiole-3-thione131 and phosphorodithioate33, 35 motifs respectively have been synthesized 
as hydrolysis-activated H2S donors, although we note the overall low H2S-releasing 
efficiencies from these donors. Towards improving releasing yields and tuning rates of H2S 
release, analyte-responsive small molecules have been prepared to release H2S as a 




Initially reported by our group,134 the conversion of carbonyl sulfide (COS) to H2S by 
carbonic anhydrase has been used to access a library of COS/H2S donors.135 Inspired by 
the endogenous production of H2S via enzymatic conversion of cysteine, a number of thiol- 
triggered H2S donors have been reported. Abundant in nature, organic polysulfides58 have 
been shown to release H2S in the presence of biological thiols including cysteine136 and 
reduced glutathione (GSH).137 The generation of persulfides, an important class of 
biologically-relevant reactive sulfur species,138 via thiol-mediated reduction has been used 
to prepare a series of synthetic H2S donors with potent protective effects against 
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myocardial-ischemia reperfusion injury.52 Similarly, the generation of N-mercaptan 
species in the presence of thiols has been demonstrated as a viable platform for H2S 
delivery with tunable releasing kinetics.139 Under physiological conditions, thionoesters 
react rapidly with cysteine via a native chemical ligation-like mechanism to afford an 
equivalent of phenol, H2S, and a cysteine-derived dihydrothiazole (Figure 3.2a). 
 
Figure 3.2 (a) Cysteine-triggered H2S release from thionoesters. (b) Cysteine-triggered 
H2S release from dithioesters. 
 
Although dithioesters have been used to prepare polymeric H2S donors,140 direct use of this 
motif as an H2S donor scaffold has not been reported. Herein, we present our findings on 
the development of dithioesters as novel, cysteine-triggered H2S donors (Figure 3.2b) In 
this chapter, we demonstrate the release of H2S in the presence of cysteine from a 
representative (bis)phenyl dithioester with a comprehensive kinetic analysis. Additionally, 
we demonstrate the ability to tune the rate of H2S release from dithioesters via simple alkyl 
functionalization. 
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3.2 Results and Discussion 
 
Building upon our previous work, we hypothesized that the intermediate dithioester 
formed during the chemoselective reaction of cysteine with thionoesters could provide a 
platform for future investigations leading to the development of novel, cysteine-triggered 
H2S donors. Unfortunately, the functionalization of thionoester-based H2S donors is 
hindered by a limited number of stable, isolable alkyl chlorothionoformates. By contrast, 
the enhanced reactivity of Lawesson's reagent toward thioesters over esters allows for 
convenient functionalization and synthetic accessibility of various dithioesters.141 To 
prepare different dithioesters, we treated the desired thiol with the desired acid chloride in 
the presence of triethylamine followed by thionation with Lawesson's reagent to access to 




Scheme 3.1 General synthesis of dithioesters. 
 
 
The modularity of this synthetic route readily allows for the introduction of various 
functional groups and can be expanded upon to include payloads of interest including 
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fluorophores and known therapeutics for the development of H2S-releasing prodrugs. In 
the interest of accessing tunable H2S donors, we hypothesized modulation of thiocarbonyl 
electrophilicity and thiolate leaving group ability would directly alter the rates of cysteine- 
triggered H2S release from dithioesters. 
With synthesized dithioesters in hand, we began our studies by examining the 
reactivity of PDTE (25 μM) as a representative dithioester towards various concentrations 
of cysteine (250, 500, 1000, and 1250 μM) and monitoring the release of H2S via the 
spectrophotometric methylene blue assay, which allows for H2S quantification (Figure 
3.3a).142 Consistent with our hypothesis, we observed increasing amounts of H2S released 
with increasing cysteine concentrations from PDTE. To quantify the H2S-releasing 
efficiency, we used a methylene blue calibration curve generated with NaSH (Figure C.25) 
and we found 25 μM PDTE released approximately 17 μM H2S after 1 h, which 
corresponds to a releasing efficiency of ∼68%. Under identical conditions, we note a slight 
decrease in H2S-releasing efficiency between dithioesters and thionoesters (80%), although 
both of these constructs are efficient H2S-releasing motifs. To quantify the rate of H2S 
release, we were able to fit these releasing curves and obtain pseudo-first order rate 
constants (kobs). A plot of log[Cys] versus log(kobs) provided a linear plot with slope near 
one, which suggests the overall reaction is first order in cysteine and proceeds via a 
mechanism similar to the reaction of thionoesters with cysteine (Figure 3.3b). A plot of 
[Cys] versus kobs yielded a second-order rate constant (k2) of 1.8 ± 0.1 M−1 s−1 (Figure 
3.3c), which is approximately five times slower relative to cysteine-triggered H2S from 




Figure 3.3 (a) Release of H2S from PDTE (25 μM) in the presence of increasing cysteine 
concentrations (250, 500, 1000, and 1250 μM). (b) Plot of log(kobs) vs. log([Cys]). (c) Plot 
of kobs vs. [Cys]. 
 
 
This difference in H2S-releasing kinetics prompted us to further investigate the kinetics of 
cysteine-triggered H2S release from dithioesters and elucidate potential mechanistic 
differences between both classes of H2S donors. To further probe the reactivity of 
dithioesters with respect to H2S release, we next investigated the effect of cysteine 
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derivatives and related thiol-based nucleophiles on H2S release from PDTE (Figure 3.4). 
In the absence of nucleophiles, we did not observe H2S release under hydrolytic conditions. 
Although the conversion of a thiocarbonyl to the corresponding carbonyl is 
thermodynamically favorable with an enthalpic gain of ∼43 kcal mol−1 when comparing 
C=S versus C=O bond strengths, the hydrolysis of dithioesters is a slow process and can 
be considered negligible when considering the  rate  of  cysteine-triggered  H2S  
release.143 Further supporting a similar mechanism of cysteine-triggered H2S release 
between thionoesters and dithioesters, masking of either the thiol or amine moieties in 
cysteine completely abolished H2S release from PDTE. Additionally, the use of cysteine 
methyl ester did not affect H2S release when compared to H2S release in the presence of 
cysteine. To assess the effect of cysteine analogues on H2S release, we measured H2S 
release in the presence of homocysteine and penicillamine. Interestingly, we observed a 
significant reduction in the H2S release rate in the presence of homocysteine relative to 
cysteine-triggered H2S release. In the presence of penicillamine, we failed to observe 
significant H2S release, which we attribute to a reduction in nucleophilicity due to the 
presence of geminal methyl groups. 
We next examined the release of H2S from PDTE in the presence of reduced 
glutathione (GSH), which is the most abundant biological thiol to determine the effect of 
competitive thiols on H2S release. In the presence of 500 μM GSH, we did not observe 
significant H2S release, but also could not rule out that transthioesterification by GSH, 
which would result in consumption of the dithioester moiety with a lack of H2S release. 
Considering the nucleophilicity of the departing thiophenol, we hypothesized that the 




Figure 3.4 Selectivity of H2S release from PDTE in the presence of different analytes. 
Data were acquired at 1, 5, 10, 15, 30, 45, and 60 min. Methylene blue absorbance values 
are relative to the maximum absorbance value obtained from H2S release in the presence 
of cysteine (1). Analytes: H2O (2), N-acetyl-L-cysteine (3), S-methyl-L-cysteine (4), L- 
cysteine methyl ester hydrochloride (5), N-acetyl-L-cysteine methyl ester (6), DL- 
homocysteine (7), DL-penicillamine (8), GSH (9), cysteine + 1 mM GSH (10). 
 
 
thionoesters, which should result in enhanced selectivity for cysteine over GSH. To test 
this hypothesis, we measured H2S release from PDTE in the presence of 500 μM cysteine 
and 1 mM GSH. In support of the expected enhanced reversibility, we observed minimal 
change on the cysteine-triggered H2S release from PDTE even in the presence of excess 
GSH. This presents a considerable advancement over the thionoester scaffold, which 
yielded a decreased H2S-releasing efficiency in the presence of GSH and cysteine. Taken 
together, these results demonstrate the selectivity of the dithioester scaffold for cysteine 
over other thiol-based nucleophiles including GSH and we proposed the following 









Initial nucleophilic attack by cysteine on PDTE generates tetrahedral intermediate 1, 
which collapses upon thiocarbonyl formation and extrusion of thiophenol to yield 
intermediate 2. Nucleophilic attack by the pendant amine generates intermediate 3, which 
extrudes H2S upon formation of dihydrothiazole 4. Based on the negligible loss in H2S- 
releasing efficiency in the presence of excess GSH, the generation of 1 and 2 is likely 
highly reversible and could provide enhanced selectivity of the dithioester moiety for 
cysteine. In the mechanism of cysteine-triggered release of H2S from thionoesters, the poor 
nucleophilicity of the departing alcohol likely impedes formation of the initial thionoester. 
In our proposed mechanism of H2S release from dithioesters, the departing thiolate bears 
enhanced nucleophilicity and likely reacts with the intermediate dithioester to regenerate 
the initial dithioester effectively reversing cysteine addition. Additionally, the enhanced 
reversibility of transthioesterification supports the considerably slower kinetics between 
dithioesters and thionoesters. Taken together, we hypothesized this enhanced reversibility 
would result in the initial nucleophilic attack by cysteine being the rate-determining step 
of cysteine-triggered H2S release from dithioesters. 
58  
To confirm the formation of a cysteine-based dihydrothiazole, PDTE (100 μM) 
was treated with l-cysteine methyl ester (2 mM, 20 equiv.) and a reaction aliquot after 1 h 
was subjected to HPLC analysis (Figure C.26). In agreement with our proposed 
mechanism, the HPLC analysis revealed the formation of the expected dihydrothiazole in 
∼61% yield, which is consistent with the H2S-releasing  efficiency  of PDTE as 
measured via the methylene blue assay. To gain insights on the rate-determining step, we 
measured the effect of temperature on the rate of H2S release from PDTE (25 μM) in the 
presence of cysteine (500 μM, 20 equiv.) (Figure 3.5). 
 
 
Figure 3.5 (a) Effect of temperature on rate of H2S release from PDTE (25 μM) in the 
presence of cysteine (500 μM, 20 equiv.). (b) Eyring analysis of cysteine-triggered H2S 
release from PDTE. 
 
If nucleophilic attack by cysteine on PDTE is the rate-determining step of the reaction, we 
would expect to observe an entropy of activation (ΔS‡) of approximately −20 eu, which 
would be characteristic of a bimolecular reaction. 
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Upon measuring the rates of H2S release at different temperatures, we constructed an 
Eyring plot using the obtained kobs values, which afforded ΔS‡ = −23 ± 1 eu. The observed 
ΔS‡ supports our mechanistic hypothesis and is consistent with the initial addition of 
cysteine to the dithioester to generate 1 being the rate-determining step of cysteine- 
triggered H2S release from dithioesters. In the reaction of thionoesters with cysteine, we 
interpreted an experimentally determined ΔS‡ = −38 ± 3 eu to suggest the intramolecular 
cyclization as the rate determining step. In comparison between both mechanisms, by 
simply altering the nucleophilicity of the leaving group (i.e. alcohol vs. thiol) we have 
shunted the rate-determining step of the reaction. Additionally, our results suggest that 
cysteine-triggered H2S release from dithioesters and native chemical ligation share a 
similar rate-determining step. 
To complement our experimental results, we used density functional theory (DFT) 
to  examine  the  potential  energy  surface  for  H2S  release  from   dithioesters.   
Because PDTE was used for our experimental mechanistic investigations, we chose to 
investigate the reaction of PDTE with cysteine thiolate using Gaussian 09 at the B3LYP/6- 
311++G(d,p) level of theory applying the IEF-PCM water solvation model. We found that 
the initial nucleophilic attack by cysteine thiolate on PDTE resulted in an activation barrier 
of 19.1 kcal mol−1, which was the highest barrier on the reaction coordinate and 
qualitatively agrees with the experimentally observed ΔH‡ of 14.4 kcal mol−1. The resultant 
transthioesterified cysteine adduct is 3.7 kcal mol−1 more stable than the PDTE starting 
material, and subsequently undergoes an intramolecular S to N thioacyl transfer reaction 
with an associated barrier of 8.9 kcal mol−1, resulting in the final and more 







Figure 3.6 Potential energy surface for the attack of cysteine thiolate on PDTE. 
Calculations were performed in Gaussian 09 at the B3LYP/6-311++G(d,p) level of theory 
applying the IEF-PCM water solvation model. 
 
 
The ease of synthesis of dithioester compounds also enabled further investigation 
into the effect of alkyl functionalization on H2S release. We hypothesized that the 
electrophilicity at the thiocarbonyl position could be modified directly by introducing 
various alkyl, and thus alter the rate of H2S release. Additionally, we hypothesized that 
modification of the departing thiolate nucleophilicity would also alter the rate of H2S 
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release from dithioesters. We anticipated the introduction of inductively donating alkyl 
groups, such as methyl and isopropyl, would decrease the thiocarbonyl electrophilicity and 
resulting in decreased rates of H2S release. Additionally, we anticipated that replacement 
of thiophenol with benzyl mercaptan would result in decreased rates of H2S release due to 
the enhanced nucleophilicity of benzyl mercaptan over thiophenol. To test our hypotheses, 
we measured H2S release from our library of alkyl functionalized dithioesters (25 μM) in 
the presence of cysteine (500 μM, 20 equiv.) (Figure 3.7). 
 
Figure 3.7 Effect of alkyl functionalization on the rate of H2S release from dithioesters. 
 
 
Contrary to our initial hypothesis, the incorporation of inductively-donating alkyl 
groups led to enhanced rates of H2S release relative to PDTE. To better understand the 
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apparent releasing trends, we considered the stability of the charge-separated thiocarbonyl 
motif and the effect of different alkyl groups (Figure 3.8). 
 
 
Figure 3.8 (a) Effect of pendant groups on thiocarbonyl electrophilicity and carbocation 
stability. (b) Scale of increasing H2S releasing rates for reported dithioesters. 
 
 
In the case of PDTE, a charge-separated thiocarbonyl yields a benzylic carbocation which 
can readily delocalize via resonance effectively altering the electrophilicity of the 
thiocarbonyl via delocalization of the carbocation. In the presence of inductively donating 
groups such as methyl and isopropyl in MPDTE and iPPDTE respectively, the resulting 
carbocation is localized to the thiocarbonyl position, which would result in enhanced rates 
of H2S release in comparison to PDTE. Incorporation of an isopropyl group in iPPDTE, 
however, also introduces the potential for an intermediate 1,2-methyl shift which would 
partially delocalize the carbocation and hinder H2S release relative to MPDTE. 
Considering these contributions, we interpret the enhanced release of H2S from alkyl- 
functionalized dithioesters as a reflection of altered thiocarbonyl 
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electrophilicity via carbocation delocalization. Although this outcome was contrary to our 
initial hypothesis, these findings demonstrate the ability to tune the rate of H2S release from 
dithioesters by simple alkyl substitutions. 
Furthering our studies, we also examined the effect of benzyl mercaptan as a 
leaving group on H2S release from MBDTE, PBDTE, and iPBDTE respectively. In 
comparison to thiophenol, benzyl mercaptan is a considerably better nucleophile and likely 
perturbs the equilibrium of transthioesterification to disfavor the addition of cysteine. In 
concert with the effect of alkyl groups on thiocarbonyl electrophilicity, we anticipated H2S 
release from dithioesters bearing benzyl mercaptan to be dramatically altered relatively to 
their thiophenol analogue. In agreement with our hypothesis, H2S release was observed 
exclusively from MBDTE. Considering the lack of carbocation delocalization by the 
pendant methyl group, this result suggests the thiocarbonyl moiety in MBDTE is 
sufficiently electrophilic to promote H2S release in the presence of cysteine. Alternatively, 
we observed effectively no H2S release from PBDTE and relatively slow H2S release 
from iPBDTE. Considering  the  effect  of  alkyl  groups  on  thiocarbonyl 
electrophilicity via carbocation delocalization in concert with the enhanced nucleophilicity 
of benzyl mercaptan, a significantly hindered rate of release from iPBDTE and complete 
shutdown of H2S release from PBDTE is also in agreement with our hypothesis. Overall, 
we found the use of benzyl mercaptan decreased overall H2S-releasing efficiency and 
yielded hindered rates of release in comparison to thiophenol-based dithioesters. Taken 
together, these findings demonstrate the rate of H2S release from dithioesters can be 




Advancing our previous work on synthetic H2S donors via the chemoselective 
condensation of thionoesters and cysteine, we have identified that dithioesters are a viable 
and tunable platform for developing cysteine-triggered H2S donors. Using PDTE as a 
representative dithioester, we have demonstrated H2S release in the presence of cysteine 
proceeds with good efficiency, and that dithioesters provide significant advancements over 
thionoesters, including ease of functionalization and enhanced selectivity for cysteine over 
other thiol-based nucleophiles including GSH. Mechanistic investigations, including rate- 
order analysis and activation parameters support a mechanism in which the initial 
nucleophilic attack by cysteine on the dithioesters is the rate-determining step of the 
reaction, which is also supported by computation. Furthermore, we demonstrated that the 
rate of H2S release from a small library of dithioesters can be controlled by alkyl 
substitution. The findings presented herein provide several advancements over thionoesters 
as cysteine-triggered H2S donors and provides a foundation for further development of 
dithioesters for expanding upon the chemical biology of H2S. 
The ability to tune H2S release from dithioesters provides a H2S donor which can 
be altered to meet the demands of specific diseases states or local cysteine concentrations. 
The enzymatic production of H2S is primarily based upon cysteine catabolism and the 
formation of H2S-releasing persulfide intermediates. Chapter IV discusses our work on 
organic tetrasulfides which release H2S through intermediate persulfide generation. 
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3.4 Experimental Details 
 
3.4.1 Materials and Methods 
 
Reagents were purchased from Tokyo Chemical Industry and/or Oakwood Chemicals and 
used directly as received. Deuterated solvents were purchased from Cambridge Isotope 
Laboratories and used as received. 1H and 13C{1H} NMR were recorded on Bruker 500 and 
600 MHz instruments. Chemical shifts are reported relative to residual protic solvent 
resonances. MS data was collected on a Xevo Waters ESI LC/MS instrument. Silica gel 
(SiliaFlash F60, Silicycle, 230- 400 mesh) was used for column chromatography. All air- 
free manipulations were performed under an inert atmosphere using standard Schlenk 
technique or an Innovative Atmospheres N2-filled glove box. UV-Vis spectra were 
acquired on an Agilent Cary 60 UV-Vis spectrophotometer equipped with a Quantum 
Northwest TC-1 temperature controller at 25 °C ± 0.05 °C. 
 
 
H2S Detection Materials and Methods 
 
Phosphate buffered saline (PBS) tablets (1X, CalBioChem) were used to prepare buffered 
solutions (140 mM NaCl, 3 mM KCl, 10 mM phosphate, pH 7.4) in deionized water. Buffer 
solutions were sparged with N2 to remove dissolved oxygen and stored in an N2-filled 
glovebox. Donor stock solutions (in DMSO) were prepared inside an N2-filled glovebox 
and stored at -25 °C until immediately before use. Trigger stock solutions (in PBS) were 
freshly prepared in an N2-filled glovebox immediately before use. 
66  
General Procedure for Measuring H2S Release via Methylene Blue Assay (MBA) 
Scintillation vials containing 20 mL of PBS were prepared in an N2-filled glovebox. To 
these solutions, 20 μL of 500 mM analyte stock solution (in PBS) was added for a final 
concentration of 500 μM. While stirring, the solutions were allowed to thermally 
equilibrate in heating block at the desired temperature for approximately 20-30 min. 
Immediately prior to donor addition, 0.5 mL solutions of methylene blue cocktail were 
prepared in disposable 1.5 mL cuvettes. The methylene blue cocktail solution contains: 200 
μL of 30 mM FeCl3 in 1.2 M HCl, 200 μL of 20 mM N,N- dimethyl-p-phenylene diamine 
in 7.2 M HCl, and 100 μL of 1% (w/v) Zn(OAc)2. To begin an experiment, 20 μL of 25 
mM donor stock solution (in DMSO) was added for a final concentration of 25 μM. At set 
time points after the addition of donor, 500 μL reaction aliquots were added to the 
methylene blue cocktail solutions and incubated for 1 h at room temperature shielded from 
light. Absorbance values at 670 nm were measured 1 h after addition of reaction aliquot. 
Each experiment was performed in quadruplicate unless stated otherwise. 
 
 
MBA Calibration Curve 
 
Solutions containing 0.5 mL of the methylene blue cocktail and 0.5 mL PBS containing 
500 μM cysteine were freshly prepared in disposable cuvettes (1.5 mL). Under inert 
conditions, a 10 mM stock solution of NaSH (Strem Chemicals) in PBS was prepared and 
diluted to 1 mM. Immediately after dilution, 1 mM NaSH was added to 1.0 mL solutions 
for final concentrations of 10, 20, 30, 40, and 50 μM. Solutions were mixed thoroughly, 
incubated at room temperature for 1 h, and shielded from light. Absorbance values at 670 
nm were measured after 1 h (Figure C.27) 
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Scheme 3.3 Preparative scale synthesis of CysDHT from PDTE 
 
 
To a 20 mL solution of 10% THF in PBS (10 mM, pH 7.4) containing 2 mM L-cysteine 
methyl ester (20 equiv.), 20 mL of 100 mM PDTE in THF was added for 100 mM PDTE 
and stirred at room temperature. After 1 h, a 1 mL reaction aliquot was analyzed by HPLC. 
HPLC analysis was performed on an Agilent 1260 HPLC instrument with a Poroshell 120 
EC-C18 4.6x100 mm column and monitored at 280 nm. Solvent A: 95% H2O, 5% MeOH, 
Solvent B: 100% MeCN. Gradient: 35% Solvent A/65% Solvent B for 2 min. Change to 
100% Solvent B over 4 min and hold for 6.5 min. Change to 35% Solvent A/65% Solvent 
B over 0.5 min and hold for 4.5 min. Flow Rate: 0.5 mL/min, 2 μL injection. The 
concentration of CysDHT present at the end of the reaction was determined by 
measurement against calibration curves for each compound. 
 
 
Computational Details and Geometries 
 
Structures were initially constructed in Avogadro and optimized using the UFF force field. 
These resultant structures were then further geometrically optimized using a hybrid GGA 
functional, B3LYP, with a large triple zeta basis, 6-311++G**, that includes diffuse and 
polarization functions for all atoms. A pseudosolvent polarizable continuum model was 
used (water), to partially account for solvent stabilization. VeryTight convergence criteria 
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for forces and displacements, as implemented in Gaussian 09. Energetics were compared 
to a double zeta basis, 6-31+G*, which showed similar trends and energies. 
Transition states were located using i) a potential energy surface scan with the 
modredundant feature to locate a good starting point for ii) a transition state search. The 
transition states were confirmed using vibrational analysis as evidenced by a single 





General procedure for the synthesis of thioesters 
 






Scheme 3.4 Synthesis of thioesters 
 
 
The desired thiol (1.1 equiv.) and triethylamine (1.1 equiv.) were added to anhydrous 
CH2Cl2 (20 mL) and cooled to 0 °C. Once cooled, the desired acid chloride (1.0 equiv.) 
was added dropwise, and the reaction was stirred at 0 °C for 1 h. The reaction was quenched 
with deionized H2O (30 mL), and the organic layer was separated. The aqueous layer was 
extracted with CH2Cl2 (2 x 20 mL) and the combined organic extractions were washed 
with brine (1 x 20 mL), dried over MgSO4, and concentrated under reduced pressured. The 




White powder, 852 mg (96%) Rf = 0.23 (25% CH2Cl2 in hexanes) 
 
1H NMR (600 MHz, CDCl3) δ: 8.04 (d, 2 H), 7.61 (t, 1 H), 7.55 – 7.44 (m, 7 H). 13C{1H} 
 
NMR (151 MHz, CDCl3) δ: 190.14, 136.63, 135.09, 133.65, 129.52, 129.24, 128.74, 
 







Clear oil, 538 mg (86%) Rf = 0.42 (50% CH2Cl2 in hexanes) 
 
1H NMR (500 MHz, CDCl3) δ: 7.42 (s, 5 H), 2.43 (s, 3 H). 13C{1H} NMR (151 MHz, 
 
CDCl3) δ: 194.06, 134.44, 129.43, 129.19, 127.91, 30.19. TOF MS (ASAP+) (m/z): [M + 
 





Clear oil, 492 mg (66%) Rf = 0.56 (50% CH2Cl2 in hexanes) 
 
1H NMR (500 MHz, CDCl3) δ: 7.41 (s, 5 H), 2.87 (hept, J = 6.9, 1.9 Hz, 1 H), 1.27 (d, J = 
 
7.0, 1.8 Hz, 6 H). 13C NMR (126 MHz, CDCl3) δ: 201.85, 134.56, 129.17, 129.09, 127.87, 
 






Clear oil, 779 mg (93%) Rf = 0.40 (33% CH2Cl2 in hexanes) 
 
1H NMR (500 MHz, CDCl3) δ: 7.98 (d, J = 7.6 Hz, 2 H), 7.57 (t, J = 7.4 Hz, 1H), 7.45  (t, 
 
J = 8.0 Hz, 2 H), 7.39 (d, J = 8.1 Hz, 2 H), 7.33 (t, J = 7.5 Hz, 2 H), 7.29 – 7.24 (m, 1  H), 
 
4.33 (s, 2 H). 13C NMR (126 MHz, CDCl3) δ: 191.27, 137.45, 136.78, 133.42, 128.96, 
 
128.61, 127.31, 127.28, 33.32. TOF MS (ASAP+) (m/z): [M + H]+ calc’d for C14H12OS 
 





Clear oil, 405 mg (67%) Rf = 0.24 (25% CH2Cl2 in hexanes) 
 
1H NMR (600 MHz, CDCl3) δ: 7.31 – 7.27 (m, 4 H), 7.27 – 7.23 (m, 1 H), 4.13 (s, 2 H), 
 
2.35 (s, 3 H). 13C NMR (151 MHz, CDCl3) δ: 195.09, 137.56, 128.77, 128.60, 127.24, 
 







Clear oil, 577 mg (66%) Rf = 0.48 (33% CH2Cl2 in hexanes) 
 
1H NMR (600 MHz, CDCl3) δ: 7.31 – 7.28 (m, 4 H), 7.25 – 7.22 (m, 1 H), 4.11 (s, 2 H), 
 
2.76 (hept, J = 6.9 Hz, 1 H), 1.21 (d, J = 6.9 Hz, 6 H). 13C NMR (151 MHz, CDCl3) δ: 
203.44, 137.73, 128.79, 128.59, 127.17, 42.88, 32.89, 19.35. TOF MS (ASAP+) (m/z): [M 
 
+ H]+ calc’d for C11H14OS 195.0844; found 195.0835 
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General procedure for the synthesis of dithioesters 
 




Scheme 3.5 Synthesis of dithioesters 
 
 
The desired thioester (1.0 equiv.) and Lawesson’s Reagent (0.75 equiv.) were added to 
anhydrous toluene (20 mL) and heated to 120 °C under reflux. After 5.5 h, the reaction 
mixture was cooled to room temperature and filtered. The filtrate was concentrated under 
reduced pressure, and the desired product purified by column chromatography. 
Phenyl benzodithioate (PDTE). 
 
Red-violet solid, 217 mg (81%) Rf = 0.42 (20% CH2Cl2 in hexanes) 
 
1H NMR (600 MHz, CDCl3) δ: 8.10 (d, J = 7.1 Hz, 1 H), 7.57 (t, 1H), 7.54 – 7.47 (m, 6 
 
H), 7.45 – 7.40 (m, 2 H). 13C NMR (151 MHz, CDCl3) δ: 228.49, 144.59, 135.38, 132.60, 
131.38, 130.36, 129.66, 128.40, 126.99. TOF MS (ASAP+) (m/z): [M + H]+  calc’d for 
 
C13H10S2 231.0302; found 231.0302 
 
 
Phenyl ethanedithioate (MPDTE). 
 
Burnt orange oil, 185 mg (67%) Rf = 0.40 (20% CH2Cl2 in hexanes) 
 
1H NMR (500 MHz, CDCl3) δ: 7.52 – 7.46 (m, 3 H), 7.45 – 7.40 (m, 2 H), 2.87 (s, 3 H). 
 
13C NMR (151 MHz, CDCl3) δ: 234.30, 134.74, 131.77, 130.36, 129.60, 38.95. TOF MS 
(ASAP+) (m/z): [M + H]+ calc’d for C8H8S2 169.0146; found 169.0132 
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Phenyl 2-methylpropanedithioate (iPPDTE). 
 
Yellow oil, 129 mg (59%) Rf = 0.58 (25% CH2Cl2 in hexanes) 
 
1H NMR (600 MHz, CDCl3) δ: 7.50 – 7.47 (m, 3 H), 7.42 – 7.39 (m, 2 H), 3.54 (hept, J = 
 
6.7 Hz, 1 H), 1.38 (d, J = 6.6 Hz, 6 H). 13C NMR (151 MHz, CDCl3) δ: 246.77, 134.97, 
130.83,  130.18,  129.51,  48.70,  24.24.  TOF MS (ASAP+)  (m/z): [M  +  H]+  calc’d   for 
 
C10H12S2 197.0459; found 197.0463 
 
 
Benzyl benzodithioate (PBDTE). 
 
Red oil, 243 mg (91%) Rf = 0.41 (20% CH2Cl2 in hexanes) 
 
1H NMR (500 MHz, CDCl3) δ: 8.00 (d, J = 7.7 Hz, 2 H), 7.53 (t, J = 7.5 Hz, 1 H), 7.42 – 
 
7.27 (m, 8 H), 4.61 (s, 2 H). 13C{1H} NMR (126 MHz, CDCl3) δ: 227.69, 144.75, 134.97, 
132.40, 129.29, 128.72, 128.34, 127.75, 126.90, 42.28. TOF MS (ASAP+) (m/z): [M + H]+ 
 
calc’d for C14H12S2 245.0459; found 245.0471 
 
 
Benzyl ethanedithioate (MBDTE). 
 
Yellow-brown oil, 181 mg, (82%) Rf = 0.54 (25% CH2Cl2 in hexanes) 
 
1H NMR (600 MHz, CDCl3) δ: 7.34 – 7.26 (m, 5 H), 4.46 (s, 2 H), 2.85 (s, 3 H). 13C{1H} 
 
NMR (151 MHz, CDCl3) δ: 232.29, 135.13, 129.09, 128.67, 127.66, 41.98, 38.85. TOF 
MS (ASAP+) (m/z): [M + Na]+ calc’d for C9H10S2 183.0302; found 183.028 
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Benzyl 2-methylpropanedithioate (iPBDTE). 
 
Orange-brown oil, 164 mg (76%) Rf = 0.58 (25% CH2Cl2 in hexanes) 
 
1H NMR (600 MHz, CDCl3) δ: 7.34 – 7.26 (m, 5 H), 4.45 (s, 2H), 3.42 (hept, J = 6.7 Hz, 
 
1 H), 1.34 (d, J = 6.7 Hz, 7 H). 13C{1H} NMR (151 MHz, CDCl3) δ: 245.91, 135.22, 129.13, 
 
128.67, 127.58, 49.35, 40.52, 24.19. TOF MS (ASAP+) (m/z): [M + H]+ calc’d for C11H14S2 
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Nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S) are small 
gaseous molecules, often called gasotransmitters, which are produced endogenously, freely 
permeate cell membranes, and act on molecular or cellular targets to exert physiological 
effects.124 Over the past decade, the accepted roles of H2S in biology have expanded and 
now include important roles in neurotransmission,144 vasodilation,145 apoptosis,146 and 
other physiological processes.127a Aligned with these physiological roles, new chemical 
tools that enable H2S delivery are needed for both research and potential therapeutic 
applications.15e, 147 Because direct administration of H2S gas is not practical in most 
biological contexts, many researchers employ inorganic sulfide salts, such as sodium 
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hydrosulfide (NaSH) or sodium sulfide (Na2S), as a primary sulfide source. By comparison 
to enzymatic H2S production profiles, these sulfide salts release H2S instantaneously upon 
dissolution, often resulting in unwanted volatilization, oxidation, and/or reduced effective 
residence times.129 To address this issue, small molecule H2S donors that release H2S at 
controlled rates comparable to enzymatic H2S production have been prepared and 
investigated.130c Current common motifs found in H2S donation include aryl 
isothiocyanates,148 phosphinodithioates,149 
thioacids132/amides,150 dithiolethiones,151 thiolysis of trisulfides,152 and protected 
persulfides153 and stimulated release of carbonyl sulfide (COS) from thiocarbamates, 
which is subsequently converted to H2S by carbonic anhydrase.134 Of these methods, one 
of the simplest and most commonly used for H2S donation is the allium-derived diallyl 
trisulfide (DATS), which releases H2S upon reaction with thiols (Figure 4.1a). The 
mechanism of this reaction has been investigated in detail,154 and the sulfide from DATS 
has been attributed to the beneficial cardiovascular effects of garlic.155 Despite this 
widespread utility, DATS is the only polysulfide that has been used broadly as an H2S 
donor despite other accessible polysulfides, many of which have higher sulfane sulfur 
content and therefore higher H2S releasing capacity. 
Polysulfides are a class of naturally occurring molecules and are in part responsible 
for the beneficial cardiovascular effects associated with consumption of alliums such as 
garlic.152, 156 More exotic polysulfides, including varacin and chaetocin C (Figure 4.1b), 
have also been isolated from natural sources indicative of their abundance and biological 
importance. Independent of H2S releasing capacities, polysulfides are also involved 
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directly in a variety of physiological processes, including inhibition of cholesterol 
synthesis, anti-inflammation, and antioxidant activity.157 Inspired by the prevalence of 
 
 
Figure 4.1 (a) Mechanism of H2S release from DATS in the presence of GSH. (b) 
Representative examples of natural products containing polysulfides. 
 
naturally occurring polysulfides and the widespread utility of DATS, we envisioned 
accessing synthetic polysulfides for GSH-triggered H2S donation and expanding the 
toolbox of polysulfide-based H2S donors. Herein, we report the synthesis and evaluation 
of bis(aryl)- and bis(alkyl) tetrasulfides which release H2S in the presence of excess GSH. 
 
 
4.2 Results and Discussion 
 
With the goal of expanding the toolbox of polysulfide based H2S donors, we 
evaluated previous methods for simple polysulfide synthesis. Both trisulfides and 
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tetrasulfides are synthetically accessible by treating a desired thiol with sulfur dichloride 
(SCl2) or sulfur monochloride (S2Cl2), respectively.158 We chose to focus on tetrasulfides 
due to their higher sulfane sulfur content, thus higher H2S releasing potential with respect 
to trisulfides. Treatment of the parent thiol with S2Cl2 and pyridine in anhydrous solvent at 
−78 °C afforded the desired tetrasulfide in good to excellent yield with no required 
purification (Table 4.1).159 
 
Table 4.1 Synthesis of bis(aryl) and bis(alkyl) tetrasulfides 
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In addition to facile tuning of the electron-donating or -withdrawing ability of the bis(aryl) 
tetrasulfides (1–6), this route also enabled access to bis(alkyl) tetrasulfides, including N- 
acetylcysteine-derived tetrasulfides (7 and 8). These two compounds provide a promising 
scaffold for combining the physiological effects of H2S with those of N-acetylcysteine 
(NAC), which is used as an antidote for acetaminophen overdose,160 CO poisoning,161 and 
other conditions. Notably, the use of S2Cl2 to access tetrasulfides is tolerant of varying thiol 
nucleophilicity and could prove useful in the synthesis of other organic tetrasulfides. 
The prepared tetrasulfides were characterized by 1H and 13C{1H} NMR spectroscopy to 
assess the purity of each product and EI-MS to confirm selective tetrasulfide formation. A 
representative mass spectrum of 3 is shown in Figure 4.2a, which clearly shows the parent 
ion peak corresponding to Ph2S4 (282.0), as well as daughter fragmentation peaks 
corresponding to extrusion of one and two sulfane sulfur atoms to generate Ph2S3 (250.0) 
and Ph2S2 (218.0), respectively. In addition, the most intense ion peak corresponds to 
homolysis of the weak162 internal S–S bond to generate PhSS• (141.0). Additionally, HPLC 
analysis of 3 further supports the high purity of the synthesized tetrasulfide (Figure D.19). 
Taken together, the spectroscopic and spectrometric data support clean formation of the 
desired tetrasulfide product. In addition, single crystals of 4 suitable for X-ray diffraction 
were obtained by slow evaporation from n-pentane, further confirming the molecular 
structure (Figure 4.2b). Tetrasulfide 4 crystallized in P21/c with a central S–S dihedral 
angle of 82.8° and nearly perpendicular 89.9° angle between the two phenyl rings, which 
were oriented in a slip stacked orientation with a 3.50 Å interplanar spacing. Additional 
stabilizing forces in the lattice include C–H hydrogen bonds from the methyl (3.7 Å)   




Figure 4.2 (a) Mass spectrum (EI-MS) of 3. (b) ORTEP representation (50% ellipsoids) of 
the molecular structure of 4. 
 
 
a C–H hydrogen bond acceptor.163 With tetrasulfides in hand, we next investigated the 
release of H2S upon addition of GSH. We chose to use GSH as the trigger for H2S release 
due to higher intracellular levels (∼1–10 mM) relative to other biological thiols, although 
other biological reductants, such as NADH, can also trigger H2S release from 
polysulfides.164 We hypothesized that H2S release from tetrasulfides is likely to proceed 
through an analogous mechanism to that of trisulfides (Figure 4.1a), although the addition 
of a second sulfane sulfur in tetrasulfides increases the mechanistic complexity because 
GSH can attack at either the α- or β-sulfur (Figure 4.3). For example, nucleophilic attack 
by GSH at the β-sulfur can either lead to a nonproductive pathway by formation of the 
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parent thiol and a mixed glutathione tetrasulfide or to a productive pathway via formation 
of a persulfide and mixed glutathione trisulfide (Figure 4.3a). 
 
 
Figure 4.3 Proposed mechanisms of H2S release from tetrasulfides, including initial 
nucleophilic attack by GSH at the (a) β-sulfur or (b) α-sulfur. 
 
These reactive intermediates would further react with GSH leading to the generation of 2 
equiv of H2S and terminating in the formation of a mixed glutathione disulfide. 
Alternatively, nucleophilic attack by GSH at the α-sulfur results in the formation of a 
hydropolysulfide and a mixed glutathione disulfide (Figure 4.3b). This hydropolysulfide 
would further react with another equivalent of GSH to generate H2S and a mixed 
glutathione trisulfide. Repetition of this process generates oxidized GSH (GSSG) and a 
persulfide, which should rapidly react with GSH to generate another equivalent of H2S and 
terminate in a mixed glutathione disulfide. Overall, a single tetrasulfide molecule should 
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release 2 equivalents of H2S following reduction by GSH and terminate in a mixed 
glutathione disulfide. 
To gain preliminary mechanistic insights into H2S release from the prepared 
tetrasulfides, we measured the GSH dependence of H2S release from 5 μM 3 (10 mM PBS, 
pH 7.4) using a sulfide-selective electrode. As expected, no H2S release was observed in 
the absence of GSH, demonstrating that the tetrasulfides are stable in solution in the 
absence of thiols. Increasing the GSH concentration resulted in an increased rate of H2S 
production (Figure 4.4a). The acquired H2S release data did not fit cleanly to pseudo-first- 
order kinetics, suggesting that the complexity of the H2S-releasing pathway and possibility 
for competing reactions may complicate the observed rate profiles. To circumvent this 
problem, we used initial rate analysis and construction of a log–log plot of rate as a function 
of [GSH], which demonstrated a first-order rate dependence (Figure 4.4b) 
 
 
Figure 4.4 (a) GSH-dependent H2S release from 3. (b) log(k) vs log[GSH] plot 
demonstrating a 1st-order dependence in [GSH] on H2S release from 3. 
 
Given the ease of functionalization for the bis(aryl) tetrasulfides, we also 
investigated the effects of electronic substitution on H2S release. We anticipated that 
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electronic modulation of the bis(aryl) tetrasulfides would favor a specific pathway due to 
change in electrophilicity at the α- or β-sulfur. Alternatively, it is possible that although the 
balance of the competing pathways could shift, it would not do so sufficiently to result in 
different H2S release profiles. Similar to our observation for 3, GSH-triggered H2S release 
from the remaining bis(aryl) tetrasulfides was observed with initial rates ranging from 
0.0032 to 0.054 nA·s–1 (Table D.2). The Hammett plot constructed from the initial rate data 
did not provide a linear relationship, suggesting that factors other than electronic effects 
may influence H2S release rates from the bis(aryl) tetrasulfides (Figure D.20). We next 
compared the rates of release of alkyl tetrasulfides 7 and 8, both of which released H2S 
more slowly than the aryl tetrasulfides (Figure 4.5). 
 
 
Figure 4.5 GSH-triggered (250 equiv) H2S release from 5 μM tetrasulfides 1–8 and 5 μM 
DATS (pH 7.4, room temperature). 
 
 
Notably, all of the prepared aryl and alkyl tetrasulfides resulted in greater H2S donation 
than the well-established trisulfide donor DATS under the reported conditions, thus 
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highlighting the efficacy of tetrasulfides as viable H2S donors. The differences in H2S 
releasing profiles of the reported donors are likely due to varying electronic contributions 
between the different compounds. Clearly further mechanistic investigations are required 





In summary, a diverse array of bis(alkyl) and bis(aryl) tetrasulfides are readily 
accessible from simple synthetic procedures. The prepared tetrasulfides readily release H2S 
upon treatment with GSH and release more H2S per molecule than commonly used DATS. 
Overall, we expect that these and other simple polysulfides will provide researchers 
interested in H2S donating molecules with a broader palette of available polysulfide donor 
motifs with different release profiles and biological activities. 
The accessibility of thiol-mediated H2S release from these compounds 
demonstrates the ability to expand the chemical toolbox of synthetic, organic polysulfides 
for H2S generation. To gain a better, fundamental understanding of H2S release from this 
class of donor compounds, we sought to investigate the effect of varying sulfane sulfur 
content within a single series of organic polysulfides on H2S release. Chapter V discusses 
our findings on thiol-mediated H2S release from benzyl polysulfides and highlights the 
potential significance of intermediate persulfide generation on the biological activity of 
polysulfides. 
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4.4 Experimental Details 
 
4.4.1 Materials and Methods 
 
4-(trifluoromethyl)benzene thiol, and p-Toluenethiol were purchased from Toyko 
Chemical Industry (TCI). 4-fluorothiophenol, and thiophenol were purchased from Alfa 
Aesar. Sulfur monochloride, 4-Methoxythiophenol, and L-Glutathione reduced were 
purchased from Sigma-Aldrich. 4-(Dimethylamino)thiophenol was purchased from 
Oakwood Chemicals. All reagents were used as received. Deuterated solvents were 
purchased from Cambridge Isotope Laboratories and used as received. 1H, 13C{1H}, and 
19F NMR spectra were recorded on a Bruker 500 MHz or 600 MHz instrument. Chemical 
shifts are reported in ppm relative to residual protic solvent resonances. Sulfide selective 
electrode data was acquired with a World Precision Instruments (WPI) ISO-H2S100 sensor 
connected to a TBR4100 Free Radical Analyzer. All air-free manipulations were 
performed under an inert atmosphere using standard Schlenk techniques or an Innovative 
Atmospheres N2-filled glove box. 
 
 
H2S Electrode Materials and Methods 
 
Phosphate buffered saline (PBS) tablets (1X, CalBioChem) were used to make buffered 
solutions (PBS, 140 mM NaCl, 3 mM KCl, 10 mM phosphate, pH 7.4) in deionized water. 
Buffer solutions were sparged with N2 to remove dissolved oxygen and stored in an N2- 
filled glovebox. Tetrasulfide stock solutions (in DMSO) were prepared in an N2-filled 
glovebox and stored at -25 °C until immediately before use. GSH stock solutions (in PBS, 
1X, pH 7.4) were freshly prepared in an N2-filled glovebox immediately before use. 
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General Procedure for H2S Electrode Experiments 
 
Scintillation vials containing 20 mL of PBS (1X, 140 mM NaCl, 3 mM KCl, 10 mM 
phosphate, pH 7.4) were prepared in an N2-filled glovebox. A split-top septum cap was 
placed on the vial after probe insertion and the headspace was sparged with Ar via balloon 
to avoid unwanted oxidation. The electrode was then inserted into the solution and the 
measured current was allowed to equilibrate over 5 min. With moderate stirring, 
tetrasulfide (20 L of 5 mM in DMSO) was injected and allowed to equilibrate for 1 min 
followed by injection of GSH (100 L of 250 mM GSH in PBS). H2S release was 






Diffraction intensities for 4 were collected at 173 K on a Bruker Apex2 CCD diffractometer 
using CuK radiation (1.54178 Å). The space group was determined based on systematic 
absences. Absorption corrections were applied by SADABS. The structure was solved by 
direct methods and Fourier techniques refining on F2 using full matrix least-squares 
procedures. All non-H atoms were refined with anisotropic thermal parameters. All H 
atoms were found on the residual density map and refined with isotropic thermal 




General Procedure for the Preparation of Aryl and Alkyl Tetrasulfides 
 
The desired thiol (1.0 equiv.) and pyridine (1.0 equiv.) were added to anhydrous solvent 
(30 mL) in an oven-dried round bottom flask under nitrogen. The solution was cooled to - 
78 °C for 1 hour, after which sulfur monochloride (0.6 equiv.) was added dropwise. A 
white precipitate formed within seconds, and the reaction was stirred for 2 hours and then 
allowed to warm to room temperature. The reaction was quenched with deionized water 
(30 mL), and the aqueous layer was discarded. The organic layer was washed with 
deionized water (30 mL) and brine (30 mL). The organic layer was dried over sodium 
sulfate, filtered, and evaporated under reduced pressure to afford the pure product. 
 
 
1,4-bis-(4-(trifluoromethyl)phenyl)tetrasulfane (1, Et2O) 
 
Yellow liquid. 256 mg (87%) 
 
1H NMR (500 MHz, CDCl3) δ 7.58 (d, J = 8.3 Hz, 4 H), 7.51 (d, J = 8.2 Hz, 4 H). 19F NMR 
(471 MHz, CDCl3) δ -62.77. 13C{1H} NMR (126 MHz, CDCl3) δ 123.89 (q, J = 272.1 Hz), 
126.13 (q, 3.7 Hz), 128.54, 130.08 (q, 32.8 Hz), 140.73. HRMS-EI+ (m/z): [M + H]+ calcd 
for C14H8S4F6, 417.94130; found, 417.94100. 
 
 
1,4-bis-(4-fluorophenyl)tetrasulfane (2, Et2O) 
 
Yellow liquid. 261 mg (84%) 
 
1H NMR (600 MHz, CDCl3) δ 7.53 (m, 4 H), 7.03 (t, J = 8.6 Hz, 4 H). 19F NMR (565 MHz, 
CDCl3) δ -111.82 (tt, J = 9.0, 5.1 Hz). 13C{1H} NMR (151 MHz, CDCl3) δ 116.54 (d, J = 
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22.1 Hz), 131.59 (d, J = 3.3 Hz), 133.53 (d, J = 8.4 Hz), 162.54, 164.19. HRMS-EI+ (m/z): 
[M + H]+ calcd for C12H8S4F2, 317.94771; found, 317.94790. 
 
1,4-phenyltetrasulfane (3, Et2O) 
 
Yellow liquid (may solidify upon standing). 225 mg (70%) 
 
1H NMR (500 MHz, CDCl3) δ 7.32 (q, J = 6.6 Hz, 6 H), 7.56 (m, 4 H). 13C{1H} NMR (126 
MHz, CDCl3) δ 128.49, 129.29, 130.32, 136.35. HRMS-EI+ (m/z): [M + H]+ calcd for 
C12H10S4, 281.96655; found, 281.96618. 
1,4-di-p-tolyltetrasulfane (4, Et2O) 
 
Yellow powder. 303 mg (73%) 
 
1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 7.9 Hz, 4 H), 7.14 (d, J = 7.9 Hz, 4 H), 2.35 (s, 
 
6 H). 13C{1H} NMR (126 MHz, CDCl3) δ 139.02, 133.00, 131.21, 130.05, 21.36. HRMS- 
EI+ (m/z): [M + H]+ calcd for C14H14S4, 309.99785; found, 309.99746. 
 
1,4-bis-(4-methoxyphenyl)tetrasulfane (5, Et2O) 
 
Yellow powder. 290 mg (95%) 
 
1H NMR (500 MHz, CDCl3) δ 3.82 (s, 6 H), 6.86 (d, J = 8.8 Hz, 4 H), 7.51 (d, J = 8.8 Hz, 
 
4 H). 13C{1H} NMR (126 MHz, CDCl3) 55.56, 114.91, 127.21, 134.33, 160.81. HRMS- 
EI+ (m/z): [M + H]+ calcd for C14H14O2S4, 341.98768; found, 341.98780. 
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4,4’-tetrasulfanediylbis(N,N-dimethylaniline) (6, Et2O) 
 
Yellow powder. 204 mg (68%) 
 
1H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 8.9 Hz, 2 H), 6.65 (d, J = 8.5 Hz, 2 H), 2.98 (s, 
 
6H). 13C {1H} NMR (126 MHz, CDCl3) δ 151.11, 135.04, 112.87, 40.58. TOF HRMS ES+ 
 
(m/z): [M + H]+ calcd for C16H21N2S4, 369.0588; found, 369.0582. 
 
 
3,3’-tetrasulfanediylbis(2-acetamidopropanoic acid) (7, THF) 
 
Modification from general procedure: S2Cl2 (0.6 equiv.) was added to parent thiol (1.0 
equiv.) dissolved in anhydrous THF at room temperature under N2. The solution was stirred 
for 2 h and subjected to an aqueous workup. 
 
 
White powder. 704 mg (80%) 
 
1H NMR (500 MHz, d6-DMSO) δ 12.95 (s, 1 H), 8.36 (d, J = 7.9 Hz, 2 H), 4.55 (td, J = 
 
8.4, 4.6 Hz, 2 H), 3.39 (dd, J = 13.8, 4.7 Hz, 2 H), 3.23 (dd, J = 13.8, 8.9 Hz, 2 H), 1.86 (s, 
 
6 H).13C{1H} NMR (126 MHz, d6-DMSO) δ 171.63, 169.38, 54.90, 51.31, 22.37. TOF 
HRMS-ES+ (m/z): [M + H]+ calcd for C10H17N2O6S4, 388.9969; found, 388.9966. 
 
Dimethyl 3,3’-tetrasulfanediylbis(2-acetamidopropanoate) (8, DCM) 
White powder. 300 mg (85%) 
1H NMR (500 MHz, d6-DMSO) δ 8.49 (s, 2 H), 4.65 (dtd, J = 13.1, 8.3, 4.9 Hz, 2 H) 3.66 
 
(s, 6 H), 3.41 (ddd, J = 23.5, 14.0, 4.9 Hz, 2 H), 3.26 (m, 2 H) 1.86 (s, 6 H). 13C{1H} NMR 
 
(126 MHz, CDCl3) δ 170.68, 169.46, 52.28, 52.26, 52.23, 51.28, 51.12, 22.29, 22.27. TOF 
HRMS-ES+ (m/z): [M + H]+ calcd for C12H21N2O6S4, 417.0282; found, 417.0275. 
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4.4.3 Crystallographic Data for 4 
 
C14H14S4, M = 310.49, 0.10 x 0.09 x 0.04 mm, T = 173(2) K, Monoclinic, space group 
P21/c, a = 14.0418(4) Å, b = 6.1192(2) Å, c = 17.3990(5) Å, β = 101.306(2)°, V = 
1465.99(8) Å3, Z = 4, Dc = 1.407 Mg/m3, μ(Cu) = 5.770 mm-1, F(000) = 648, 2θmax  = 
133.24°, 8807 reflections, 2535 independent reflections [Rint = 0.0406], R1 = 0.0356, wR2 
 
= 0.0928 and GOF = 1.036 for 2535 reflections (219 parameters) with I>2σ(I), R1 = 0.0412, 
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Sulfane sulfur (S0) is formally defined as a sulfur atom that bears six valence 
electrons, has no formal charge, can exist in a thiosulfoxide tautomer, and is bonded to two 
or  more  sulfur  atoms  or  to  a  sulfur  atom  and  an  ionizable  hydrogen.165  This  
sulfur oxidation state is found in various sulfur-containing species including elemental 
sulfur, persulfides, and polysulfides.166 Under physiological conditions, S0 can be reduced 
in the presence of biological thiols, such as reduced glutathione (GSH) or cysteine (Cys), 




Figure 5.1 Common S0-containing small molecule species release H2S upon reaction with 
biological thiols. 
 
H2S is now commonly associated with the gasotransmitter family,  which  
includes nitric oxide and carbon monoxide, because it is produced endogenously, can 
freely permeate cell membranes, and can act on specific cellular and/or molecular targets 
to exert physiological effects.124 Recent work has demonstrated H2S-mediated signaling in 
processes including neurotransmission,168 vasodilation,169 and anti-inflammation.170 
Towards efforts to provide exogenous H2S as either a pharmacological tool or as a 
potential therapeutic,127a a number of groups have prepared small molecules capable of 
releasing H2S under different conditions.15a, 130 Notably, a number of these developed donor 
motifs generate persulfides en route to H2S release, which complicates whether the 
observed biological effects from such donors is due to H2S release or S0. Recently, 
evaluation of H2S-signaling mechanisms has revealed the formation of persulfides as a 
common intermediate leading to questions of whether persulfides and related S0-containing 
species are key signaling intermediates.171 
When considering sulfur oxidation states, persulfides possess reduced sulfur and 
S0, implying potential significance of S0 in sulfur biology.172 Under physiological 
conditions, S0 readily oxidizes free thiol residues to generate persulfides via a reaction 
mechanism known as persulfidation,173 and this process has been shown to upregulate the 
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activity of key enzymes such as xanthine oxidase.174 Additionally, the formation of 
persulfides under physiological conditions has been proposed to occur via the reaction of 
oxidized reactive sulfur species including disulfides, sulfenic acids, and S-nitrosothiols 
with H2S.175 Interestingly, persulfidation of thiol-based antioxidants such as GSH leads to 
enhanced antioxidant activity when compared to corresponding thiols.176 Within the active 
sites of specific enzymes, persulfides can be stabilized and the H2S release from an 
enzyme-bound persulfide has been shown in 3-mercaptopyruvate sulfurtransferase via 
thioredoxin-mediated reduction.177 Toward directly studying small molecule persulfide 
reactivity, recent work has demonstrated the ability to generate persulfides under 
physiological conditions178 for applications in protein persulfidation,179 reactive oxygen 
species scavenging,180 and H-atom transfer agents.181 Previous work by our group 
demonstrated the ability to access discrete persulfides182 and study their reactivity under 
various conditions.183 A common, yet understudied pathway for accessing persulfides, 
hydropolysulfides, and other closely related reactive sulfur species is the thiol-mediated 
reduction of organic polysulfides. 
Polysulfides are a class of organosulfur species commonly found in nature,156, 184 
that have unique biological properties.185 Readily  isolated  from alliums such  as 
garlic186, diallyl trisulfide (DATS) is a simple, organic polysulfide which has been studied 
heavily  in  the  field  of  biological  sulfur  chemistry.  The  commercial  availability      
of DATS has led to its broad use as an H2S donor and source of S0. For example, the 
cytotoxicity of DATS has been reported in a wide array of human cancer cell lines,187 
although we note the cytotoxicity of DATS appears to be directly correlated to S0 content 
as the analogous monosulfide and disulfide demonstrate minimal cytotoxicity.188 Upon 
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examining the mechanism of action, DATS was found to suppress cell proliferation in 
human colon cancer cells (HCT-15) via S-allylation of Cys-12β and Cys-354β in β- 
tubulin rather than direct H2S or persulfide release.189 By contrast, the thiol-dependent 
release of H2S from DATS in human red blood cells and the vasoactivity of garlic extract 
administration was found to be directly related to H2S production.152 In the presence of 
thiols, DATS releases   H2S   upon nucleophilic attack    at    the    α-sulfur    to    
generate allyl persulfide, which further reacts with a second equivalent of thiol to generate 
H2S.154 Despite the accessibility of other organic polysulfides, studies have been primarily 
limited to DATS. Alternatively, researchers have relied heavily on the use of inorganic 
polysulfides,190 which spontaneously disproportionate under mild, aqueous conditions to 
yield complex mixtures.191 Recently, our group and others136 have demonstrated the ability 
to access192 and utilize organic polysulfides beyond DATS for thiol-triggered H2S 
delivery.137 Aligned with our interests in studying S0-containing reactive sulfur species, we 
sought to expand the toolbox of available organic polysulfides and study the effect of 
varying S0 content in a single series of polysulfides. Herein, we demonstrate the thiol- 
mediated release of H2S from benzyl trisulfide and benzyl tetrasulfide respectively. 
Additionally, we demonstrate the ability of S0-containing benzyl polysulfides to suppress 
cell proliferation in bEnd.3 cells in a S0 content-dependent manner. 
 
5.2 Results and Discussion 
 
To investigate the impacts of sulfur content in polysulfides, we chose to study 
benzyl polysulfides ranging from benzyl sulfide (Bn2S) up to and including benzyl 
tetrasulfide (Bn2S4). Using previously reported conditions,193 we synthesized Bn2S4 in 
94  
89% yield via treatment of benzyl mercaptan with sulfur monochloride (S2Cl2) in the 
presence of pyridine at −78 °C (Figure 5.2a). 
 
Figure 5.2 (a) Synthesis of Bn2S4. (b) Synthesis of Bn2S3. (c) Comparison of benzylic 1H 
NMR (500 MHz) signals between Bn2S2, Bn2S3, and Bn2S4 in CDCl3. 
 
To access benzyl trisulfide (Bn2S3), we evaluated prior reports of symmetrical trisulfide 
synthesis. Most reports cite the use of sulfur dichloride (SCl2), an unstable sulfur chloride 
reagent that exists in equilibrium with S2Cl2. To avoid the use of SCl2, we were drawn to 
a report by Harpp and co-workers that used alkoxide-mediated decomposition of 
sulfenylthiocarbonates to access trisulfides.194 Although treatment of 
methoxycarbonylsulfenyl chloride with benzyl mercaptan readily afforded the desired 
precursor in 83% yield, we found that further treatment with potassium tert-butoxide 
(KOtBu) in methanol  provided  an  inseparable  mixture  of  benzyl disulfide (Bn2S2)  
and Bn2S3. The proposed reaction mechanism by Harpp and co-workers involves an 
initial nucleophilic attack by the tert-butoxide anion at the carbonyl to form a carbonate 
and release benzyl persulfide. Based on previous work from our group, treatment of BnSSH 
with different bases resulted in disproportionation to yield various benzyl polysulfides, 
which supports the formation of benzyl persulfide under the current reaction conditions.195 
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Due to steric congestion and poor nucleophilicity, we viewed that nucleophilic attack by 
KOtBu was unlikely  and  hypothesized  that  the  active nucleophile in  this  reaction  
was hydroxide, which can be generated upon deprotonation of residual water in methanol 
by the tert-butoxide anion. 
To test this hypothesis, we treated the benzyl sulfenylthiocarbonate precursor  
with tBuOK in a mixture of tetrahydrofuran and water. Consistent with our hypothesis, we 
were able to isolate Bn2S3 in 36% yield (Figure 5.2b). Considering hydroxide as the active 
nucleophile, we have proposed a new reaction mechanism for the synthesis of symmetrical 
trisulfides via hydroxide-mediated decomposition of sulfenylthiocarbonates (Scheme E.1). 
In comparison to current methods of mild trisulfide synthesis, we note the use of hydroxide 
likely prevents the formation of symmetrical trisulfides containing base-sensitive 
functional groups. Using 1H NMR spectroscopy, benzyl polysulfides can be identified by 
their respective peaks corresponding to benzylic protons which are unique to each 
polysulfide ranging from Bn2S2 to benzyl pentasulfide in deuterated chloroform allowing 
for ease of characterization (Figure 5.2c).196 
With a series of benzyl polysulfides in hand, we next investigated the release of 
H2S in the presence of cysteine and GSH. We anticipated that only Bn2S3 and Bn2S4 would 
release H2S and that Bn2S4 would release twice as much H2S relative to Bn2S3. To test our 
hypothesis, dibenzyl polysulfides (25 μM) were treated with an excess of cysteine or GSH 
(500 μM, 20 equiv.) in PBS (10 mM, pH 7.4) at 25 °C and H2S release was measured via 
the spectrophotometric methylene blue assay (Figure 5.3). As expected, we did not observe 
H2S release from Bn2S and Bn2S2 in the presence of cysteine or GSH, consistent with a 
lack of S0 content. Additionally, we note that the lack of H2S release from Bn2S2 suggests 
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that nucleophilic attack by Cys or GSH at the benzylic carbon to generate a H2S-releasing 
persulfide intermediate does not occur.61 For both GSH and Cys, we observed 
approximately twice as much H2S released from Bn2S4 than from Bn2S3, which is 
consistent with the higher S0 content of tetrasulfides when compared to trisulfides. 
 
Figure 5.3 (a) Reaction conditions for thiol-triggered release of H2S from Bn2Sn (n = 1, 2, 




In the presence of cysteine (500 μM, 20 equiv.), Bn2S3 and Bn2S4 released 8.6 (34% 
releasing efficiency) and 17.5 μM (35% releasing efficiency) H2S respectively after 
90 min. Similarly, we observed 4.3 μM (17% releasing efficiency) and 16 μM (32% 
releasing efficiency) H2S released from Bn2S3 and Bn2S4 respectively in the presence of 
GSH (500 μM, 20 equiv.) after 90 min. To compare the release of H2S from benzyl 
polysulfides to other commonly-used organic polysulfides, we measured the H2S release 
from DATS under the reported conditions. By comparison, DATS is a faster H2S donor 
than the benzyl polysulfides tested and yields approximately the same quantity of H2S after 
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110 min as Bn2S4. To rationalize this observation, we compared the stability of the 
intermediate persulfides for each donor system (i.e. benzyl persulfide vs. allyl persulfide). 
To the best of our knowledge, allyl persulfide has never been isolated and is simply 
observed as a fleeting intermediate, which suggests that is may be significantly less stable 
than benzyl persulfide, which has been isolated, characterized, and studied previously. 
Additionally, a comparison of the H2S releasing curves demonstrates a brief induction 
period for Bn2S3 and Bn2S4 which we attribute to a buildup of benzyl persulfide in 
solution. Taken together, these results demonstrate the significance of pendant alkyl 
groups in organic polysulfides and their overall effect on the chemical reactivity of 
downstream reactive sulfur species including persulfides. Relative to other synthetic H2S 
donors, we note that organic polysulfides provide lower H2S releasing efficiencies, which 
is likely a result of higher lipophilicity. We anticipate the design of water-soluble 
polysulfides should provide more efficient H2S donors.183 
Further advancing our studies, we sought to examine the effect of benzyl 
polysulfides on cell proliferation in murine epithelial bEnd.3 cells to determine whether 
the different releasing efficiencies for tri- and tetra-sulfides in solution translated into 
cellular   environments.   Previously,   studies   have   shown    administration    of 
sodium hydrosulfide (NaSH) led a pro-proliferative effect in bEnd.3 cells.197 The reported 
organic polysulfide library provides us a unique opportunity to directly examine the effects 
of S0 within a single series of polysulfides. With these compounds in hand, we sought to 
determine the impact of increasing S0 delivery on cell proliferation following 24 h 
treatments (Figure 5.4). Use of synthetic H2S donors such as AP39198 and direct 
administration of H2S via NaSH199 has been shown to have cytoprotective effects on 
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bEnd.3 cells. To the best of our knowledge, the effect of polysulfide administration has not 
been studied in this specific cell line. Consistent with a lack of S0 content, 24 h incubation 
with Bn2S and Bn2S2 (up to 200 μM) did not reduce cell viability. 
 
 
Figure 5.4 bEnd.3 cell viability after 24-h treatment of a series of organic polysulfides: 




Interestingly, S0-containing Bn2S3 and Bn2S4 at concentrations of 100 μM and higher 
demonstrated considerable cytotoxicity. Notably, Bn2S4 appears to be significantly more 
cytotoxic than Bn2S3, which is consistent with the increased S0 content in Bn2S4 relative 
to Bn2S3. Because biological thiols react with the tri- and tetrasulfides to generate two 
equivalents of benzyl mercaptan as a byproduct, we also tested the cytotoxicity of benzyl 
mercaptan to confirm that the observed cytotoxicity was due to the S0 content rather than 
the organic byproducts of the reaction. We elected to use S-benzyl ethanethioate (BnSAc) 
as  a  source  of  benzyl  mercaptan  to   enhance cell   permeability.   We   anticipated 
that hydrolysis of this ester under physiological conditions would generate benzyl 
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mercaptan and allow us to directly probe the effect of this thiol on cytotoxicity. Using 
treatment    up    to    400 μM,    we    did    not    observe    significant     cytotoxicity 
from BnSAc suggesting the observed cytotoxicity for benzyl polysulfides is a direct 
reflection of S0 content, rather than organic byproducts of the reaction (Figure E.9). To 
compare our results with a well-known organic polysulfide, we examined the effect        
of DATS administration on cell proliferation in bEnd.3 cells under the same conditions. 
Interestingly, treatment of bEnd.3 cells with increasing concentrations of DATS did not 
demonstrate significant cytotoxicity and suggests pendant alkyl groups in organic 
polysulfides can directly alter biological activities. Taken together, these results 
demonstrate the effect of increasing S0 content on cell proliferation in bEnd.3 cells and 





The identification of key intermediates in sulfur biology responsible for 
physiological changes such as vasodilation and anti-inflammation is of utmost importance. 
Recent work has begun to suggest the importance of S0 over H2S in biology and modern 
synthetic       techniques       readily       allow       for       access        to        simple 
organic polysulfides beyond DATS. Towards advancing our knowledge of reactive sulfur 
species in biology, we report our studies on examining S0 content in a single series of 
organic polysulfides ranging from monosulfide up to and including tetrasulfide. In the 
presence of biological thiols including cysteine and GSH, we demonstrate the release of 
H2S from Bn2S3 and Bn2S4 respectively under physiological conditions. Additionally, we 
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demonstrate the unique ability of Bn2S3 and Bn2S4 to suppress cell  proliferation,  
whereas DATS has no effect in bEnd.3 cells. The results of this study warrant future 
investigations into the effects of various organic polysulfides and supports the significance 
of S0 in sulfur biology. 
The results discussed in this Chapter demonstrate the H2S-releasing efficacy of 
organic polysulfides with increasing S0 content and suggests intermediate persulfides 
govern the biological activity of this compounds. In parallel to expanding donor 
compounds which generate H2S via intermediate reactive sulfur species, Chapter VI 
discusses the use of dithiasuccinoyl compounds as carbonyl sulfide-based H2S donors in 
the presence of biological thiols. 
 
 
5.4 Experimental Details 
 
5.4.1 Materials and Methods 
 
Reagents were purchased from Sigma-Aldrich,  Tokyo  Chemical  Industry  (TCI),  
and/or Cayman Chemical Company and used directly as received. Deuterated solvents 
were purchased from Cambridge Isotope Laboratories and used as received. 1H and 13C 1H 
NMR spectra were recorded on a Bruker 500 or 600 MHz instrument. Chemical shifts are 
reported relative to residual protic solvent resonances. Silica gel (SiliaFlash F60, Silicycle, 
230–400 mesh) was used for column chromatography. All air-free manipulations were 
performed under an inert atmosphere using standard Schlenk technique or an Innovative 
Atmospheres N2-filled glove box. UV–Vis spectra were acquired on an Agilent Cary 60 
UV–Vis spectrophotometer equipped with a Quantum Northwest TC-1 temperature 
controller at 25 °C ± 0.05 °C. 
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H2S Measurement Materials and Methods 
 
Phosphate buffered saline (PBS) tablets (1×, CalBioChem) were used to prepare buffered 
solutions (140 mM NaCl, 3 mM KCl, 10 mM phosphate, pH 7.4) in deionized water. Buffer 
solutions were sparged with N2 to remove dissolved oxygen and stored in an N2-filled 
glovebox. Donor stock solutions (in DMSO) were freshly prepared inside an N2-filled 
glovebox prior to an experiment. Thiol (cysteine or GSH) stock solutions (in PBS) were 
freshly prepared in an N2-filled glovebox immediately before use. 
 
 
General Procedure for Measuring H2S Release via Methylene Blue Assay (MBA) 
Scintillation vials containing 20 mL of PBS were prepared in an N2-filled glovebox. To 
these solutions, 20 μL of 500 mM analyte stock solution (in PBS) was added for a final 
concentration of 500 μM. The solutions were allowed to thermally equilibrate while stirring 
in a heating block at the desired temperature for approximately 20–30 min. Immediately 
prior to donor addition, 0.5 mL solutions of the methylene blue cocktail were prepared in 
disposable 1.5 mL cuvettes. The methylene blue cocktail solution contained: 200 μL of 
30 mM FeCl3 in 1.2 M HCl, 200 μL of 20 mM N,N-dimethyl-p-phenylene diamine in 
7.2 M HCl, and 100 μL of 1% (w/v) Zn(OAc)2. To begin an experiment, 20 μL of the 
25 mM donor stock solution (in DMSO) was added for a final concentration of 25 μM. At 
set time points after the addition of donor, 500 μL reaction aliquots were added to the 
methylene blue cocktail solutions and incubated for 1 h at room temperature shielded from 
light. Absorbance values were measured at 670 nm 1 h after addition of reaction aliquot. 
Each experiment was performed in quadruplicate unless stated otherwise. 
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MBA Calibration Curve 
 
Solutions containing 0.5 mL of the methylene blue cocktail and 0.5 mL PBS containing 
500 μM thiol (cysteine or GSH) were freshly prepared in disposable cuvettes (1.5 mL). 
Under inert conditions, a 10 mM stock solution of NaSH (Strem Chemicals) in PBS was 
prepared and diluted to 1 mM. Immediately after dilution, 1 mM NaSH was added to 
1.0 mL solutions for final concentrations of 10, 20, 30, 40, and 50 μM. Solutions were 
mixed thoroughly, incubated at room temperature for 1 h, and shielded from light. 





The murine brain endothelial cell line bEnd.3 was obtained by ATCC (CRL-2299) and 
cultured in phenol red DMEM containing 10% premium grade fetal bovine serum (FBS) 
and 1% penicillin-streptomycin (PS) (10,000 units/mL penicillin and 10,000 µg/mL 
streptomycin). Cells were incubated at 37 °C under 5% CO2. 
 
 
Cell Proliferation Assay 
 
bEnd.3 cells were seeded in Nunc® 96 well plates at 20,000 cells/well in 10% FBS, 1% 
PS DMEM and grown overnight. The next day, media was aspirated off and cells were 
rinsed in 1% PS-containing DMEM containing no FBS or phenol red. Media was replaced 
with the FBS-free DMEM containing either 0.5% DMSO (vehicle) or the tested 
compounds and cells were incubated under these conditions for 24 h before treatment with 
Cell Counting Kit-8 (CCK-8, Dojindo Molecular Technologies). No turbidity of the tested 




Cell proliferation data is represented as a percentage viability compared to the vehicle 
(Veh). Data for each treatment condition were averaged from several trials using a pooled 
average. Error was pooled from the standard deviations for each treatment condition found 
in each of these trials. A two-tailed Student's t-test was then performed comparing each 





SS-Benzyl O-methyl carbono(dithioperoxoate) 
 
Methoxycarbonylsulfenyl chloride (2.6 mmol, 1.1 equiv.) was added to anhydrous 
CH2Cl2 (20 mL) and cooled to 0 °C in an ice bath under N2. Once cooled, benzyl 
mercaptan (2.4 mmol, 1.0 equiv.) was added dropwise, and the reaction mixture was stirred 
for 1 h at 0 °C under N2. After 1 h, the reaction was quenched with the addition of deionized 
H2O (30 mL), and the organic layer was separated. The remaining aqueous layer was 
extracted with CH2Cl2 (2 ×30 mL), and the combined organic layers were washed with 
brine (x1) and dried over MgSO4. After filtration, the solvent was removed under reduced 
pressure, and the desired  product  purified  by  column  chromatography  (10%  EtOAc 
in hexanes, Rf = 0.46). The product was isolated as a clear liquid. Mass: 430 mg (83%) 1H 
NMR (500 MHz, DMSO-d6) δ: 7.38–7.26 (m, 5H), 4.07 (s, 2H), 3.79 (s, 3H). 13C 1H NMR 
(126 MHz, DMSO-d6) δ: 168.35, 136.13, 129.44, 128.41, 127.60, 55.77, 42.07. TOF 
MS EI + (m/z) [M + H]+ calc’d for C9H10O2S2 214.0122; found, 214.0120. 
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5.4.2.2 Benzyl tetrasulfide 
 
Benzyl mercaptan (2.0 mmol, 1.0 equiv.) and pyridine (2.0 mmol, 1.0 equiv.) were added 
to anhydrous Et2O (20 mL) and cooled to −78 °C over 1 h under N2. Sulfur monochloride 
(1.2 mmol, 0.6 equiv.) was added dropwise, and the reaction mixture was stirred at −78 °C 
for 2 h. The reaction was quenched with the addition of dH2O (30 mL) and diluted with 
CH2Cl2 (30 mL). The organic layer was removed, and the aqueous layer was extracted with 
CH2Cl2 (20 mL x 2). The combined organic layers were washed organic layers with brine 
(20 mL x 1), dried over MgSO4, filtered, and evaporated under reduced pressure to yield 
the product as a yellow solid. Mass: 280 mg (89%). 1H NMR (500 MHz, CDCl3) δ 7.37– 
7.27 (m, 10H), 4.16 (s, 4H). 13C 1H NMR (126 MHz, CDCl3) δ 136.39, 129.64, 128.81, 
127.87, 43.81. (HRMS experiments did not show the parent ion peak due to the weak 
 
internal S-S bond.) 
 
 
5.4.2.3 S-Benzyl ethanethioate 
 
Benzyl mercaptan (1.6 mmol, 1.1 equiv.) and triethylamine (1.6 mmol, 1.1 equiv.) were 
added to anhydrous CH2Cl2 (30 mL) and cooled to 0 °C in an ice bath under N2. Once 
cooled, acetyl chloride (1.4 mmol, 1.0 equiv.) was added dropwise, and the reaction was 
stirred at 0 °C for 2 h under N2. The reaction was quenched with the addition of deionized 
H2O (20 mL), and the organic layer was separated. The remaining aqueous layer was 
extracted with CH2Cl2 (2 × 20 mL) and the combined organic extractions were washed 
with brine (1 ×20 mL) and dried over MgSO4. After filtration, the solvent was removed 
under reduced pressure, and the desired product purified by column chromatography (20% 
CH2Cl2 in Hexanes, Rf = 0.25). The product was isolated as a clear liquid. 
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Mass: 126 mg (52%). 1H NMR (600 MHz, CDCl3) δ: 7.31–7.27 (m, 4H), 7.27–7.23 (m, 
1H), 4.13 (s, 2H), 2.35 (s, 3H). 13C 1H NMR (151 MHz, CDCl3) δ: 195.09, 137.56, 128.77, 
128.60,  127.24,  33.42,  30.29.  TOF  MS  (EI+)  (m/z):  [M + H]+ calc’d  for  C9H10OS 
 





USE OF DITHIASUCCINOYL-CAGED AMINES ENABLES COS/H2S RELEASE 
LACKING ELECTROPHILIC BYPRODUCTS 
 
 
This chapter includes previously published and coauthored material from Cerda, M.M.; 
Mancuso, J.L.; Mullen, E.J.; Hendon, C.H.; Pluth, M.D. Use of Dithiasuccinoyl-Caged 
Amines Enables COS/H2S Release Lacking Electrophilic Byproducts. Chem. Eur. J. 2020, 
DOI: 10.1002/chem.201905577. This manuscript was written by Matthew M. Cerda with 
editorial assistance from Professor Michael D. Pluth. The project in this chapter was 
conceived by Matthew M. Cerda. The experimental work in this chapter was performed by 
Matthew M. Cerda and Emma J. Mullen. The computational work in this chapter was 





Despite being a malodorous gas,200 hydrogen sulfide (H2S) is an important 
biological signaling molecule often referred to as a gasotransmitter alongside carbon 
monoxide and nitric oxide.1c, 90 H2S‐mediated signaling is important in several 
physiological processes including vasodilation,201 neurotransmission,202 and 
inflammation.14b These findings have led researchers to propose the use of H2S as a 
potential therapeutic agent for a variety of conditions and pathologies.92 Toward this goal, 
researchers have relied heavily on the use of NaSH and Na2S as sources of H2S due to ease 
of handling and commercial availability; however, H2S release from these salts is 
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considerably different relative to enzymatic H2S generation.96 To better mimic endogenous 
H2S production, methods of generating H2S at controlled rates under physiologically‐ 
relevant conditions are needed,127b and the development of small molecule “H2S donors” 
is an active research area aimed at addressing this need.203 Such compounds typically 
generate H2S by passive hydrolysis33, 37 or activation in the presence of specific stimuli 
including light,74 biological thiols,52 and cellular enzymes including esterases.17 
Recently, an alternative approach to H2S generation has utilized the hydrolysis of 
carbonyl  sulfide  (COS)  by  carbonic  anhydrase  (CA),  a  ubiquitous  
metalloenzyme.204 Existing in Nature as the most abundant sulfur‐containing gas in the 
atmosphere,100 COS is rapidly converted to H2S and carbon dioxide (CO2) in the presence 
of bovine carbonic anhydrase II (kcat/KM=2.2×104 m−1 s−1).205 In our initial approach, we 
were inspired by self‐immolative carbamates, which release CO2 as a byproduct upon 
activation,206 and developed analogous self‐immolative thiocarbamates that function as 
tunable COS‐based H2S donors (Figure 6.1a).16 
The high modularity of self‐immolative COS‐releasing motifs has enabled the rapid 
expansion of this approach by our group204 as well as others to prepare COS‐based H2S 
donors activated by various stimuli including acidic pH,40 esterases,20-21, 207 reactive 
oxygen species,24, 208 and cysteine.67-68 This approach has also been extended to provide 
oligomeric COS‐based H2S donors.209 A critical, yet often overlooked component of this 
approach is the formation of a quinone methide byproduct, which is a potent electrophile 
and known Michael acceptor in biological systems.210 Although we have not observed 





Figure 6.1 (a) Generalized reaction mechanism for COS release from self‐immolative 
thiocarbamates and subsequent hydrolysis of COS to H2S by carbonic anhydrase. (b) 
Overall reaction scheme of COS release from dithiasuccinoyl groups in the presence of 
thiols. 
 
these compounds may induce electrophilic stress leading to long‐term cytotoxicity.211 As 
an alternative approach, Matson and co‐workers have reported both small molecule and 
polymeric N‐thiocarboxyanhydrides (NTAs) as COS/H2S donors, which only result in 
small peptide byproducts.15b, 87 These donor compounds, however, exhibit a relatively low 
H2S‐releasing efficiencies. To further develop COS‐based H2S donors as both research 
tools and potential pharmacological agents, alternative donor motifs are needed that lack 
electrophilic byproducts, maximize COS/H2S release, and allow for simple tuning of 
release rates. 
To address these needs, we focused on the reactivity of the dithiasuccinoyl (DTS) 
group, which has been used previously as a protecting group for amines in peptide 
synthesis.212 The DTS group is cleaved by thiols, which results in reduction to a symmetric 
disulfide, two equivalents of COS, and an amine (Figure 6.1b). We note that previous 
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studies on thiol‐mediated reduction of DTS groups examined this reactivity in organic 
solvents using β‐mercaptoethanol as the reductant and quantified reaction kinetics through 
the use of an amino acid analyzer without direct observation of COS.213 We envisioned 
that this reactivity could be harnessed to prepare a library of COS‐based H2S donors that 
do not release electrophilic byproducts, but that readily release COS/H2S under 
physiologically relevant conditions in the presence of CA. Herein, we demonstrate that 
DTS‐caged amines function as versatile COS/H2S donors activated by biological 
nucleophiles, including cysteine and reduced glutathione (GSH). Additionally, we use a 
combination of experimental and computational investigations to demonstrate that the rate 
of COS/H2S release can be readily tuned by electronic modulation and subsequent 
stabilization of the COS‐releasing thiocarbamic acid intermediate. 
 
 
6.2 Results and Discussion 
 
To prepare a small library of COS‐based H2S donors with tunable release rates, we 
treated alkyl and aryl isothiocyanates with N,N‐dimethylethanolamine in the presence of 
sodium hydride to generate the desired thiocarbamate intermediate. Subsequent treatment 
with chlorocarbonylsulfenyl chloride afforded the desired DTS‐caged compounds (Scheme 
6.1). The amines chosen for this library included aryl amines with different electron 
donating/withdrawing properties, as well as alkyl amines with increasing steric bulk. To 
assess the viability of these compounds as COS/H2S donors, we examined the release of 
H2S from PhDTS (25 μm) in the presence of biologically‐relevant nucleophiles (500 μm, 
20 equiv) and CA (25 μg mL−1) using the methylene blue assay to measure H2S generation 








Figure 6.2 Activation profiles of H2S release from PhDTS (25 μM) in the presence of 
different nucleophiles (500 μM, 20 equiv) and carbonic anhydrase (25 μg mL−1). Data were 
acquired at 1, 5, 10, 15, 30, 45, and 60 min. Methylene blue absorbance values are relative 
to the maximum absorbance value obtained from H2S release in the presence of cysteine 
(3). Analytes: H2O with no carbonic anhydrase (1), cysteine with no carbonic anhydrase 
(2), N‐acetyl‐l‐cysteine (4), L‐cysteine methyl ester (5), N‐acetyl‐l‐cysteine methyl ester 
(6), homocysteine (7), reduced glutathione (8), serine (9), lysine (10), only carbonic 
anhydrase (11), S‐methyl cysteine (12). 
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broadly by different nucleophiles rather than one specific biological nucleophile, thus 
broadening the scope of potential activation pathways. 
In the absence of CA, we did not observe  hydrolysis-mediated  H2S  release  
from PhDTS. The addition of cysteine to PhDTS in the absence of CA resulted in slow, 
yet gradual H2S release. We attribute this observation to the hydrolysis of COS at 
physiological  pH,  which  has  been   reported   previously   to   be   slow.215 Treatment 
of PhDTS with cysteine in the presence of CA resulted in significant H2S generation. 
Using a calibration curve generated with known concentrations of NaSH, we measured 40 
μm H2S generation from 25 μM PhDTS in the presence of 500 μm cysteine, which 
corresponds to an H2S releasing efficiency of 80% (Figure F.46). This observation not only 
highlights the high efficiency of H2S release from DTS‐caged compounds, but also 
supports that two equivalents of COS are released per DTS group. 
In addition to COS/H2S release, we also observed the formation of aniline following 
treatment of PhDTS with cysteine by HPLC, which further supports the proposed 
releasing mechanism (Figure S48). Protection of the amine and/or carboxylate groups on 
cysteine did not significantly impact the rate or quantity of COS/H2S release from PhDTS, 
which supports a thiol‐mediated releasing pathway. Interestingly, the use of S‐methyl 
cysteine resulted in slow, yet considerable H2S release suggesting a less favorable, thiol‐ 
independent reaction pathway. In previous studies, the direct reaction of amines at the 
carbonyl position of DTS groups has been observed and proposed to result in the generation 
of COS and sulfane sulfur.213 We observed a similar rate of H2S release in the presence of 
lysine, which further supports a minor, amine‐mediated mechanism of H2S release. We 
note an induction phase in the rate of amine activation and find that this reaction is slower 
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relative to the thiol‐mediated reduction of DTS groups (Figure F.49). Together with the 
decreased nucleophilicity of amines due to protonation at physiological pH and lower 
biological concentrations relative to thiols, we expect this mechanism of activation to be 
negligible in a biological context. In the presence of homocysteine and GSH, we observed 
lower quantities of COS/H2S released, which we attribute to the lower nucleophilicity of 
these thiols as a function of thiolate/thiol speciation at physiological pH.108, 216 We failed 
to observe COS/H2S release in the presence of serine, which implies that alcohol‐mediated 
mechanisms are not a significant activation pathway. 
In the presence of CA, but absence of any added nucleophiles, we did observe slight 
H2S  production.  We  hypothesized  that  this  release  could  be  due  to  coordination   
of PhDTS to the Zn2+ center in CA, which would facilitate hydrolysis by carbonyl 
activation. To probe this reactivity, we pre‐incubated CA with the CA inhibitor 
acetazolamide (5 μM) and measured H2S release from PhDTS (Figure F.47). Under these 
conditions, we failed to observe H2S generation, which supports the hypothesis of a minor 
CA/Zn2+‐mediated hydrolysis mechanism. Alternatively, this could also be due to minor 
background DTS hydrolysis followed by COS conversion to H2S by CA. Further 
experiments using a catalytic amount of Zn(OAc)2 (5 μM) did not result in COS/H2S 
release from PhDTS, which suggests the need for the protein microenvironment present in 
CA for activation of PhDTS (Figure F.48).217 Similar to the reactivity with amines, the rate 
of CA/Zn2+‐mediated hydrolysis is slower than the thiol‐mediated reduction. Taken 
together, these results demonstrate the validity of PhDTS and related compounds to serve 





Figure 6.3 (a) H2S release from aryl‐based DTS compounds. (b) H2S release from alkyl‐ 
based DTS compounds. 
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With a small library of DTS‐based donors in hand, we next examined the effect of 
the amine payload on COS/H2S release using each donor (25 μM) in the presence of 
cysteine (500 μM, 20equiv.) and CA (25 μg mL−1) at physiological pH (Figure 6.3). We 
hypothesized that DTS‐caging of functionalized anilines would allow COS/H2S release 
rates to be tuned based on prior work aimed at solvent‐dependent linear free energy 
relationship investigations  into  the  phosphine‐mediated  sulfur  extrusion  from  
DTS.218 Additionally, we expected that the caging of alkyl amines would lead to 
stabilization of the COS‐releasing thiocarbamic acid intermediate and subsequently 
decrease the rate of H2S release relative to that observed for DTS‐caged anilines. In the 
presence of cysteine and CA, we observed varying rates and quantities of H2S release from 
the reported aryl‐based DTS compounds with 3‐MePhDTS and 4‐tBuPhDTS displaying 
the fastest and slowest rates of H2S release, respectively (Figure 6.3a). The releasing curves 
from the DTS‐caged anilines did not fit cleanly to first‐order exponential decay, which we 
attribute to competing COS‐releasing and DTS consumption pathways, such as direct thiol 
activation versus CA‐mediated activation. Additionally, previous work has reported the 
formation of isothiocyanates from sufficiently acidic thiocarbamates, which likely further 
complicates the rates of release from DTS‐caged anilines containing electron‐withdrawing 
groups.219 Overall, the functionalization of caged anilines directly alters rates of COS/H2S 
release from DTS‐based donors, and the ability to control tuning of these releasing kinetics 
merits future investigation. By contrast, we observed the caging of alkyl amines resulted 
in  significantly  slower  rates   of   H2S   release   relative   to   DTS‐caged   anilines   
with tBuDTS and EtDTS displaying the fastest and slowest rates of H2S release, 
respectively (Figure 6.3b). We reasoned that inductively donating alkyl amines likely 
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To further investigate the differences between aryl and alkyl amine substitution, we 
used density functional theory (DFT) to examine the potential energy surface for COS 
release from PhDTS and AlkylDTS compounds. In these systems, we used methyl thiol 
(MeSH) to simplify possible protonation states of non‐participating functional groups 
during the reaction. Calculations were performed using Gaussian 09 at the B3LYP/6– 
311++G(d,p) level of theory applying the IEF‐PCM water solvation model (Figure 6.4). 
 
Figure 6.4 Potential energy surface for COS release from PhDTS and AlkylDTS 
compounds. Calculations were performed using Gaussian 09 at the B3LYP/6– 
311++G(d,p) level of theory applying the IEF‐PCM water solvation model. MeSH was 
used as the thiol nucleophile to simplify accessible protonation states of non‐participating 
functional groups on the thiol nucleophile. 
 
 
For PhDTS, we found that the initial nucleophilic attack by the thiolate was the 
highest barrier (21.7 kcal mol−1) on the reaction coordinate and dethiocarboxylation of the 
thiocarbamic acid intermediate was only moderately endothermic (+3.2 kcal mol−1) with 
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respect to the starting materials. By contrast, although the AlkylDTS compounds showed 
similar activation barriers for the initial attack by thiolate (23.5–26.8 kcal mol−1), the 
activation barrier for the final dethiocarboxylation varied significantly as a function of the 
alkyl group. The  highest  activation  barrier  for  dethiocarboxylation  was  found  for  
the EtDTS compound (+29.8 kcal mol−1), but this barrier decreased with the increasing 
donating ability of iPrDTS (+27.5 kcal mol−1), and tBuDTS (+20.9 kcal mol−1); all of 
which were competitive with the activation barriers for initial thiol attack on the DTS motif. 
These relative energetic barriers are consistent with the observed rates of COS/H2S release 
from the AlkylDTS compounds. Moreover, these results suggest that the inductive 
contributions, rather than the steric bulk differences of the alkyl substituents, have a larger 
impact on the release of COS from thiocarbamic acid intermediates. Taken together, the 
combination of experimental and computational data demonstrates the ability to tune 
H2S/COS release from this scaffold by simple structural modifications. More broadly, these 
results provide guidance for controlling the COS/H2S release rate from donor motifs that 





We demonstrated the use of DTS‐based compounds to serve as COS/H2S donors in 
the presence of thiols without the formation of electrophilic byproducts. Reactivity studies 
using PhDTS as a model compound were used to investigate COS/H2S release as a 
function of biological nucleophiles and thiol identity. By modifying the structure of the 
amine payloads, we also demonstrated that the rate of COS/H2S release from DTS‐based 
donors can be modified by simple structural modifications. The results from DFT 
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calculations has shed light on the impact of amine identity on COS release from 
thiocarbamic acids and provides a foundation to guide future work on this reactive 
intermediate. Specifically, this work directly elaborates on the observed reactivity 
differences between aryl and alkyl thiocarbamates as COS‐releasing motifs, which 
provides fundamental information upon which to expand the utility of these donors. The 
simple synthetic conditions and unique reactivity of this donor scaffold would readily allow 
for the incorporation amine‐based payloads including fluorophores220 and known 
therapeutics221 to provide COS‐based H2S fluorescent donors and prodrugs. 
The chemistry described in Chapter VI provides a modular platform for the 
development of COS-based H2S donors with no electrophilic byproducts and potential 
prodrug applications. Aligned with our interests in the potential signaling properties of 
COS independent of H2S, there exists a need to develop a method of selective COS 
detection. The work in Chapter VII describes the validity of a colorimetric and fluorescent 
probe for selective detection of COS over carbon dioxide and carbon disulfide. 
 
 
6.4 Experimental Details 
 
6.4.1 Materials and Methods 
 
Reagents were purchased from Sigma‐Aldrich, Tokyo Chemical Industry, or VWR and 
used directly as received. Deuterated solvents were purchased from Cambridge Isotope 
Laboratories and used as received. 1H, 13C 1H, and 19F NMR spectra were recorded on a 
Bruker 500 MHz instrument. Chemical shifts were reported relative to residual protic 
solvent resonances. MS data was collected on a Xevo G2‐XS QTof (Waters) instrument. 
Silica gel (SiliaFlash F60, Silicycle, 230–500 mesh) was used for column chromatography. 
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H2S Detection Materials and Methods 
 
Phosphate buffered saline (PBS) tablets (1X, CalBioChem) were used to prepare buffered 
solutions (140 mm NaCl, 3 mm KCl, 10 mm phosphate, pH 7.4) in deionized water. Buffer 
solutions were sparged with nitrogen to remove dissolved oxygen and stored in an 
Innovative Atmosphere nitrogen‐filled glovebox. Donor stock solutions (in acetonitrile) 
were prepared inside a nitrogen‐filled glovebox immediately before use. Trigger stock 
solutions (in PBS) were freshly prepared in an N2‐filled glovebox immediately before use. 
CA stock solutions (in PBS) were freshly prepared in a nitrogen‐filled glovebox 
immediately before use. 
 
 
General Procedure for Measuring H2S Release via Methylene Blue Assay (MBA) 
Scintillation vials containing 20 mL of 10 mm PBS (pH 7.4) were prepared in a nitrogen‐ 
filled glovebox. To these solutions, 20 μL of 500 mm analyte stock solution and 50 μL of 
10 mg mL−1 CA were added for final concentrations of 500 μm and 25 
μg mL−1 respectively. While stirring, solutions were allowed to thermally equilibrate in 
heating block set at 25 °C for approximately 20–30 min. Immediately prior to donor 
addition, 0.5 mL solutions of methylene blue cocktail were prepared in disposable 1.5 mL 
cuvettes. The methylene blue cocktail solution contains: 200 μL of 30 mm FeCl3  in  
1.2 m HCl, 200 μL of 20 mm N,N‐dimethyl‐p‐phenylene diamine in 7.2 m HCl, and 100 
μL of 1% (w/v) Zn(OAc)2. To begin an experiment, 20 μL of 25 mm donor stock solution 
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was added for a final concentration of 25 μm. At set time points after the addition of donor, 
500 μL reaction aliquots were added to the methylene blue cocktail solutions and incubated 
for 1 h at room temperature shielded from light. Absorbance values at 670 nm were 
measured 1 h after addition of reaction aliquot. Each experiment was performed in 
quadruplicate unless stated otherwise. UV/Vis spectra were acquired on an Agilent Cary 
60 UV/Vis spectrophotometer equipped with a Quantum Northwest TC‐1 temperature 
controller set at 25±0.05 °C. 
 
 
MBA Calibration Curve 
 
Solutions containing 0.5 mL of methylene blue cocktail and 0.5 mL PBS (pH 7.4) 
containing 500 μM cysteine and 25 g/mL CA were freshly prepared in disposable 1.5 mL 
cuvettes. Under inert conditions, a 10 mM stock solution of NaSH (Strem Chemicals) in 
PBS was prepared and diluted to 1 mM. Immediately after dilution, 1 mM NaSH was added 
to 1.0 mL solutions for final concentrations of 10, 20, 30, 40, 50, and 60 μM. Solutions 
were mixed thoroughly, incubated at room temperature for 1 h, and shielded from light. 





All structures were initially constructed, and optimized using the UFF force field as 
implemented, in Avogadro.222 The resultant structures were further optimized using the 
unrestricted hybrid GGA functional, B3LYP, as implemented in Gaussian 09,223 with a 
triple zeta basis set that includes diffuse and polarization functions on heavy atoms, 6– 
311+G*. A pseudosolvent polarizable continuum model for water was used to account for 
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solvation effects. Attacking thiols were modeled as methyl thiol to reduce computational 
expense. 
Transition state searches were carried out at the same level of theory as ground state 
structures. First, a potential energy surface scan of the active reaction coordinate was used 
to obtain a good starting point for the ultimate transition state search algorithm. Vibrational 
analysis confirmed a single imaginary frequency corresponding to the direction of bond 
formation or breaking for each activated complex. No transition state was found for thiol 
disulfide exchange, which could indicate a barrierless transition, or a shallow potential 
energy surface with a loose transition state. Biologically relevant thiols, such as cysteine, 
may undergo a more sterically hindered attack when compared to the methyl thiol 






General procedure for the synthesis of thiocarbamates 
 
This procedure has been modified from a previous report.218 
 
In a flame‐dried round bottom flask under nitrogen, sodium hydride (1.25 equiv) and N,N‐ 
dimethylethanolamine were added to anhydrous toluene (20 mL). After stirring briefly 
until gas evolution ceased, the desired isothiocyanate (1.0 equiv) was added dropwise (if 
liquid) or in a single portion (if solid). The reaction was stirred at room temperature for 3 
h under nitrogen, quenched with deionized H2O (30 mL), and extracted with ethyl acetate 
(3×15 mL). The combined organic extractions were washed with brine (1×20 mL), dried 
over MgSO4, and concentrated under reduced pressure. The desired product was obtained 
121  
following purification by column chromatography. All NMR data for these compounds 
was obtained at 60 °C due to hindered rotation of thiocarbamates at room temperature. We 
note the alkyl thiocarbamates displayed hindered rotation at 60 °C giving rise to two sets 
of peaks corresponding to the E and Z isomers. 
 
 
O-(2-(Dimethylamino)ethyl) phenylcarbamothioate (PhTC) 
Slightly yellow oil, 339 mg (68%) Rf = 0.30 (5% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) δ: 7.50 (br s, 2 H), 7.37 – 7.26 (m, 2 H), 7.23 – 7.06 (m, 1 
 
H), 4.56 (t, J = 5.7 Hz, 2 H), 2.65 (t, J = 5.8 Hz, 2 H), 2.22 (s, 6 H). 13C{1H} NMR (126 
 
MHz, DMSO-d6) δ: 187.48, 137.98, 128.29, 124.55, 122.17, 67.88, 56.80, 44.98. 
TOF MS (ASAP+) (m/z): [M + H]+ calc’d for C11H17N2OS 225.1062; found 225.1047 
 
O-(2-(Dimethylamino)ethyl) (4-(tert-butyl)phenyl)carbamothioate (4-tBuPhTC) 
Slightly yellow oil, 368 mg (84%) Rf = 0.43 (5% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) δ: 10.85 (br s, 1 H), 7.41 (br s, 2 H), 7.34 (d, J = 8.5 Hz, 
 
2 H), 4.55 (t, J = 5.8 Hz, 2 H), 2.65 (t, J = 5.8 Hz, 2 H), 2.23 (s, 6 H), 1.28 (s, 9 H). 
 
13C{1H} NMR (126 MHz, DMSO-d6) δ: 187.25, 147.09, 135.45, 124.90, 121.80, 56.79, 
 
54.51, 44.96, 33.83, 30.86. TOF MS (ASAP+) (m/z): [M + H]+ calc’d for C15H25N2OS 
 
281.1688; found 281.1707 
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O-(2-(Dimethylamino)ethyl) (3-fluorophenyl)carbamothioate (3-FPhTC) 
White powder, 395 mg (83%) Rf = 0.34 (5% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) δ: 7.51 (br s, 1 H), 7.44 – 7.25 (m, 2 H), 6.95 (dt, J = 9.0, 
 
4.5 Hz, 1 H), 4.58 (t, J = 5.7 Hz, 2 H), 2.66 (t, J = 5.6 Hz, 2 H), 2.24 (s, 6 H). 19F NMR 
 
(471 MHz, DMSO-d6) δ: -112.32. 13C{1H} NMR (126 MHz, DMSO-d6) δ: 187.40, 161.72 
 
(d, J = 242.0 Hz), 139.60, 129.85 (d, J = 9.4 Hz), 117.42, 110.85 (d, J = 20.9 Hz), 108.66 
(d, J = 25.9 Hz), 67.99, 56.70, 44.88. TOF MS (ASAP+) (m/z): [M + H]+ calc’d for 
C11H16FN2OS 243.0967; found 243.0969 
 
 
O-(2-(Dimethylamino)ethyl) m-tolylcarbamothioate (3-MePhTC) 
Slightly yellow oil, 403 mg (84%) Rf = 0.50 (10% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) δ: 10.84 (br s, 1 H), 7.43 – 7.24 (m, 2 H), 7.20 (t, J = 7.7 
 
Hz, 1 H), 6.96 (d, J = 7.3 Hz, 1 H), 4.55 (t, J = 5.7 Hz, 2 H), 2.64 (t, J = 5.7 Hz, 2 H), 2.29 
 
(s, 3 H), 2.23 (s, 6 H). 13C{1H} NMR (126 MHz, DMSO-d6) δ: 187.39, 137.90, 137.58, 
 
128.06, 125.17, 122.66, 119.09, 68.04, 56.79, 44.93, 20.72. TOF MS (ASAP+) (m/z): [M 
 
+ H]+ calc’d for C12H19N2OS 239.1218; found 239.1200 
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O-(2-(Dimethylamino)ethyl) (4-isopropylphenyl)carbamothioate (4-iPrPhTC) 
Slightly yellow oil, 350 mg (78%) Rf = 0.45 (10% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) δ: 10.84 (br s, 1 H), 7.40 (br s, 2 H), 7.19 (d, J = 8.5 Hz, 
 
2 H), 4.55 (t, J = 5.8 Hz, 2 H), 2.87 (hept, J = 6.9 Hz, 1 H), 2.64 (t, J = 5.8 Hz, 2 H), 2.22 
 
(s, 6 H), 1.20 (d, J = 6.9 Hz, 6 H). 13C{1H} NMR (126 MHz, DMSO-d6) δ: 187.34, 144.82, 
 
135.80, 126.01, 122.41, 67.66, 48.33, 44.98, 32.60, 23.50. TOF MS (ASAP+) (m/z): [M + 
H]+ calc’d for C14H23N2OS 267.1531; found 267.1540 
 
O-(2-(Dimethylamino)ethyl) (3-chlorophenyl)carbamothioate (3-ClPhTC) 
Faint yellow powder, 331 mg (72%) Rf = 0.51 (10% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) δ: 7.72 (s, 1 H), 7.45 (s, 1 H), 7.34 (t, J = 8.1 Hz, 1 H), 
 
7.18 (d, J = 7.9 Hz, 1 H), 4.57 (t, J = 5.6 Hz, 2 H), 2.65 (t, J = 5.6 Hz, 2 H), 2.24 (s, 6 H). 
 
13C{1H} NMR (126 MHz, DMSO-d6) δ: 187.46, 139.36, 132.70, 129.88, 124.09,  121.49, 
 
120.14, 68.03, 56.71, 44.90. TOF MS (ASAP+) (m/z): [M + H]+ calc’d for C11H16ClN2OS 
 
259.0672; found 259.0681 
 
 
O-(2-(Dimethylamino)ethyl) (4-fluorophenyl)carbamothioate (4-FPhTC) 
Yellow oil, 324 mg (68%) Rf = 0.34 (5% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) δ: 10.92 (s, 1 H), 7.52 (s, 2 H), 7.14 (t, J = 8.9 Hz, 2 H), 
 
4.55 (t, J = 5.7 Hz, 2 H), 2.64 (t, J = 5.7 Hz, 2 H), 2.22 (s, 6 H). 19F NMR (471 MHz, 
DMSO-d6) δ: -117.76. 13C{1H} NMR (126 MHz, DMSO-d6) δ: 187.57, 158.90 (d, J = 
242.2 Hz), 134.34, 124.29, 114.88 (d, J = 22.4 Hz), 67.77, 56.75, 44.93. TOF MS (ASAP+) 
(m/z): [M + H]+ calc’d for C11H16FN2OS 243.0967; found 243.0952 
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O-(2-(Dimethylamino)ethyl) ethylcarbamothioate (EtTC) 
Yellow oil, 805 mg (80%) Rf = 0.20 (5% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) : 8.95 (s, 1H), 4.42 (t, J = 5.8 Hz, 2H), 3.39 (p, J = 7.0 
 
Hz, 2H), 2.55 (t, J = 5.8 Hz, 2H), 2.20 (s, 6H), 1.10 (t, J = 7.3 Hz, 3H). 13C NMR (500 
MHz, DMSO-d6) : 189.01, 66.60, 57.05, 44.99, 36.95, 13.06 TOF MS (ASAP+) (m/z): [M 
+ H]+ calc’d for C7H17N2OS 177.1062; found 177.1048 
 
 
O-(2-(Dimethylamino)ethyl) isopropylcarbamothioate (iPrTC) 
 
Yellow oil, 354 mg (64%) Rf = 0.46 (5% MeOH in DCM) 
 
1H NMR (500 MHz, DMSO-d6) : 8.87 (s, 1H), 4.41 (t, J = 5.8 Hz, 2H), 4.20 (m, J = 6.7 
 
Hz, 1H), 2.56 (t, J = 5.9 Hz, 2H), 2.20 (s, 6H), 1.13 (d, J = 6.6 Hz, 6H) 13C NMR (500 
MHz, DMSO-d6) : 187.95, 66.40, 57.06, 46.38, 44.98, 20.99 TOF MS (ASAP+) (m/z): [M 
+ H]+ calc’d for C8H19N2OS 191.1218; found 191.1206 
 
 
O-(2-(Dimethylamino)ethyl) tert-butylcarbamothioate (tBuTC) 
Yellow oil, 418 mg (47%) Rf = 0.41 (5% MeOH in DCM) 
1H NMR (500 MHz, DMSO-d6) : 8.50 (s, 1H), 4.48 (t, J = 5.9 Hz, 2H), 2.59 (t, J = 5.8 
 
Hz, 2H), 2.20 (s, 6H), 1.29 (s, 9H) 13C NMR (500 MHz, DMSO-d6) : 188.75, 67.86, 57.07, 
53.50, 45.00, 28.71 TOF MS (ASAP+) (m/z): [M + H]+ calc’d for C9H21N2OS 205.1375; 
found 205.1363 
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General procedure for the synthesis of dithiasuccinoyls 
 
This procedure has been modified from a previous report.218 
 
To a flame‐dried round bottom flask under N2, chlorocarbonylsulfenyl chloride (1.0 equiv) 
was added to anhydrous DCM (20 mL). In a separate vial, the desired thiocarbamate (1.0 
equiv) was dissolved in anhydrous DCM (1 mL) and added dropwise to the reaction. The 
reaction mixture was stirred at room temperature for 1 h, after which it was quenched with 
1 m HCl (15 mL). The organic layer was separated and washed with deionized water (2×20 
mL) and brine (1×20 mL). The resultant solution was dried over MgSO4 and concentrated 






White solid, 70 mg (49%) Rf = 0.43 (40% Hexanes in DCM) 
 
1H NMR (500 MHz, CD3CN) δ: 7.60 – 7.47 (m, 3 H), 7.42 – 7.26 (m, 2 H). 13C NMR (126 
 
MHz, CD3CN) δ: 169.01, 136.01, 130.93, 130.68, 129.04. TOF MS (ASAP+) (m/z): [M + 
 




White powder, 70 mg (41%) Rf = 0.42 (1:1 Hexanes/DCM) 
1H NMR (500 MHz, CD3CN) δ: 7.60 (d, J = 8.7 Hz, 2 H), 7.27 (d, J = 8.7 Hz, 2 H), 1.35 
 
(s, 9 H). 13C{1H} NMR (126 MHz, CD3CN) δ: 169.08, 154.25, 133.42, 128.57, 127.69, 
 





White solid, 80 mg (56%) Rf = 0.28 (1:1 Hexanes:DCM) 
1H NMR (500 MHz, CD3CN) δ: 7.58 (td, J = 8.2, 6.2 Hz, 1 H), 7.30 (tdd, J = 8.6, 2.6, 0.9 
 
Hz, 1 H), 7.22 (ddd, J = 8.0, 2.0, 0.9 Hz, 1 H), 7.18 (dt, J = 9.3, 2.3 Hz, 1 H). 19F NMR 
(471 MHz, CD3CN) δ -112.52 (td, J = 8.9, 6.2 Hz). 13C{1H} NMR (126 MHz, CD3CN) δ: 
168.74, 164.59, 162.63, 137.05 (d, J = 10.5 Hz), 132.18 (d, J = 9.0 Hz), 125.32 (d, J = 3.3 
Hz), 117.98 (d, J = 21.1 Hz), 116.51 (d, J = 24.5 Hz). TOF MS (ASAP+) (m/z): [M + H]+ 
 




White solid, 70 mg (46%) Rf = 0.40 (1:1 Hexanes/DCM) 
1H NMR (500 MHz, CD3CN) δ: 7.43 (t, J = 7.8 Hz, 1 H), 7.35 (d, J = 7.7 Hz, 1 H), 7.21 – 
 
7.09 (m, 2 H), 2.39 (s, 3 H). 13C{1H} NMR (126 MHz, CD3CN) δ: 168.99, 141.06, 135.99, 
131.62, 130.50, 129.41, 126.02, 21.25. TOF MS (ASAP+) (m/z): [M + H]+  calc’d for 
 




White solid, 20 mg (14%) Rf = 0.37 (1:1 Hexanes:DCM) 
1H NMR (500 MHz, CD3CN) δ: 7.43 (d, J = 8.3 Hz, 2 H), 7.26 (d, J = 8.5 Hz, 2 H), 3.00 
 
(hept, J = 6.9 Hz, 1 H), 1.27 (d, J = 6.9 Hz, 6 H). 13C{1H} NMR (126 MHz, CD3CN) δ: 
169.08, 152.08, 133.67, 128.92, 128.68, 34.72, 24.08. TOF MS (ASAP+) (m/z): [M + H]+ 
 
calc’d for C11H12NO2S2 254.0309; found 254.0316 
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4-(3-Chlorophenyl)-1,2,4-dithiazolidine-3,5-dione (3-ClPhDTS) 
White solid, 60 mg (42%) Rf = 0.28 (1:1 Hexanes/DCM) 
1H NMR (500 MHz, CD3CN) δ: 7.58 – 7.52 (m, 2 H), 7.45 – 7.38 (m, 1 H), 7.37 – 7.28 
 
(m, 1 H). 13C{1H} NMR (126 MHz, CD3CN) δ: 168.74, 136.94, 135.32, 132.05, 131.08, 
 





White solid, 71 mg (53%) Rf = 0.32 (3:2 DCM/Hexanes) 
1H NMR (500 MHz, CD3CN) δ: 7.43 – 7.35 (m, 2 H), 7.33 – 7.24 (m, 2 H). 19F NMR (471 
 
MHz, CD3CN) δ: -112.38 – -112.54 (m). 13C{1H} NMR (126 MHz, CD3CN) δ: 168.99, 
163.94 (d, J = 248.0 Hz), 131.94 (d, J = 3.2 Hz), 131.29 (d, J = 9.1 Hz), 117.58 (d, J = 23.6 




Yellow oil, 54 mg (35%) Rf = 0.33 (50% DCM in hexanes) 
 
1H NMR (500 MHz, CDCl3) : 3.85 (q, J = 7.1 Hz, 2H), 1.27 (t, J = 7.1 Hz, 3H) 13C NMR 
(500 MHz, CDCl3) : 167.54, 41.76, 12.88 TOF MS (ASAP+) (m/z): [M + H]+ calc’d for 




White solid, 32 mg (22%) Rf = 0.42 (50% DCM in hexanes) 
 
1H NMR (500 MHz, CDCl3) : 4.68 (hept, J = 6.9 Hz, 1H), 1.47 (d, J = 6.9 Hz, 6H) 13C 
 
NMR (500 MHz, CDCl3) : 167.70, 52.19, 18.84 TOF MS (ASAP+) (m/z): [M + H]+ calc’d 




White solid, 35 mg (21%) Rf = 0.50 (50% DCM in hexanes) 
1H NMR (500 MHz, CDCl3) : 1.68 (s, 9H) 13C NMR (500 MHz, CDCl3) : 168.73, 67.31, 
 














Scheme 6.2 Reaction analysis products of PhDTS in the presence of cysteine 
 
 
To a 20 mL solution of 10 mM PBS (pH 7.4) containing 2 mM L-cysteine, 20 mL of 100 
mM PhDTS in MeCN was added and stirred at room temperature. After 1 h, 1.0 mL 
reaction aliquot was analyzed by HPLC. HPLC analysis was performed on an Agilent 1260 
HPLC instrument with a Poroshell 120 EC-C18 4.6x100 mm column and monitored at 230 
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nm. Solvent A: Solvent A: 95% H2O, 5% MeOH, Solvent B: 100% MeCN. Gradient: 35% 
Solvent A/65% Solvent B for 2 min. Change to 100% Solvent B over 4 min and hold for 
6.5 min. Change to 35% Solvent A/65% Solvent B over 0.5 min and hold for 4.5 min. Flow 
 
Rate: 0.5 mL/min, 2 μL injection. 
 
 
CA Inhibition Experiment 
 
A 5 mM stock solution of acetazolamide (AAA) in DMSO was prepared in an N2-filled 
glovebox immediately prior to use. To 20 mL solutions containing 10 mM PBS (pH 7.4), 
20 L of 5 mM AAA and 50 L of 10 mg/mL CA were added for final concentrations of 
5 μM and 25 g/mL respectively. While stirring, solutions were allowed to thermally 
equilibrate in a heating block set at 25 °C for approximately 20-30 min. To begin the 
experiment, 20 μL of 25 mM PhDTS was added for a final concentration of 25 μM. At set 
time points after the addition of donor, 0.5 mL reaction aliquots were added to the 
methylene blue cocktail solutions and incubated for 1 h at room temperature shielded from 
light. Absorbance values at 670 nm were measured 1 h after addition of reaction aliquot. 
 
 
Zn2+-Mediated Hydrolysis Experiment 
 
A 5 mM stock solution Zn(OAc)2 in PBS was prepared in an N2-filled glovebox 
immediately prior to use. To 20 mL solutions containing 10 mM PBS (pH 7.4), 20 L of 5 
mM Zn(OAc)2 was added for a final concentration of 5 μM. While stirring, solutions were 
allowed to thermally equilibrate in a heating block set at 25 °C for approximately 20-30 
min. To begin the experiment, 20 μL of 25 mM PhDTS was added for a final concentration 
of 25 μM. At set time points after the addition of donor, 500 μL reaction aliquots were 
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added to the methylene blue cocktail solutions and incubated for 1 h at room temperature 
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Carbonyl sulfide (COS) is an important organosulfur species in the global sulfur 
cycle224 that is generated during the burning of biomass225 combustion of biofuels,226 and 
in different production processes in the pulp and paper industries.227 In addition, 
geochemical production of COS arises from volcanic activity, emission from hot springs, 
and deep sea thermal vents.228 Although the chemical properties and reactivity of COS 
have long been established,229 the biological implications of COS have only recently begun 
to emerge.100 As an example, treatment of -amino acids with COS under prebiotic 
reaction conditions results in the formation of dipeptides, demonstrating the potential role 
of COS in origin of life chemical ligation.230 Aligned with our interests in studying 
biological reactive sulfur species,172 our group has recently advanced the use of COS- 
releasing compounds for the controlled release of hydrogen sulfide (H2S) due to the rapid 
catalyzed hydrolysis of COS by carbonic anhydrase, a ubiquitous metalloenzyme.204 
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Although enzymatic pathways for endogenous COS production in mammals remain 
undiscovered, COS has been detected in porcine cardiovascular tissues231 and exhaled 
breath from cystic fibrosis patients232 by using gas chromatography mass spectrometry 
(GC-MS). More recently, in our investigation of esterase-sensitive COS-based H2S donors 
in human lung epithelial (BEAS2B) cells, we observed COS-dependent inhibition of 
mitochondrial bioenergetics. This finding suggests that COS may possess biological 
activities and properties akin to H2S.20 As the potential roles of COS in biological systems 
and investigations into COS releasing compounds expand, a currently unmet need to 
further such investigations is the development of minimally invasive and sensitive methods 
for COS detection. Based on the significant impacts of colorimetric and fluorescent 
activity-based probes for the detection of reactive sulfur species (RSS), such as cysteine, 
reduced glutathione, and H2S, we envisioned that analogous platforms could be developed 
for COS detection.233 
Based on the electrophilicity and structural similarities between carbon dioxide 
(CO2), carbon disulfide (CS2), and COS,229 we anticipated that a nucleophilic platform 
could be used to develop chemical tools for COS detection. For example, N-heterocyclic 
carbenes can insert into heterocumulenes, which has been demonstrated separately for 
CO2,234 CS2,235 and COS,236 respectively. Bridging the gap to heterocumulene detection, 
the vast majority of work has aimed at the spectroscopic237 or electrochemical detection238 
of CO2. Of these reported methods, we were drawn to the prior use of a fluorescent, 
colorimetric benzobisimidazolium probe (TBBI) for CO2 detection.239 In this system, 
treatment of TBBI with tetra-n-butylammonium fluoride (TBAF) produces a “carbene- 
like” intermediate240 that readily reacts with CO2 through carbene insertion into CO2 and 
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subsequent hydrolysis to form bicarbonate (Figure 7.1). This reactivity was also 
investigated for CS2 by 13C NMR spectroscopy and shown to result in the generation of an 
imidazolium-dithiocarboxylate betaine through carbene insertion into CS2 (Figure 1b). 
Building from structural similarities between these compounds, we hypothesized the 
treatment of TBBI with COS in the presence of fluoride would provide a unique 
spectroscopic response for COS that would be distinguishable from that of CO2 and CS2. 
Based on this motivation, we report here the first demonstration of selective COS detection 
by UV- Vis and fluorescence spectroscopy. 
 
 
Figure 7.1 (a) Reaction of CO2 and TBBI in the presence of fluoride. (b) Reaction between 
CS2 and TBBI in the presence of fluoride. (c) Proposed reaction between COS and TBBI 
in the presence of fluoride. 
 
7.2 Results and Discussion 
 
One challenge when working with COS is that commercial sources often contain 
H2S as a common impurity. To overcome this challenge, we have previously prepared COS 
through the acidic hydrolysis of KSCN using modifications of known methods (Figure 
7.2a).241 Based on the growing interest in various aspects of COS chemistry, including 
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delivery, organometallic chemistry, and chemical biology, we have included this method 
here and in the Supporting Information (Appendix G). A key requirement when preparing 
COS is purification of the product, which can be accomplished by sparging through 
aqueous KOH, aniline in anhydrous ethanol, ice water, and neat H2SO4. The purified COS 
can be collected and stored in a gas storage flask or added directly into a solution or NMR 
tube for use as a reactant or reagent (Figure 7.2b). COS has a characteristic 13C chemical 




Figure 7.2 (a) Acid-mediated hydrolysis of KSCN to generate COS. (b) Schematic of 
laboratory-scale COS synthesis and purification. 
 
To investigate the strategy of carbene insertion for COS detection, we prepared 
TBBI239 and monitored its reactivity toward COS in the presence of TBAF by UV-Vis 
spectroscopy (Figure 7.3b). The parent TBBI compound (15 M in MeCN containing 1% 
(v/v) H2O) has an absorption band centered at 290 nm, which shifts to 344 nm upon 
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addition of TBAF (6.0 equiv.). This change in absorbance is consistent with the previous 
report of hydrogen bond formation between the C1-H in TBBI and F–.239 Subsequent 
addition of COS in 0.5 mL increments resulted in a decrease in the 344 nm absorbance and 
concomitant increase of a new absorbance at 321 nm. We note that this observed reaction 
with COS did not occur if anhydrous MeCN was used, which highlights that residual H2O 
is required. The new absorbance at 321 nm is unique to COS and is not observed upon 
reaction of TBBI with CO2 or CS2 in the presence of TBAF. 
Building from this observation, we next investigated the reaction by fluorescence 
spectroscopy. The parent TBBI compound (15 M, MeCN containing 1% (v/v) H2O) 
showed negligible fluorescence when excited at 321 nm, but addition of TBAF (6.0 equiv.) 
resulted in the appearance of a broad emission centered at 434 nm, which we attribute to 
formation of the hydrogen bonded TBBI intermediate. Subsequent addition of COS in 0.5 
mL increments led to a clean ratiometric response, with a decrease at the 434 nm emission 
and concomitant increase at 354 nm (Figure 7.3c). The product formed upon COS addition 
is persistent, unlike in the case for CO2 in which rapid hydrolysis to bicarbonate is 
observed. Taken together, these results demonstrate that TBBI can be used to 
spectroscopically distinguish between CO2, CS2, and COS in the presence of the fluoride. 
The stability and unique spectroscopic properties of product formed upon COS 
addition prompted us to investigate whether this TBBI system could be used for naked- 
eye optical detection of COS. The recognition of CS2 by 10 mM TBBI in the presence of 
fluoride was previously reported to generate a color change from clear to yellow red and 
form an imidazolium-dithiocarboxylate betaine.239 To further investigate this reactivity, we 
charged series of cuvettes with 10 mM TBBI and 60 mM TBAF in MeCN containing 1% 
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(v/v) H2O to generate the hydrogen bonded intermediate; this was followed by addition of 
CO2, CS2, or COS (Figure 7.4). Consistent with previous results, the cuvette containing 
 
Figure 7.3 (a) Reaction of TBBI with COS. (b) UV-Vis spectra and (c) Fluorescence 
spectra for TBBI (15 M), TBAF (90 M), and COS (5.0 mL). 
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CO2 yielded a white precipitate corresponding to the bicarbonate salt of TBBI, whereas 
the cuvette containing CS2 yielded a pale orange solution. The reaction between TBBI and 
COS yielded a teal green color and transitioned to a dark forest green upon standing for an 
extended period of time. These results demonstrate the unique ability of TBBI to serve as 




Figure 7.4 Naked-eye detection and differentiation of CO2, CS2, and COS using TBBI 




In summary, we have demonstrated that the TBBI platform can be used for the 
colorimetric and fluorescent detection of COS. Importantly, these spectroscopic responses 
for COS are distinct from those generated by CO2 or CS2.  We  view  that  these  
advances provide a first step toward developing chemical tools that can be used to 
investigate the growing evidence for a biological role of COS in complex systems. 
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7.4 Concluding Remarks 
 
In this dissertation, I have discussed contributions to the development of chemical 
tools capable to generating reactive sulfur species including H2S, COS, and persulfides in 
the presence of biological thiols such as cysteine and GSH. The chemical reactivity 
between thiocarbonyl-based compounds and free cysteine described in Chapters II and III 
could be extended to the development of cysteine selective probes and synthesis of 
dihydrothiazoles under mild reaction conditions. The basic research on H2S release from 
organic polysulfides discussed in Chapters IV and V highlights the potential impact of 
persistence persulfides on the biological activity of organic polysulfides and merits future 
investigation. The chemical tools for studying COS discussed in Chapter VI and VII 
provide researchers with key tools to further elucidate the biological implications of COS. 
Overall, the development of chemical tools to study reactive sulfur species is an area of 
rapidly expanding research which will likely contribute to our fundamental understanding 
of these compounds in biology, physiology, and medicine. 
 
 
7.5 Experimental Details 
 
7.5.1 Materials and Methods 
 
Reagents were purchased from Sigma-Aldrich, TCI, Fisher Scientific, or Combi-Blocks 
and used as received. Non-fritted gas washing bottles were purchased from ChemGlass 
(CG-1112). UV- Vis spectra were acquired on a Cary 100 spectrophotometer equipped 
with a Quantum Northwest TLC-42 dual cuvette temperature controller set at 25.00 ± 0.05 
°C. Fluorescence spectra were obtained on a Quanta Master 40 spectrofluorometer (Photon 
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Technology International) equipped with a Quantum Northwest TLC-50 temperature 
controller set at 25.00 ± 0.05 °C. 
 
 
General Procedure for UV-Vis Measurements 
 
A septum-sealed cuvette was charged with 3.00 mL of MeCN containing 1% (v/v) 
deionized H2O and 20 L of 2.5 mM TBBI in anhydrous MeCN for a final concentration 
of 15 M TBBI. An initial UV-Vis absorbance spectrum was recorded (250-450 nm). A 
6.75 mM solution of TBAF in anhydrous MeCN was prepared via dilution of 1.0 M TBAF 
in THF and 40 L was added to the cuvette solution for a final concentration of 90 M 
TBAF (6.0 equiv.) Another UV-Vis absorbance spectrum was recorded (250-450 nm).  A 
5.0 mL gastight Hamilton syringe was charged with COS (g) and added in 0.5 mL 
increments to the cuvette solution. A UV-Vis absorbance spectrum was recorded (250-450 
nm) between additions. 
 
 
General Procedure for Fluorescent Intensity Measurements 
 
A septum-sealed cuvette was charged with 3.00 mL of MeCN containing 1% (v/v) 
deionized H2O and 20 L of 2.5 mM TBBI in anhydrous MeCN for a final concentration 
of 15 M TBBI. An initial fluorescence spectrum was recorded (ex = 321 nm, em = 330- 
600 nm). A 6.75 mM solution of TBAF in anhydrous MeCN was prepared via dilution of 
1.0 M TBAF in THF and 40 L was added to the cuvette solution for a final concentration 
of 90 M TBAF (6.0 equiv.) Another fluorescence spectrum was recorded (ex  = 321 nm, 
em = 330-600 nm). A 5.0 mL gastight Hamilton syringe was charged with COS (g) and 
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added in 0.5 mL increments to the cuvette solution. A fluorescence measurement was 
recorded (ex = 321 nm, em = 330-600 nm) between additions. 
 
7.5.2 Synthesis of TBBI 
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Appendix A is the supplementary appendix for Chapter I of this dissertation. It includes 





















Scheme A.2 Mechanism of H2S release from thioaminoacids (R = Me or H) in the presence 










Scheme A.3 Generalized hydrolysis mechanism of H2S release from GYY4137, 















Scheme A.4 Mechanism of acid-mediated H2S release from JK-2 
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Scheme A.5 Mechanism of COS/H2S release from -KetoTCM-1 in the presence of 
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Scheme A.6 Mechanism of COS/H2S release from S-pHTCM via imine hydrolysis in the 
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Scheme A.8 Mechanism of cysteine-mediated H2S release from thionoesters (R = Ph, X = 
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Scheme A.11 Mechanism of cysteine-selective COS/H2S release from OA-CysTCM-1 in 
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Scheme A.12 Proposed mechanism of H2S release from 1,2,4-thiadiazolidine-3,5-diones 
in the presence of cysteine 
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Scheme A.15 Mechanism of COS/H2S release from FLD-1 in the presence of thiols and 
















































Scheme A.17 Mechanism of H2S release from organic polysulfides including DATS in the 
presence of thiols. We note the presence of a pendant allyl group likely complicates the 

















Scheme A.18 Mechanism of thiol-mediated COS/H2S release from cyclic 
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Scheme A.22 Mechanism of H2S release from Esterase-TCM-OA in the presence of 
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Scheme A.23 Mechanism of H2S release from Esterase-TCM-SA in the presence of 
esterase and carbonic anhydrase 
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Scheme A.25 Mechanism of H2S release from H2O2-triggered thiocarbamates and 
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Scheme A.27 Mechanism of H2S release from ortho-nitrophenyl thiocarbamates 
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Scheme A.29 Mechanism of H2S release from photo-caged thiobenzaldehydes in the 
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Scheme A.30 Mechanism of H2S release from DPBT in the presence of a photosensitizer 
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SUPPLEMENTARY INFORMATION FOR CHAPTER II 
 
 
Appendix B is the supplementary information for Chapter II of this dissertation. It includes 




































































Figure B.7 HPLC calibration curve of phenol 
y = 1.1727x + 1.2822 
R² = 0.9998 
y = 0.3867x + 0.0673 





























SUPPLEMENTARY INFORMATION FOR CHAPTER III 
 
 
Appendix C is the supplementary information for Chapter III of this dissertation. It includes 
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Figure C.1 1H NMR (600 MHz, CDCl3) spectrum of S-phenyl benzothioate 
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Figure C.15 1H NMR (500 MHz, CDCl3) spectrum of MPDTE 
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Figure C.23 1H NMR (600 MHz, CDCl3) spectrum of iPBDTE 
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y = 1.1727x + 1.2822 

















































































Figure C.26 a) 100 ppm PDTE in Hexanes b) 100 M CysDHT in 10 mM PBS (pH 7.4) 
with 10% THF c) Reaction aliquot after 1 h. 
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MBA Calibration Curve 
 
 





SUPPLEMENTARY INFORMATION FOR CHAPTER IV 
 
 
Appendix D is the supplementary information for Chapter IV of this dissertation. It 










Figure D.2 19F NMR (471 MHz, CDCl3) spectrum of 1 
 
 




Figure D.4 1H NMR (600 MHz, CDCl3) spectrum of 2 
 
 




Figure D.6 13C{1H} NMR (151 MHz, CDCl3) spectrum of 2 
 
 
Figure D.7 1H NMR (500 MHz, CDCl3) spectrum of 3 





Figure D.8 13C{1H} NMR (126 MHz, CDCl3) spectrum of 3 
 





Figure D.10 13C{1H} NMR (126 MHz, CDCl3) spectrum of 4 
 





Figure D.12 13C{1H} NMR (126 MHz, CDCl3) spectrum of 5 
 





Figure D.14 13C{1H} NMR (126 MHz, CDCl3) spectrum of 6 
 















Figure D.19 HPLC Trace of 3 
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Hammett Plot Data 
 
Donor R 
1 -CF3 0.54 
2 -F 0.06 
3 -H 0 
4 -Me -0.17 
5 -OMe -0.27 
6 -NMe2 -0.83 
 
Table D.1 Hammett  parameters 
 
 
Figure D.20 Hammett plot for H2S release from tetrasulfides 
 
Donor Initial Rate (nA/s) Relative Rate 
1 0.01128 ± 0.002 5.1 
2 0.0151 ± 0.009 6.8 
3 0.0547 ± 0.008 24.7 
4 0.0041 ± 0.0009 1.9 
5 0.0231 ± 0.001 10.4 
6 0.0038 ± 0.002 1.7 
7 0.0032 ± 0.0008 1.5 
8 0.0033 ± 0.0002 1.5 
DATS 0.0022 ± 0.0003 1.0 
 





SUPPLEMENTARY INFORMATION FOR CHAPTER V 
 
 
Appendix E is the supplementary information for Chapter V of this dissertation. It includes 







Figure E.1 1H NMR (500 MHz, DMSO-d6) spectrum of SS-benzyl O-methyl 
carbono(dithioperoxoate) 























Figure E.6 13C{1H} NMR (126 MHz, CDCl3) spectrum of Bn2S4 
 
 




Figure E.8 13C{1H} NMR (126 MHz, CDCl3) spectrum of S-benzyl ethanethioate 
 





























Figure E.14 Pooled average of cell proliferation data under DATS treatment. (n=4) 
 
MBA Calibration Curves 
 
 
Figure E.15 MBA calibration curve generated using known concentrations of NaSH in the 




Figure E.16 MBA calibration curve generated using known concentrations of NaSH in the 
presence of 500 M GSH. 
 




Scheme E.1 Proposed reaction mechanism for trisulfide synthesis via hydroxide-mediated 





SUPPLEMENTARY INFORMATION FOR CHAPTER VI 
 
 
Appendix F is the supplementary information for Chapter VI of this dissertation. It includes 




















































































































   
  
 

































































































































































































































Figure F.31 13C{1H} NMR (126 MHz, CD3CN) spectrum of 3-MePhDTS 





















































































































































Figure F.45 a) 100 M PhDTS in 10 mM PBS (pH 7.4) with 0.1% MeCN (b) 50 M 
aniline in 10 mM PBS (pH 7.4) with 0.1% MeCN (c) Reaction aliquot after 1 h 
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Figure F.46 MBA calibration curve generated using known concentrations of NaSH 
 
CA Inhibition Experiment 
 




y = 0.0164x + 0.0158 
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Zn2+-mediated Hydrolysis Experiment 
 
 

















Scheme F.1 Proposed mechanism of Zn2+-mediated COS/H2S release from DTS- 
functionalized amines in the presence of carbonic anhydrase at physiological pH 
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Figure F.49 Comparison of cysteine- and lysine-mediated COS/H2S release from PhDTS 
(25 M) in the presence of nucleophile (500 M, 20 equiv.) and carbonic anhydrase (25 





SUPPLEMENTARY INFORMATION FOR CHAPTER VII 
 
 
Appendix G is the supplementary information for Chapter VII of this dissertation. It 
includes spectra and experimental data relevant to the content in Chapter VII. 
 
 
Synthesis and Purification of Carbonyl Sulfide 
 
KSCN (25 g, 0.26 mol) was dissolved in deionized H2O (150 mL) and added to a closed 
addition funnel. Concentrated H2SO4 (50 mL) and a stir bar were added to a three-necked 
round bottom flask. KOH (100 g, 1.78 mol) was dissolved in deionized H2O (100 mL) and 
added to the first gas washing bottle. Aniline (25 mL, 0.27 mol) was dissolved in anhydrous 
ethanol (75 mL) and added to the second gas washing bottle. Ice chips were added directly 
to the third gas washing bottle. Concentrated H2SO4 (50 mL) was added directly to the 
fourth gas washing bottle. A sulfide-quenching solution containing Zn(OAc)2 (24 g, 0.13 
mol), sodium citrate dihydrate (2.25 g, 7.65 mmol), NaOH (1.66 g, 41.5 mmol), and bleach 
(300 mL) was added to a 1 L graduated cylinder. The solution was filled to 1 L with 
deionized H2O. The gas washing bottles were sealed with vacuum grease and the system 
was assembled as shown below (Figure G.1). 
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Figure G.1 Assembled glassware for synthesis and purification of COS 
 
 
The assembled system was charged with a stream of nitrogen and sparged for 
approximately 1 hour. The potassium thiocyanate and concentrated H2SO4 solutions were 
both sparged for 30 min. To begin the synthesis of COS, nitrogen sparging was stopped 
and aqueous potassium thiocyanate was added dropwise to concentrated H2SO4. 
 
 




The purified COS was collected in a 500 mL round bottom, Schlenk storage flask with a 
Teflon Kontes screw valve with a 14/20 sidearm joint. After approximately two-thirds of 
the potassium thiocyanate solution was added, the storage flask was sealed, and the excess 
COS gas was bubbled directly into the sulfide-quenching solution. 
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The purity of the synthesized COS (g) could be assessed by 13C NMR (Figure G.2). The 
gas was bubbled directly into an NMR tube containing 0.5 mL CD3CN briefly. 
















1. (a) Abe, K.; Kimura, H. The possible role of hydrogen sulfide as an endogenous 
neuromodulator. Journal of Neuroscience 1996, 16 (3), 1066-1071; (b) Li, L.; Hsu, A.; 
Moore, P. K. Actions and interactions of nitric oxide, carbon monoxide and hydrogen 
sulphide in the cardiovascular system and in inflammation--a tale of three gases! 
Pharmacol Ther 2009, 123 (3), 386-400; (c) Wang, R. Two's company, three's a crowd: 
can H2S be the third endogenous gaseous transmitter? FASEB J 2002, 16 (13), 1792-8. 
 
2. (a) Cuevasanta, E.; Moller, M. N.; Alvarez, B. Biological chemistry of hydrogen 
sulfide and persulfides. Arch Biochem Biophys 2017, 617, 9-25; (b) Hartle, M. D.; Pluth, 
M. D. A practical guide to working with H2S at the interface of chemistry and biology. 
Chem Soc Rev 2016, 45 (22), 6108-6117; (c) Li, Q.; Lancaster, J. R., Jr. Chemical 
foundations of hydrogen sulfide biology. Nitric Oxide 2013, 35, 21-34; (d) Ono, K.; 
Akaike, T.; Sawa, T.; Kumagai, Y.; Wink, D. A.; Tantillo, D. J.; Hobbs, A. J.; Nagy, P.; 
Xian, M.; Lin, J.; Fukuto, J. M. Redox chemistry and chemical biology of H2S, 
hydropersulfides, and derived species: implications of their possible biological activity and 
utility. Free Radic Biol Med 2014, 77, 82-94; (e) Szabo, C. A timeline of hydrogen sulfide 
(H2S) research: From environmental toxin to biological mediator. Biochem Pharmacol 
2018, 149, 5-19; (f) Zhao, Y.; Biggs, T. D.; Xian, M. Hydrogen sulfide (H2S) releasing 
agents: chemistry and biological applications. Chem Commun (Camb) 2014, 50 (80), 
11788-805. 
 
3. Calvert, J. W.; Coetzee, W. A.; Lefer, D. J. Novel insights into hydrogen sulfide-- 
mediated cytoprotection. Antioxid Redox Signal 2010, 12 (10), 1203-17. 
 
4. (a) Cao, X.; Ding, L.; Xie, Z. Z.; Yang, Y.; Whiteman, M.; Moore, P. K.; Bian, J. 
S. A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is 
Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer? Antioxid Redox Signal 
2019, 31 (1), 1-38; (b) Durante, W. Hydrogen Sulfide Therapy in Diabetes-Accelerated 
Atherosclerosis: A Whiff of Success. Diabetes 2016, 65 (10), 2832-4; (c) Kasinath, B. S.; 
Feliers, D.; Lee, H. J. Hydrogen sulfide as a regulatory factor in kidney health and disease. 
Biochem Pharmacol 2018, 149, 29-41; (d) Kolluru, G. K.; Shen, X.; Bir, S. C.; Kevil, C. 
G. Hydrogen sulfide chemical biology: pathophysiological roles and detection. Nitric 
Oxide 2013, 35, 5-20. 
 
5. (a) Cao, X.; Cao, L.; Ding, L.; Bian, J. S. A New Hope for a Devastating Disease: 
Hydrogen Sulfide in Parkinson's Disease. Mol Neurobiol 2018, 55 (5), 3789-3799; (b) 
Panthi, S.; Manandhar, S.; Gautam, K. Hydrogen sulfide, nitric oxide, and 
neurodegenerative disorders. Transl Neurodegener 2018, 7, 3; (c) Shefa, U.; Kim, M. S.; 
Jeong, N. Y.; Jung, J. Antioxidant and Cell-Signaling Functions of Hydrogen Sulfide in 
the Central Nervous System. Oxid Med Cell Longev 2018, 2018, 1873962. 
 
6. Chen, Y.; Wang, R. The message in the air: hydrogen sulfide metabolism in chronic 
respiratory diseases. Respir Physiol Neurobiol 2012, 184 (2), 130-8. 
226  
7. (a) Donnarumma, E.; Trivedi, R. K.; Lefer, D. J. Protective Actions of H2S in Acute 
Myocardial Infarction and Heart Failure. Compr Physiol 2017, 7 (2), 583-602; (b) Yu, X. 
H.; Cui, L. B.; Wu, K.; Zheng, X. L.; Cayabyab, F. S.; Chen, Z. W.; Tang, C. K. Hydrogen 
sulfide as a potent cardiovascular protective agent. Clin Chim Acta 2014, 437, 78-87; (c) 
Wu, D.; Wang, J.; Li, H.; Xue, M.; Ji, A.; Li, Y. Role of Hydrogen Sulfide in Ischemia- 
Reperfusion Injury. Oxid Med Cell Longev 2015, 2015, 186908. 
 
8. Kondo, K.; Bhushan, S.; King, A. L.; Prabhu, S. D.; Hamid, T.; Koenig, S.; 
Murohara, T.; Predmore, B. L.; Gojon, G., Sr.; Gojon, G., Jr.; Wang, R.; Karusula, N.; 
Nicholson, C. K.; Calvert, J. W.; Lefer, D. J. H(2)S protects against pressure overload- 
induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 
2013, 127 (10), 1116-27. 
 
9. (a) Wang, G.; Li, W.; Chen, Q.; Jiang, Y.; Lu, X.; Zhao, X. Hydrogen sulfide 
accelerates wound healing in diabetic rats. Int J Clin Exp Pathol 2015, 8 (5), 5097-104; (b) 
Zheng, D.; Chen, Z.; Chen, J.; Zhuang, X.; Feng, J.; Li, J. Exogenous hydrogen sulfide 
exerts proliferation, anti-apoptosis, migration effects and accelerates cell cycle progression 
in multiple myeloma cells via activating the Akt pathway. Oncol Rep 2016, 36 (4), 1909- 
16. 
 
10. Alshorafa, A. K.; Guo, Q.; Zeng, F.; Chen, M.; Tan, G.; Tang, Z.; Yin, R. Psoriasis 
is associated with low serum levels of hydrogen sulfide, a potential anti-inflammatory 
molecule. Tohoku J Exp Med 2012, 228 (4), 325-32. 
 
11. Yang, G.; Sun, X.; Wang, R. Hydrogen sulfide-induced apoptosis of human aorta 
smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. 
FASEB J 2004, 18 (14), 1782-4. 
 
12. (a) Gemici, B.; Wallace, J. L. Anti-inflammatory and Cytoprotective Properties of 
Hydrogen Sulfide. In Hydrogen Sulfide in Redox Biology, Pt B, Cadenas, E.; Packer, L., 
Eds. 2015; Vol. 555, pp 169-193; (b) Wallace, J. L. Hydrogen sulfide-releasing anti- 
inflammatory drugs. Trends Pharmacol Sci 2007, 28 (10), 501-5; (c) Wallace, J. L.; 
Blackler, R. W.; Chan, M. V.; Da Silva, G. J.; Elsheikh, W.; Flannigan, K. L.; Gamaniek, 
I.; Manko, A.; Wang, L.; Motta, J. P.; Buret, A. G. Anti-inflammatory and cytoprotective 
actions of hydrogen sulfide: translation to therapeutics. Antioxid Redox Signal 2015, 22 
(5), 398-410. 
 
13. Wu, D.; Hu, Q.; Liu, X.; Pan, L.; Xiong, Q.; Zhu, Y. Z. Hydrogen sulfide protects 
against apoptosis under oxidative stress through SIRT1 pathway in H9c2 cardiomyocytes. 
Nitric Oxide 2015, 46, 204-12. 
 
14. (a) Tamizhselvi, R.; Moore, P. K.; Bhatia, M. Inhibition of hydrogen sulfide 
synthesis attenuates chemokine production and protects mice against acute pancreatitis and 
associated lung injury. Pancreas 2008, 36 (4), e24-31; (b) Zanardo, R. C.; Brancaleone, 
V.; Distrutti, E.; Fiorucci, S.; Cirino, G.; Wallace, J. L. Hydrogen sulfide is an endogenous 
modulator of leukocyte-mediated inflammation. FASEB J 2006, 20 (12), 2118-20. 
227  
15. (a) Bora, P.; Chauhan, P.; Pardeshi, K. A.; Chakrapani, H. Small molecule 
generators of biologically reactive sulfur species. RSC Advances 2018, 8 (48), 27359- 
27374; (b) Dillon, K. M.; Powell, C. R.; Matson, J. B. Self-Immolative Prodrugs: Effective 
Tools for the Controlled Release of Sulfur Signaling Species. Synlett 2019, 30 (5), 525- 
531; (c) Papapetropoulos, A.; Whiteman, M.; Cirino, G. Pharmacological tools for 
hydrogen sulphide research: a brief, introductory guide for beginners. Br J Pharmacol 
2015, 172 (6), 1633-7; (d) Powell, C. R.; Dillon, K. M.; Matson, J. B. A review of hydrogen 
sulfide (H2S) donors: Chemistry and potential therapeutic applications. Biochem 
Pharmacol 2018, 149, 110-123; (e) Song, Z. J.; Ng, M. Y.; Lee, Z.-W.; Dai, W.; Hagen, 
T.; Moore, P. K.; Huang, D.; Deng, L.-W.; Tan, C.-H. Hydrogen sulfide donors in research 
and drug development. Med. Chem. Commun. 2014, 5 (5), 557-570; (f) Szabo, C.; 
Papapetropoulos, A. International Union of Basic and Clinical Pharmacology. CII: 
Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis 
Inhibitors. Pharmacol Rev 2017, 69 (4), 497-564; (g) Wu, D.; Hu, Q.; Zhu, Y. Therapeutic 
application of hydrogen sulfide donors: the potential and challenges. Front Med 2016, 10 
(1), 18-27. 
 
16. Steiger, A. K.; Pardue, S.; Kevil, C. G.; Pluth, M. D. Self-Immolative 
Thiocarbamates Provide Access to Triggered H2S Donors and Analyte Replacement 
Fluorescent Probes. J Am Chem Soc 2016, 138 (23), 7256-9. 
 
17. Zheng, Y.; Yu, B.; Ji, K.; Pan, Z.; Chittavong, V.; Wang, B. Esterase-Sensitive 
Prodrugs with Tunable Release Rates and Direct Generation of Hydrogen Sulfide. Angew 
Chem Int Ed Engl 2016, 55 (14), 4514-8. 
 
18. Fukami, T.; Yokoi, T. The emerging role of human esterases. Drug Metab 
Pharmacokinet 2012, 27 (5), 466-77. 
 
19. Chauhan, P.; Bora, P.; Ravikumar, G.; Jos, S.; Chakrapani, H. Esterase Activated 
Carbonyl Sulfide/Hydrogen Sulfide (H2S) Donors. Org Lett 2017, 19 (1), 62-65. 
 
20. Steiger, A. K.; Marcatti, M.; Szabo, C.; Szczesny, B.; Pluth, M. D. Inhibition of 
Mitochondrial Bioenergetics by Esterase-Triggered COS/H2S Donors. ACS Chem Biol 
2017, 12 (8), 2117-2123. 
 
21. Levinn, C. M.; Steiger, A. K.; Pluth, M. D. Esterase-Triggered Self-Immolative 
Thiocarbamates Provide Insights into COS Cytotoxicity. ACS Chem Biol 2019, 14 (2), 170- 
175. 
 
22. Shukla, P.; Khodade, V. S.; SharathChandra, M.; Chauhan, P.; Mishra, S.; 
Siddaramappa, S.; Pradeep, B. E.; Singh, A.; Chakrapani, H. "On demand" redox buffering 
by H2S contributes to antibiotic resistance revealed by a bacteria-specific H2S donor. 
Chem Sci 2017, 8 (7), 4967-4972. 
 
23. (a) Brown, J. M.; Wilson, W. R. Exploiting tumour hypoxia in cancer treatment. 
Nat Rev Cancer 2004, 4 (6), 437-47; (b) Wilson, W. R.; Hay, M. P. Targeting hypoxia in 
cancer therapy. Nat Rev Cancer 2011, 11 (6), 393-410. 
228  
24. Zhao, Y.; Pluth, M. D. Hydrogen Sulfide Donors Activated by Reactive Oxygen 
Species. Angew Chem Int Ed Engl 2016, 55 (47), 14638-14642. 
 
25. Zhao, Y.; Henthorn, H. A.; Pluth, M. D. Kinetic Insights into Hydrogen Sulfide 
Delivery from Caged-Carbonyl Sulfide Isomeric Donor Platforms. J Am Chem Soc 2017, 
139 (45), 16365-16376. 
 
26. Chauhan, P.; Jos, S.; Chakrapani, H. Reactive Oxygen Species-Triggered Tunable 
Hydrogen Sulfide Release. Org Lett 2018, 20 (13), 3766-3770. 
 
27. Hu, Y.; Li, X.; Fang, Y.; Shi, W.; Li, X.; Chen, W.; Xian, M.; Ma, H. Reactive 
oxygen species-triggered off-on fluorescence donor for imaging hydrogen sulfide delivery 
in living cells. Chem Sci 2019, 10 (33), 7690-7694. 
 
28. Lehrman, L. Thioacetamide as a source of hydrogen sulfide in qualitative analysis. 
Journal of Chemical Education 1955, 32 (9). 
 
29. Martelli, A.; Testai, L.; Citi, V.; Marino, A.; Pugliesi, I.; Barresi, E.; Nesi, G.; 
Rapposelli, S.; Taliani, S.; Da Settimo, F.; Breschi, M. C.; Calderone, V. Arylthioamides 
as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro 
and in Vivo. ACS Med Chem Lett 2013, 4 (10), 904-8. 
 
30. Zhou, Z.; von Wantoch Rekowski, M.; Coletta, C.; Szabo, C.; Bucci, M.; Cirino, 
G.; Topouzis, S.; Papapetropoulos, A.; Giannis, A. Thioglycine and L-thiovaline: 
biologically active H(2)S-donors. Bioorg Med Chem 2012, 20 (8), 2675-8. 
 
31. Lecher, H. Z.; Greenwood, R. A.; Whitehouse, K. C.; Chao, T. H. The 
Phosphonation of Aromatic Compounds with Phosphorus Pentasulfide. Journal of the 
American Chemical Society 1956, 78 (19), 5018-5022. 
 
32. Pedersen, B. S.; Scheibye, S.; Nilsson, N. H.; Lawesson, S. O. STUDIES ON 
ORGANOPHOSPHORUS COMPOUNDS .10. SYNTHESES OF THIOKETONES. 
Bulletin Des Societes Chimiques Belges 1978, 87 (3), 223-228. 
 
33. Li, L.; Whiteman, M.; Guan, Y. Y.; Neo, K. L.; Cheng, Y.; Lee, S. W.; Zhao, Y.; 
Baskar, R.; Tan, C. H.; Moore, P. K. Characterization of a novel, water-soluble hydrogen 
sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. 
Circulation 2008, 117 (18), 2351-60. 
 
34. Nin, D. S.; Idres, S. B.; Song, Z. J.; Moore, P. K.; Deng, L. W. Biological Effects 
of Morpholin-4-Ium 4 Methoxyphenyl (Morpholino) Phosphinodithioate and Other 
Phosphorothioate-Based Hydrogen Sulfide Donors. Antioxid Redox Signal 2020, 32 (2), 
145-158. 
 
35. Park, C. M.; Zhao, Y.; Zhu, Z.; Pacheco, A.; Peng, B.; Devarie-Baez, N. O.; 
Bagdon, P.; Zhang, H.; Xian, M. Synthesis and evaluation of phosphorodithioate-based 
hydrogen sulfide donors. Mol Biosyst 2013, 9 (10), 2430-4. 
229  
36. Feng, W.; Teo, X. Y.; Novera, W.; Ramanujulu, P. M.; Liang, D.; Huang, D.; 
Moore, P. K.; Deng, L. W.; Dymock, B. W. Discovery of New H2S Releasing 
Phosphordithioates and 2,3-Dihydro-2-phenyl-2- 
sulfanylenebenzo[d][1,3,2]oxazaphospholes with Improved Antiproliferative Activity. J 
Med Chem 2015, 58 (16), 6456-80. 
 
37. Kang, J.; Li, Z.; Organ, C. L.; Park, C. M.; Yang, C. T.; Pacheco, A.; Wang, D.; 
Lefer, D. J.; Xian, M. pH-Controlled Hydrogen Sulfide Release for Myocardial Ischemia- 
Reperfusion Injury. J Am Chem Soc 2016, 138 (20), 6336-9. 
 
38. Sagi, A.; Weinstain, R.; Karton, N.; Shabat, D. Self-immolative polymers. J Am 
Chem Soc 2008, 130 (16), 5434-5. 
 
39. Zhao, Y.; Steiger, A. K.; Pluth, M. D. Colorimetric Carbonyl Sulfide 
(COS)/Hydrogen Sulfide (H2 S) Donation from gamma-Ketothiocarbamate Donor Motifs. 
Angew Chem Int Ed Engl 2018, 57 (40), 13101-13105. 
 
40. Gilbert, A. K.; Zhao, Y.; Otteson, C. E.; Pluth, M. D. Development of Acid- 
Mediated H2S/COS Donors That Respond to a Specific pH Window. J Org Chem 2019, 
84 (22), 14469-14475. 
 
41. Barresi, E.; Nesi, G.; Citi, V.; Piragine, E.; Piano, I.; Taliani, S.; Da Settimo, F.; 
Rapposelli, S.; Testai, L.; Breschi, M. C.; Gargini, C.; Calderone, V.; Martelli, A. 
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the 
Vascular Effects. J Med Chem 2017, 60 (17), 7512-7523. 
 
42. Martelli, A.; Testai, L.; Citi, V.; Marino, A.; Bellagambi, F. G.; Ghimenti, S.; 
Breschi, M. C.; Calderone, V. Pharmacological characterization of the vascular effects of 
aryl isothiocyanates: is hydrogen sulfide the real player? Vascul Pharmacol 2014, 60 (1), 
32-41. 
 
43. Lin, Y.; Yang, X.; Lu, Y.; Liang, D.; Huang, D. Isothiocyanates as H2S Donors 
Triggered by Cysteine: Reaction Mechanism and Structure and Activity Relationship. Org 
Lett 2019, 21 (15), 5977-5980. 
 
44. Dawson, P. E.; Muir, T. W.; Clark-Lewis, I.; Kent, S. B. Synthesis of proteins by 
native chemical ligation. Science 1994, 266 (5186), 776-9. 
 
45. Cerda, M. M.; Zhao, Y.; Pluth, M. D. Thionoesters: A Native Chemical Ligation- 
Inspired Approach to Cysteine-Triggered H2S Donors. J Am Chem Soc 2018, 140 (39), 
12574-12579. 
 
46. Cerda, M. M.; Newton, T. D.; Zhao, Y.; Collins, B. K.; Hendon, C. H.; Pluth, M. 
D. Dithioesters: simple, tunable, cysteine-selective H2S donors. Chem Sci 2019, 10 (6), 
1773-1779. 
230  
47. Kim, N. H.; Moon, H.; Kim, J. H.; Huh, Y.; Kim, Y. J.; Kim, B. M.; Kim, D. A 
benzothioate native chemical ligation-based cysteine-selective fluorescent probe. Dyes and 
Pigments 2019, 171. 
 
48. Zhao, Y.; Kang, J.; Park, C. M.; Bagdon, P. E.; Peng, B.; Xian, M. Thiol-activated 
gem-dithiols: a new class of controllable hydrogen sulfide donors. Org Lett 2014, 16 (17), 
4536-9. 
 
49. Zhu, Y.; Romero, E. L.; Ren, X.; Sanca, A. J.; Du, C.; Liu, C.; Karim, Z. A.; 
Alshbool, F. Z.; Khasawneh, F. T.; Zhou, J.; Zhong, D.; Geng, B. Clopidogrel as a donor 
probe and thioenol derivatives as flexible promoieties for enabling H2S biomedicine. Nat 
Commun 2018, 9 (1), 3952. 
 
50. Zhao, Y.; Wang, H.; Xian, M. Cysteine-activated hydrogen sulfide (H2S) donors. 
J Am Chem Soc 2011, 133 (1), 15-7. 
 
51. Zhao, Y.; Yang, C.; Organ, C.; Li, Z.; Bhushan, S.; Otsuka, H.; Pacheco, A.; Kang, 
J.; Aguilar, H. C.; Lefer, D. J.; Xian, M. Design, Synthesis, and Cardioprotective Effects 
of N-Mercapto-Based Hydrogen Sulfide Donors. J Med Chem 2015, 58 (18), 7501-11. 
 
52. Zhao, Y.; Bhushan, S.; Yang, C.; Otsuka, H.; Stein, J. D.; Pacheco, A.; Peng, B.; 
Devarie-Baez, N. O.; Aguilar, H. C.; Lefer, D. J.; Xian, M. Controllable hydrogen sulfide 
donors and their activity against myocardial ischemia-reperfusion injury. ACS Chem Biol 
2013, 8 (6), 1283-90. 
 
53. Foster, J. C.; Powell, C. R.; Radzinski, S. C.; Matson, J. B. S-aroylthiooximes: a 
facile route to hydrogen sulfide releasing compounds with structure-dependent release 
kinetics. Org Lett 2014, 16 (6), 1558-61. 
 
54. Kang, J.; Ferrell, A. J.; Chen, W.; Wang, D.; Xian, M. Cyclic Acyl Disulfides and 
Acyl Selenylsulfides as the Precursors for Persulfides (RSSH), Selenylsulfides (RSeSH), 
and Hydrogen Sulfide (H2S). Org Lett 2018, 20 (3), 852-855. 
 
55. Hamsath, A.; Wang, Y.; Yang, C. T.; Xu, S.; Canedo, D.; Chen, W.; Xian, M. Acyl 
Selenyl Sulfides as the Precursors for Reactive Sulfur Species (Hydrogen Sulfide, 
Polysulfide, and Selenyl Sulfide). Org Lett 2019, 21 (14), 5685-5688. 
 
56. Roger, T.; Raynaud, F.; Bouillaud, F.; Ransy, C.; Simonet, S.; Crespo, C.; 
Bourguignon, M. P.; Villeneuve, N.; Vilaine, J. P.; Artaud, I.; Galardon, E. New 
biologically active hydrogen sulfide donors. Chembiochem 2013, 14 (17), 2268-71. 
 
57. (a) Yang, C. T.; Devarie-Baez, N. O.; Hamsath, A.; Fu, X. D.; Xian, M. S- 
Persulfidation: Chemistry, Chemical Biology, and Significance in Health and Disease. 
Antioxid Redox Signal 2019; (b) Park, C. M.; Weerasinghe, L.; Day, J. J.; Fukuto, J. M.; 
Xian, M. Persulfides: current knowledge and challenges in chemistry and chemical 
biology. Mol Biosyst 2015, 11 (7), 1775-85. 
231  
58. Pluth, M.; Bailey, T.; Hammers, M.; Hartle, M.; Henthorn, H.; Steiger, A. Natural 
Products Containing Hydrogen Sulfide Releasing Moieties. Synlett 2015, 26 (19), 2633- 
2643. 
 
59. Benavides, G. A.; Squadrito, G. L.; Mills, R. W.; Patel, H. D.; Isbell, T. S.; Patel, 
R. P.; Darley-Usmar, V. M.; Doeller, J. E.; Kraus, D. W. Hydrogen sulfide mediates the 
vasoactivity of garlic. Proc Natl Acad Sci U S A 2007, 104 (46), 17977-82. 
 
60. Liang, D.; Wu, H.; Wong, M. W.; Huang, D. Diallyl Trisulfide Is a Fast H2S Donor, 
but Diallyl Disulfide Is a Slow One: The Reaction Pathways and Intermediates of 
Glutathione with Polysulfides. Org Lett 2015, 17 (17), 4196-9. 
 
61. Cai, Y. R.; Hu, C. H. Computational Study of H2S Release in Reactions of Diallyl 
Polysulfides with Thiols. J Phys Chem B 2017, 121 (26), 6359-6366. 
 
62. Yao, H.; Luo, S.; Liu, J.; Xie, S.; Liu, Y.; Xu, J.; Zhu, Z.; Xu, S. Controllable 
thioester-based hydrogen sulfide slow-releasing donors as cardioprotective agents. Chem 
Commun (Camb) 2019, 55 (44), 6193-6196. 
 
63. Cerda, M. M.; Hammers, M. D.; Earp, M. S.; Zakharov, L. N.; Pluth, M. D. 
Applications of Synthetic Organic Tetrasulfides as H2S Donors. Org Lett 2017, 19 (9), 
2314-2317. 
 
64. Bolton, S. G.; Cerda, M. M.; Gilbert, A. K.; Pluth, M. D. Effects of sulfane sulfur 
content in benzyl polysulfides on thiol-triggered H2S release and cell proliferation. Free 
Radic Biol Med 2019, 131, 393-398. 
 
65. Toohey, J. I. Sulfur signaling: is the agent sulfide or sulfane? Anal Biochem 2011, 
413 (1), 1-7. 
 
66. Ercole, F.; Whittaker, M. R.; Halls, M. L.; Boyd, B. J.; Davis, T. P.; Quinn, J. F. 
Garlic-inspired trisulfide linkers for thiol-stimulated H2S release. Chem Commun (Camb) 
2017, 53 (57), 8030-8033. 
 
67. Zhao, Y.; Cerda, M. M.; Pluth, M. D. Fluorogenic hydrogen sulfide (H2S) donors 
based on sulfenyl thiocarbonates enable H2S tracking and quantification. Chem Sci 2019, 
10 (6), 1873-1878. 
 
68. Zhao, Y.; Steiger, A. K.; Pluth, M. D. Cysteine-activated hydrogen sulfide (H2S) 
delivery through caged carbonyl sulfide (COS) donor motifs. Chem Commun (Camb) 
2018, 54 (39), 4951-4954. 
 
69. Severino, B.; Corvino, A.; Fiorino, F.; Luciano, P.; Frecentese, F.; Magli, E.; 
Saccone, I.; Di Vaio, P.; Citi, V.; Calderone, V.; Servillo, L.; Casale, R.; Cirino, G.; 
Vellecco, V.; Bucci, M.; Perissutti, E.; Santagada, V.; Caliendo, G. 1,2,4-Thiadiazolidin- 
3,5-diones as novel hydrogen sulfide donors. Eur J Med Chem 2018, 143, 1677-1686. 
232  
70. (a) Ai, X.; Mu, J.; Xing, B. Recent Advances of Light-Mediated Theranostics. 
Theranostics 2016, 6 (13), 2439-2457; (b) Chen, H.; Zhao, Y. Applications of Light- 
Responsive Systems for Cancer Theranostics. ACS Appl Mater Interfaces 2018, 10 (25), 
21021-21034. 
 
71. Devarie-Baez, N. O.; Bagdon, P. E.; Peng, B.; Zhao, Y.; Park, C. M.; Xian, M. 
Light-induced hydrogen sulfide release from "caged" gem-dithiols. Org Lett 2013, 15 (11), 
2786-9. 
 
72. (a) Li, Z.; Li, D.; Wang, L.; Lu, C.; Shan, P.; Zou, X.; Li, Z. Photocontrollable 
water-soluble polymeric hydrogen sulfide (H2S) donor. Polymer 2019, 168, 16-20; (b) 
Wang, L.; Ma, F.; Zou, X.; Li, Z. Block copolymer nanoparticles as light-induced hydrogen 
sulfide (H2S) donors. J Control Release 2015, 213, e71-2. 
 
73. Chen, W.; Chen, M.; Zang, Q.; Wang, L.; Tang, F.; Han, Y.; Yang, C.; Deng, L.; 
Liu, Y. N. NIR light controlled release of caged hydrogen sulfide based on upconversion 
nanoparticles. Chem Commun (Camb) 2015, 51 (44), 9193-6. 
 
74. Fukushima, N.; Ieda, N.; Sasakura, K.; Nagano, T.; Hanaoka, K.; Suzuki, T.; 
Miyata, N.; Nakagawa, H. Synthesis of a photocontrollable hydrogen sulfide donor using 
ketoprofenate photocages. Chem Commun (Camb) 2014, 50 (5), 587-9. 
 
75. Fukushima, N.; Ieda, N.; Kawaguchi, M.; Sasakura, K.; Nagano, T.; Hanaoka, K.; 
Miyata, N.; Nakagawa, H. Development of photo-controllable hydrogen sulfide donor 
applicable in live cells. Bioorg Med Chem Lett 2015, 25 (2), 175-8. 
 
76. Xiao, Z.; Bonnard, T.; Shakouri-Motlagh, A.; Wylie, R. A. L.; Collins, J.; White, 
J.; Heath, D. E.; Hagemeyer, C. E.; Connal, L. A. Triggered and Tunable Hydrogen Sulfide 
Release from Photogenerated Thiobenzaldehydes. Chemistry 2017, 23 (47), 11294-11300. 
 
77. Yi, S. Y.; Moon, Y. K.; Kim, S.; Kim, S.; Park, G.; Kim, J. J.; You, Y. Visible light- 
driven photogeneration of hydrogen sulfide. Chem Commun (Camb) 2017, 53 (86), 11830- 
11833. 
 
78. Zhao, Y.; Bolton, S. G.; Pluth, M. D. Light-Activated COS/H2S Donation from 
Photocaged Thiocarbamates. Org Lett 2017, 19 (9), 2278-2281. 
 
79. Sharma, A. K.; Nair, M.; Chauhan, P.; Gupta, K.; Saini, D. K.; Chakrapani, H. 
Visible-Light-Triggered Uncaging of Carbonyl Sulfide for Hydrogen Sulfide (H2S) 
Release. Org Lett 2017, 19 (18), 4822-4825. 
 
80. (a) Dabrowski, J. M.; Arnaut, L. G. Photodynamic therapy (PDT) of cancer: from 
local to systemic treatment. Photochem Photobiol Sci 2015, 14 (10), 1765-80; (b) Phan, T. 
G.; Bullen, A. Practical intravital two-photon microscopy for immunological research: 
faster, brighter, deeper. Immunol Cell Biol 2010, 88 (4), 438-44. 
 
81. Stacko, P.; Muchova, L.; Vitek, L.; Klan, P. Visible to NIR Light Photoactivation 
of Hydrogen Sulfide for Biological Targeting. Org Lett 2018, 20 (16), 4907-4911. 
233  
82. Woods, J. J.; Cao, J.; Lippert, A. R.; Wilson, J. J. Characterization and Biological 
Activity of a Hydrogen Sulfide-Releasing Red Light-Activated Ruthenium(II) Complex. J 
Am Chem Soc 2018, 140 (39), 12383-12387. 
 
83. Luo, X.; Wu, J.; Lv, T.; Lai, Y.; Zhang, H.; Lu, J.-J.; Zhang, Y.; Huang, Z. 
Synthesis and evaluation of novel O2-derived diazeniumdiolates as photochemical and 
real-time monitoring nitric oxide delivery agents. Organic Chemistry Frontiers 2017, 4 
(12), 2445-2449. 
 
84. Venkatesh, Y.; Das, J.; Chaudhuri, A.; Karmakar, A.; Maiti, T. K.; Singh, N. D. P. 
Light triggered uncaging of hydrogen sulfide (H2S) with real-time monitoring. Chem 
Commun (Camb) 2018, 54 (25), 3106-3109. 
 
85. Steiger, A. K.; Yang, Y.; Royzen, M.; Pluth, M. D. Bio-orthogonal "click-and- 
release" donation of caged carbonyl sulfide (COS) and hydrogen sulfide (H2S). Chem 
Commun (Camb) 2017, 53 (8), 1378-1380. 
 
86. Bruins, J. J.; Blanco-Ania, D.; van der Doef, V.; van Delft, F. L.; Albada, B. 
Orthogonal, dual protein labelling by tandem cycloaddition of strained alkenes and alkynes 
to ortho-quinones and azides. Chem Commun (Camb) 2018, 54 (53), 7338-7341. 
 
87. Powell, C. R.; Foster, J. C.; Okyere, B.; Theus, M. H.; Matson, J. B. Therapeutic 
Delivery of H2S via COS: Small Molecule and Polymeric Donors with Benign Byproducts. 
J Am Chem Soc 2016, 138 (41), 13477-13480. 
 
88. Powell, C. R.; Kaur, K.; Dillon, K. M.; Zhou, M.; Alaboalirat, M.; Matson, J. B. 
Functional N-Substituted N-Thiocarboxyanhydrides as Modular Tools for Constructing 
H2S Donor Conjugates. ACS Chem Biol 2019, 14 (6), 1129-1134. 
 
89. Kaur, K.; Carrazzone, R. J.; Matson, J. B. The Benefits of 
Macromolecular/Supramolecular Approaches in Hydrogen Sulfide Delivery: A Review of 
Polymeric and Self-Assembled Hydrogen Sulfide Donors. Antioxid Redox Signal 2020, 32 
(2), 79-95. 
 
90. Wang, R. Physiological implications of hydrogen sulfide: a whiff exploration that 
blossomed. Physiol Rev 2012, 92 (2), 791-896. 
 
91. Kabil, O.; Banerjee, R. Enzymology of H2S biogenesis, decay and signaling. 
Antioxid Redox Signal 2014, 20 (5), 770-82. 
 
92. Wallace, J. L.; Wang, R. Hydrogen sulfide-based therapeutics: exploiting a unique 
but ubiquitous gasotransmitter. Nat Rev Drug Discov 2015, 14 (5), 329-45. 
 
93. Zhao, W.; Zhang, J.; Lu, Y.; Wang, R. The vasorelaxant effect of H(2)S as a novel 
endogenous gaseous K(ATP) channel opener. EMBO J 2001, 20 (21), 6008-16. 
 
94. Kimura, H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA 
receptor. Biochem Biophys Res Commun 2000, 267 (1), 129-33. 
234  
95. Papapetropoulos, A.; Pyriochou, A.; Altaany, Z.; Yang, G.; Marazioti, A.; Zhou, 
Z.; Jeschke, M. G.; Branski, L. K.; Herndon, D. N.; Wang, R.; Szabo, C. Hydrogen sulfide 
is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A 2009, 106 (51), 
21972-7. 
 
96. DeLeon, E. R.; Stoy, G. F.; Olson, K. R. Passive loss of hydrogen sulfide in 
biological experiments. Anal Biochem 2012, 421 (1), 203-7. 
 
97. Yang, X.; Guo, Y.; Strongin, R. M. Conjugate addition/cyclization sequence 
enables selective and simultaneous fluorescence detection of cysteine and homocysteine. 
Angew Chem Int Ed Engl 2011, 50 (45), 10690-3. 
 
98. Valiyaveetil, F. I.; MacKinnon, R.; Muir, T. W. Semisynthesis and folding of the 
potassium channel KcsA. J Am Chem Soc 2002, 124 (31), 9113-20. 
 
99. Johnson, E. C.; Kent, S. B. Insights into the mechanism and catalysis of the native 
chemical ligation reaction. J Am Chem Soc 2006, 128 (20), 6640-6. 
 
100. Steiger, A. K.; Zhao, Y.; Pluth, M. D. Emerging Roles of Carbonyl Sulfide in 
Chemical Biology: Sulfide Transporter or Gasotransmitter? Antioxid Redox Signal 2018, 
28 (16), 1516-1532. 
 
101. Hewitt, R. J.; Ong, M. J. H.; Lim, Y. W.; Burkett, B. A. Investigations of the 
Thermal Responsiveness of 1,4,2-Oxathiazoles. European Journal of Organic Chemistry 
2015, 2015 (30), 6687-6700. 
 
102. Prangova, L.; Osternack, K.; Voss, J. ELECTROREDUCTION OF ORGANIC- 
COMPOUNDS .26. ONE-ELECTRON REDUCTION OF O-PHENYL 
ARENECARBOTHIOATES AS STUDIED BY DIFFERENTIAL-PULSE 
POLAROGRAPHY AND CYCLOVOLTAMMETRY. Journal of Chemical Research-S 
1995, (6), 234-&. 
 
103. Legnani, L.; Toma, L.; Caramella, P.; Chiacchio, M. A.; Giofre, S.; Delso, I.; 
Tejero, T.; Merino, P. Computational Mechanistic Study of Thionation of Carbonyl 
Compounds with Lawesson's Reagent. J Org Chem 2016, 81 (17), 7733-40. 
 
104. Siegel, L. M. A Direct Microdetermination for Sulfide. Anal Biochem 1965, 11 (1), 
126-32. 
 
105. Castro, E. A. Kinetics and Mechanisms of Reactions of Thiol, Thiono, and Dithio 
Analogues of Carboxylic Esters with Nucleophiles. Chem Rev 1999, 99 (12), 3505-3524. 
 
106. Um, I. H.; Lee, J. Y.; Kim, H. T.; Bae, S. K. Curved Hammett plot in alkaline 
hydrolysis of O-aryl thionobenzoates: change in rate-determining step versus ground-state 
stabilization. J Org Chem 2004, 69 (7), 2436-41. 
235  
107. Um, I. H.; Hwang, S. J.; Yoon, S.; Jeon, S. E.; Bae, S. K. Aminolysis of O-aryl 
thionobenzoates: amine basicity combines with modulation of the nature of substituents in 
the leaving group and thionobenzoate moiety to control the reaction mechanism. J Org 
Chem 2008, 73 (19), 7671-7. 
 
108. Benesch, R. E.; Benesch, R. The Acid Strength of the -SH Group in Cysteine and 
Related Compounds. Journal of the American Chemical Society 1955, 77 (22), 5877-5881. 
 
109. Beesley, R. M.; Ingold, C. K.; Thorpe, J. F. CXIX.—The formation and stability of 
spiro-compounds. Part I. spiro-Compounds from cyclohexane. J. Chem. Soc., Trans. 1915, 
107 (0), 1080-1106. 
 
110. Oliveira, B. L.; Guo, Z.; Bernardes, G. J. L. Inverse electron demand Diels-Alder 
reactions in chemical biology. Chem Soc Rev 2017, 46 (16), 4895-4950. 
 
111. Walsh, C. T.; Nolan, E. M. Morphing peptide backbones into heterocycles. Proc 
Natl Acad Sci U S A 2008, 105 (15), 5655-6. 
 
112. Miethke, M.; Marahiel, M. A. Siderophore-based iron acquisition and pathogen 
control. Microbiol Mol Biol Rev 2007, 71 (3), 413-51. 
 
113. Gehring, A. M.; Mori, I.; Perry, R. D.; Walsh, C. T. The nonribosomal peptide 
synthetase HMWP2 forms a thiazoline ring during biogenesis of yersiniabactin, an iron- 
chelating virulence factor of Yersinia pestis. Biochemistry 1998, 37 (33), 11637-50. 
 
114. Quadri, L. E.; Keating, T. A.; Patel, H. M.; Walsh, C. T. Assembly of the 
Pseudomonas aeruginosa nonribosomal peptide siderophore pyochelin: In vitro 
reconstitution of aryl-4, 2-bisthiazoline synthetase activity from PchD, PchE, and PchF. 
Biochemistry 1999, 38 (45), 14941-54. 
 
115. Schneider, T. L.; Shen, B.; Walsh, C. T. Oxidase domains in epothilone and 
bleomycin biosynthesis: thiazoline to thiazole oxidation during chain elongation. 
Biochemistry 2003, 42 (32), 9722-30. 
 
116. Lim, Y. W.; Hewitt, R. J.; Burkett, B. A. The Dual Reactivity of 5-S/5-O-Phenyl- 
1,4,2-oxathiazoles: A Fragmentation Pathway That Affords Nitriles in the Presence of 
Water. European Journal of Organic Chemistry 2015, 2015 (22), 4840-4842. 
 
117. Zhang, G.; Liu, C.; Yi, H.; Meng, Q.; Bian, C.; Chen, H.; Jian, J. X.; Wu, L. Z.; 
Lei, A. External Oxidant-Free Oxidative Cross-Coupling: A Photoredox Cobalt-Catalyzed 
Aromatic C-H Thiolation for Constructing C-S Bonds. J Am Chem Soc 2015, 137 (29), 
9273-80. 
 
118. Kim, T. S.; Lee, Y. J.; Jeong, B. S.; Park, H. G.; Jew, S. S. Enantioselective 
synthesis of (R)- and (S)-alpha-alkylcysteines via phase-transfer catalytic alkylation. J Org 
Chem 2006, 71 (21), 8276-8. 
236  
119. Chiefari, J.; Chong, Y. K.; Ercole, F.; Krstina, J.; Jeffery, J.; Le, T. P. T.; 
Mayadunne, R. T. A.; Meijs, G. F.; Moad, C. L.; Moad, G.; Rizzardo, E.; Thang, S. H. 
Living Free-Radical Polymerization by Reversible Addition−Fragmentation Chain 
Transfer: The RAFT Process. Macromolecules 1998, 31 (16), 5559-5562. 
 
120. (a) Chiefari, J.; Mayadunne, R. T. A.; Moad, C. L.; Moad, G.; Rizzardo, E.; Postma, 
A.; Thang, S. H. Thiocarbonylthio Compounds (SC(Z)S−R) in Free Radical 
Polymerization with Reversible Addition-Fragmentation Chain Transfer (RAFT 
Polymerization). Effect of the Activating Group Z. Macromolecules 2003, 36 (7), 2273- 
2283; (b) Chong, Y. K.; Krstina, J.; Le, T. P. T.; Moad, G.; Postma, A.; Rizzardo, E.; 
Thang, S. H. Thiocarbonylthio Compounds [SC(Ph)S−R] in Free Radical Polymerization 
with Reversible Addition-Fragmentation Chain Transfer (RAFT Polymerization). Role of 
the Free-Radical Leaving Group (R). Macromolecules 2003, 36 (7), 2256-2272. 
 
121. Cerda, M. M.; Zhao, Y.; Pluth, M. D. Thionoesters: A Native Chemical Ligation- 
Inspired Approach to Cysteine-Triggered H2S Donors. Journal of the American Chemical 
Society 2018, 140 (39), 12574-12579. 
 
122. Newton, J. J.; Britton, R.; Friesen, C. M. Base-Catalyzed Transesterification of 
Thionoesters. J Org Chem 2018, 83 (20), 12784-12792. 
 
123. Mustafa, A. K.; Gadalla, M. M.; Snyder, S. H. Signaling by gasotransmitters. Sci 
Signal 2009, 2 (68), re2. 
 
124. Wang, R. Two's company, three's a crowd: can H2S be the third endogenous 
gaseous transmitter? Faseb Journal 2002, 16 (13), 1792-1798. 
 
125. Altaany, Z.; Yang, G.; Wang, R. Crosstalk between hydrogen sulfide and nitric 
oxide in endothelial cells. J Cell Mol Med 2013, 17 (7), 879-88. 
 
126. Yang, G.; Zhao, K.; Ju, Y.; Mani, S.; Cao, Q.; Puukila, S.; Khaper, N.; Wu, L.; 
Wang, R. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of 
Keap1 and activation of Nrf2. Antioxid Redox Signal 2013, 18 (15), 1906-19. 
 
127. (a) Wallace, J. L.; Wang, R. Hydrogen sulfide-based therapeutics: exploiting a 
unique but ubiquitous gasotransmitter. Nature Reviews Drug Discovery 2015, 14 (5), 329- 
345; (b) Zheng, Y.; Yu, B.; De La Cruz, L. K.; Roy Choudhury, M.; Anifowose, A.; Wang, 
B. Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and 
Developability Issues. Med Res Rev 2018, 38 (1), 57-100. 
 
128. Whiteman, M.; Li, L.; Rose, P.; Tan, C. H.; Parkinson, D. B.; Moore, P. K. The 
effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of 
inflammatory mediators in macrophages. Antioxid Redox Signal 2010, 12 (10), 1147-54. 
 
129. DeLeon, E. R.; Stoy, G. F.; Olson, K. R. Passive loss of hydrogen sulfide in 
biological experiments. Analytical Biochemistry 2012, 421 (1), 203-207. 
237  
130. (a) Powell, C. R.; Dillon, K. M.; Matson, J. B. A review of hydrogen sulfide (H2S) 
donors: Chemistry and potential therapeutic applications. Biochemical Pharmacology 
2018, 149, 110-123; (b) Szabo, C.; Papapetropoulos, A. International Union of Basic and 
Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and 
H2S Biosynthesis Inhibitors. Pharmacological Reviews 2017, 69 (4), 497-564; (c) Zhao, 
Y.; Biggs, T. D.; Xian, M. Hydrogen sulfide (H2S) releasing agents: chemistry and 
biological applications. Chemical Communications 2014, 50 (80), 11788-11805. 
 
131. Li, L.; Rossoni, G.; Sparatore, A.; Lee, L. C.; Del Soldato, P.; Moore, P. K. Anti- 
inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol 
Med 2007, 42 (5), 706-19. 
 
132. Zheng, Y.; Yu, B.; Ji, K.; Pan, Z.; Chittavong, V.; Wang, B. Esterase-Sensitive 
Prodrugs with Tunable Release Rates and Direct Generation of Hydrogen Sulfide. 
Angewandte Chemie-International Edition 2016, 55 (14), 4514-4518. 
 
133. (a) Xiao, Z.; Bonnard, T.; Shakouri-Motlagh, A.; Wylie, R. A. L.; Collins, J.; 
White, J.; Heath, D. E.; Hagemeyer, C. E.; Connal, L. A. Triggered and Tunable Hydrogen 
Sulfide Release from Photogenerated Thiobenzaldehydes. Chemistry-a European Journal 
2017, 23 (47), 11294-11300; (b) Woods, J. J.; Cao, J.; Lippert, A. R.; Wilson, J. J. 
Characterization and Biological Activity of a Hydrogen Sulfide-Releasing Red Light- 
Activated Ruthenium(II) Complex. Journal of the American Chemical Society 2018, 140 
(39), 12383-12387. 
 
134. Steiger, A. K.; Pardue, S.; Kevil, C. G.; Pluth, M. D. Self-Immolative 
Thiocarbamates Provide Access to Triggered H2S Donors and Analyte Replacement 
Fluorescent Probes. Journal of the American Chemical Society 2016, 138 (23), 7256-7259. 
 
135. (a) Zhao, Y.; Steiger, A. K.; Pluth, M. D. Colorimetric Carbonyl Sulfide 
(COS)/Hydrogen Sulfide (H2S) Donation from gamma-Ketothiocarbamate Donor Motifs. 
Angewandte Chemie-International Edition 2018, 57 (40), 13101-13105; (b) Sharma, A. K.; 
Nair, M.; Chauhan, P.; Gupta, K.; Saini, D. K.; Chakrapani, H. Visible-Light-Triggered 
Uncaging of Carbonyl Sulfide for Hydrogen Sulfide (H2S) Release. Organic Letters 2017, 
19 (18), 4822-4825; (c) Powell, C. R.; Foster, J. C.; Okyere, B.; Theus, M. H.; Matson, J. 
B. Therapeutic Delivery of H2S via COS: Small Molecule and Polymeric Donors with 
Benign Byproducts. Journal of the American Chemical Society 2016, 138 (41), 13477- 
13480. 
 
136. Ercole, F.; Whittaker, M. R.; Halls, M. L.; Boyd, B. J.; Davis, T. P.; Quinn, J. F. 
Garlic-inspired trisulfide linkers for thiol-stimulated H2S release. Chemical 
Communications 2017, 53 (57), 8030-8033. 
 
137. Cerda, M. M.; Hammers, M. D.; Earp, M. S.; Zakharov, L. N.; Pluth, M. D. 
Applications of Synthetic Organic Tetrasulfides as H2S Donors. Organic Letters 2017, 19 
(9), 2314-2317. 
 
138. Filipovic, M. R.; Zivanovic, J.; Alvarez, B.; Banerjee, R. Chemical Biology of H2S 
Signaling through Persulfidation. Chem Rev 2018, 118 (3), 1253-1337. 
238  
139. (a) Zhao, Y.; Wang, H.; Xian, M. Cysteine-Activated Hydrogen Sulfide (H2S) 
Donors. Journal of the American Chemical Society 2011, 133 (1), 15-17; (b) Zhao, Y.; 
Yang, C.; Organ, C.; Li, Z.; Bhushan, S.; Otsuka, H.; Pacheco, A.; Kang, J.; Aguilar, H. 
C.; Lefer, D. J.; Xian, M. Design, Synthesis, and Cardioprotective Effects of N-Mercapto- 
Based Hydrogen Sulfide Donors. Journal of Medicinal Chemistry 2015, 58 (18), 7501- 
7511; (c) Foster, J. C.; Powell, C. R.; Radzinski, S. C.; Matson, J. B. S-Aroylthiooximes: 
A Facile Route to Hydrogen Sulfide Releasing Compounds with Structure-Dependent 
Release Kinetics. Organic Letters 2014, 16 (6), 1558-1561. 
 
140. (a) Foster, J. C.; Radzinski, S. C.; Zou, X.; Finkielstein, C. V.; Matson, J. B. H2S- 
Releasing Polymer Micelles for Studying Selective Cell Toxicity. Mol Pharm 2017, 14 (4), 
1300-1306; (b) Ercole, F.; Mansfeld, F. M.; Kavallaris, M.; Whittaker, M. R.; Quinn, J. F.; 
Halls, M. L.; Davis, T. P. Macromolecular Hydrogen Sulfide Donors Trigger 
Spatiotemporally Confined Changes in Cell Signaling. Biomacromolecules 2016, 17 (1), 
371-83. 
 
141. Ozturk, T.; Ertas, E.; Mert, O. Use of Lawesson's reagent in organic syntheses. 
Chem Rev 2007, 107 (11), 5210-78. 
 
142. Siegel, L. M. A DIRECT MICRODETERMINATION FOR SULFIDE. Analytical 
Biochemistry 1965, 11 (1), 126-&. 
 
143. (a) Levesque, G.; Arsene, P.; Fanneau-Bellenger, V.; Pham, T. N. Protein 
thioacylation: 2. Reagent stability in aqueous media and thioacylation kinetics. 
Biomacromolecules 2000, 1 (3), 400-6; (b) Thomas, D. B.; Convertine, A. J.; Hester, R. 
D.; Lowe, A. B.; McCormick, C. L. Hydrolytic Susceptibility of Dithioester Chain Transfer 
Agents and Implications in Aqueous RAFT Polymerizations†. Macromolecules 2004, 37 
(5), 1735-1741. 
 
144. Austgen, J. R.; Hermann, G. E.; Dantzler, H. A.; Rogers, R. C.; Kline, D. D. 
Hydrogen sulfide augments synaptic neurotransmission in the nucleus of the solitary tract. 
J Neurophysiol 2011, 106 (4), 1822-32. 
 
145. Zhao, W. M.; Zhang, J.; Lu, Y. J.; Wang, R. The vasorelaxant effect of H2S as a 
novel endogenous gaseous K-ATP channel opener. Embo Journal 2001, 20 (21), 6008- 
6016. 
 
146. Sen, N.; Paul, B. D.; Gadalla, M. M.; Mustafa, A. K.; Sen, T.; Xu, R.; Kim, S.; 
Snyder, S. H. Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its 
antiapoptotic actions. Mol Cell 2012, 45 (1), 13-24. 
 
147. Hartle, M. D.; Pluth, M. D. A practical guide to working with H2S at the interface 
of chemistry and biology. Chemical Society Reviews 2016, 45 (22), 6108-6117. 
 
148. Martelli, A.; Testai, L.; Citi, V.; Marino, A.; Bellagambi, F. G.; Ghimenti, S.; 
Breschi, M. C.; Calderone, V. Pharmacological characterization of the vascular effects of 
aryl isothiocyanates: Is hydrogen sulfide the real player? Vascular Pharmacology 2014, 60 
(1), 32-41. 
239  
149. Li, L.; Whiteman, M.; Guan, Y. Y.; Neo, K. L.; Cheng, Y.; Lee, S. W.; Zhao, Y.; 
Baskar, R.; Tan, C.-H.; Moore, P. K. Characterization of a novel, water-soluble hydrogen 
sulfide - Releasing molecule (GYY4137): New insights into the biology of hydrogen 
sulfide. Circulation 2008, 117 (18), 2351-2360. 
 
150. Martelli, A.; Testai, L.; Citi, V.; Marino, A.; Pugliesi, I.; Barresi, E.; Nesi, G.; 
Rapposelli, S.; Taliani, S.; Da Settimo, F.; Breschi, M. C.; Calderone, V. Arylthioamides 
as H2S Donors: L-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro 
and in Vivo. Acs Medicinal Chemistry Letters 2013, 4 (10), 904-908. 
 
151. Beltowski, J. Hydrogen sulfide in pharmacology and medicine--An update. 
Pharmacol Rep 2015, 67 (3), 647-58. 
 
152. Benavides, G. A.; Squadrito, G. L.; Mills, R. W.; Patel, H. D.; Isbell, T. S.; Patel, 
R. P.; Darley-Usmar, V. M.; Doeller, J. E.; Kraus, D. W. Hydrogen sulfide mediates the 
vasoactivity of garlic. Proceedings of the National Academy of Sciences of the United 
States of America 2007, 104 (46), 17977-17982. 
 
153. Zhao, Y.; Bhushan, S.; Yang, C.; Otsuka, H.; Stein, J. D.; Pacheco, A.; Peng, B.; 
Devarie-Baez, N. O.; Aguilar, H. C.; Lefer, D. J.; Xian, M. Controllable Hydrogen Sulfide 
Donors and Their Activity against Myocardial Ischemia-Reperfusion Injury. Acs Chemical 
Biology 2013, 8 (6), 1283-1290. 
 
154. Liang, D.; Wu, H.; Wong, M. W.; Huang, D. Diallyl Trisulfide Is a Fast H2S Donor, 
but Diallyl Disulfide Is a Slow One: The Reaction Pathways and Intermediates of 
Glutathione with Polysulfides. Organic Letters 2015, 17 (17), 4196-4199. 
 
155. Yeh, Y. Y.; Liu, L. Cholesterol-lowering effect of garlic extracts and organosulfur 
compounds: human and animal studies. J Nutr 2001, 131 (3s), 989S-93S. 
 
156. Pluth, M. D.; Bailey, T. S.; Hammers, M. D.; Hartle, M. D.; Henthorn, H. A.; 
Steiger, A. K. Natural Products Containing Hydrogen Sulfide Releasing Moieties. Synlett 
2015, 26 (19), 2633-2643. 
 
157. Iciek, M.; Kwiecien, I.; Wlodek, L. Biological properties of garlic and garlic- 
derived organosulfur compounds. Environ Mol Mutagen 2009, 50 (3), 247-65. 
 
158. Derbesy, G.; Harpp, D. N. A simple method to prepare unsymmetrical di- tri- and 
tetrasulfides. Tetrahedron Letters 1994, 35 (30), 5381-5384. 
 
159. Zysman-Colman, E.; Harpp, D. N. Optimization of the synthesis of symmetric 
aromatic tri- and tetrasulfides. J Org Chem 2003, 68 (6), 2487-9. 
 
160. Smilkstein, M. J.; Knapp, G. L.; Kulig, K. W.; Rumack, B. H. Efficacy of oral N- 
acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national 
multicenter study (1976 to 1985). N Engl J Med 1988, 319 (24), 1557-62. 
240  
161. Flanagan, R. J.; Meredith, T. J. Use of N-acetylcysteine in clinical toxicology. The 
American Journal of Medicine 1991, 91 (3), S131-S139. 
 
162. Pickering, T. L.; Saunders, K. J.; Tobolsky, A. V. Disproportionation of organic 
polysulfides. Journal of the American Chemical Society 1967, 89 (10), 2364-2367. 
 
163. Hartle, M. D.; Hansen, R. J.; Tresca, B. W.; Prakel, S. S.; Zakharov, L. N.; Haley, 
M. M.; Pluth, M. D.; Johnson, D. W. A Synthetic Supramolecular Receptor for the 
Hydrosulfide Anion. Angew Chem Int Ed Engl 2016, 55 (38), 11480-4. 
 
164. Peng, B.; Liu, C.; Li, Z.; Day, J. J.; Lu, Y.; Lefer, D. J.; Xian, M. Slow generation 
of hydrogen sulfide from sulfane sulfurs and NADH models. Bioorg Med Chem Lett 2017, 
27 (3), 542-545. 
 
165. Toohey, J. I. Sulfur signaling: Is the agent sulfide or sulfane? Analytical 
Biochemistry 2011, 413 (1), 1-7. 
 
166. Toohey, J. I. Sulphane sulphur in biological systems: a possible regulatory role. 
Biochem J 1989, 264 (3), 625-32. 
 
167. Wang, R. PHYSIOLOGICAL IMPLICATIONS OF HYDROGEN SULFIDE: A 
WHIFF EXPLORATION THAT BLOSSOMED. Physiological Reviews 2012, 92 (2), 
791-896. 
 
168. Kimura, H.; Nagai, Y.; Umemura, K.; Kimura, Y. Physiological roles of hydrogen 
sulfide: synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid 
Redox Signal 2005, 7 (5-6), 795-803. 
 
169. Yang, G.; Wu, L.; Jiang, B.; Yang, W.; Qi, J.; Cao, K.; Meng, Q.; Mustafa, A. K.; 
Mu, W.; Zhang, S.; Snyder, S. H.; Wang, R. H2S as a physiologic vasorelaxant: 
hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008, 322 
(5901), 587-90. 
 
170. Whiteman, M.; Li, L.; Rose, P.; Tan, C.-H.; Parkinson, D. B.; Moore, P. K. The 
Effect of Hydrogen Sulfide Donors on Lipopolysaccharide-Induced Formation of 
Inflammatory Mediators in Macrophages. Antioxidants & Redox Signaling 2010, 12 (10), 
1147-1154. 
 
171. Filipovic, M. R.; Zivanovic, J.; Alvarez, B.; Banerjee, R. Chemical Biology of H2S 
Signaling through Persulfidation. Chemical Reviews 2018, 118 (3), 377-461. 
 
172. Lau, N.; Pluth, M. D. Reactive sulfur species (RSS): persulfides, polysulfides, 
potential, and problems. Curr Opin Chem Biol 2019, 49, 1-8. 
 
173. Kimura, H. Hydrogen sulfide and polysulfides as biological mediators. Molecules 
2014, 19 (10), 16146-57. 
241  
174. Iciek, M.; Wlodek, L. Biosynthesis and biological properties of compounds 
containing highly reactive, reduced sulfane sulfur. Pol J Pharmacol 2001, 53 (3), 215-25. 
 
175. Mishanina, T. V.; Libiad, M.; Banerjee, R. Biogenesis of reactive sulfur species for 
signaling by hydrogen sulfide oxidation pathways. Nat Chem Biol 2015, 11 (7), 457-64. 
 
176. Ida, T.; Sawa, T.; Ihara, H.; Tsuchiya, Y.; Watanabe, Y.; Kumagai, Y.; Suematsu, 
M.; Motohashi, H.; Fujii, S.; Matsunaga, T.; Yamamoto, M.; Ono, K.; Devarie-Baez, N. 
O.; Xian, M.; Fukuto, J. M.; Akaike, T. Reactive cysteine persulfides and S-polythiolation 
regulate oxidative stress and redox signaling. Proc Natl Acad Sci U S A 2014, 111 (21), 
7606-11. 
 
177. Mikami, Y.; Shibuya, N.; Kimura, Y.; Nagahara, N.; Ogasawara, Y.; Kimura, H. 
Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase 
to produce hydrogen sulfide. Biochem J 2011, 439 (3), 479-85. 
 
178. Artaud, I.; Galardon, E. A persulfide analogue of the nitrosothiol SNAP: formation, 
characterization and reactivity. Chembiochem 2014, 15 (16), 2361-4. 
 
179. Yu, B.; Zheng, Y.; Yuan, Z.; Li, S.; Zhu, H.; De La Cruz, L. K.; Zhang, J.; Ji, K.; 
Wang, S.; Wang, B. Toward Direct Protein S-Persulfidation: A Prodrug Approach That 
Directly Delivers Hydrogen Persulfide. J Am Chem Soc 2018, 140 (1), 30-33. 
 
180. Powell, C. R.; Dillon, K. M.; Wang, Y.; Carrazzone, R. J.; Matson, J. B. A 
Persulfide Donor Responsive to Reactive Oxygen Species: Insights into Reactivity and 
Therapeutic Potential. Angew Chem Int Ed Engl 2018, 57 (21), 6324-6328. 
 
181. Chauvin, J. R.; Griesser, M.; Pratt, D. A. Hydropersulfides: H-Atom Transfer 
Agents Par Excellence. J Am Chem Soc 2017, 139 (18), 6484-6493. 
 
182. Bailey, T. S.; Pluth, M. D. Reactions of isolated persulfides provide insights into 
the interplay between H2S and persulfide reactivity. Free Radic Biol Med 2015, 89, 662- 
7. 
 
183. Bailey, T. S.; Zakharov, L. N.; Pluth, M. D. Understanding hydrogen sulfide 
storage: probing conditions for sulfide release from hydrodisulfides. J Am Chem Soc 2014, 
136 (30), 10573-6. 
 
184. Jiang, C. S.; Muller, W. E.; Schroder, H. C.; Guo, Y. W. Disulfide- and 
multisulfide-containing metabolites from marine organisms. Chem Rev 2012, 112 (4), 
2179-207. 
 
185. Steudel, R. The chemistry of organic polysulfanes R-S(n)-R (n > 2). Chem Rev 
2002, 102 (11), 3905-45. 
 
186. Block, E. The Organosulfur Chemistry of the GenusAllium - Implications for the 
Organic Chemistry of Sulfur. Angewandte Chemie International Edition in English 1992, 
31 (9), 1135-1178. 
242  
187. (a) Powolny, A. A.; Singh, S. V. Multitargeted prevention and therapy of cancer by 
diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer 
Lett 2008, 269 (2), 305-14; (b) Li, Y.; Zhang, J.; Zhang, L.; Si, M.; Yin, H.; Li, J. Diallyl 
trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by 
switching on suppressor microRNAs and inactivating of Notch-1 signaling. 
Carcinogenesis 2013, 34 (7), 1601-10; (c) Xiao, D.; Lew, K. L.; Kim, Y. A.; Zeng, Y.; 
Hahm, E. R.; Dhir, R.; Singh, S. V. Diallyl trisulfide suppresses growth of PC-3 human 
prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin Cancer 
Res 2006, 12 (22), 6836-43; (d) Li, W.; Tian, H.; Li, L.; Li, S.; Yue, W.; Chen, Z.; Qi, L.; 
Hu, W.; Zhu, Y.; Hao, B.; Gao, C.; Si, L.; Gao, F. Diallyl trisulfide induces apoptosis and 
inhibits proliferation of A549 cells in vitro and in vivo. Acta Biochim Biophys Sin 
(Shanghai) 2012, 44 (7), 577-83; (e) Wang, Y. B.; Qin, J.; Zheng, X. Y.; Bai, Y.; Yang, 
K.; Xie, L. P. Diallyl trisulfide induces Bcl-2 and caspase-3-dependent apoptosis via 
downregulation of Akt phosphorylation in human T24 bladder cancer cells. Phytomedicine 
2010, 17 (5), 363-8. 
 
188. Antosiewicz, J.; Herman-Antosiewicz, A.; Marynowski, S. W.; Singh, S. V. c-Jun 
NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of 
reactive oxygen species and cell cycle arrest in human prostate cancer cells. Cancer Res 
2006, 66 (10), 5379-86. 
 
189. Hosono, T.; Fukao, T.; Ogihara, J.; Ito, Y.; Shiba, H.; Seki, T.; Ariga, T. Diallyl 
trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells 
through oxidative modification of beta-tubulin. J Biol Chem 2005, 280 (50), 41487-93. 
 
190. Liu, H.; Radford, M. N.; Yang, C. T.; Chen, W.; Xian, M. Inorganic hydrogen 
polysulfides: chemistry, chemical biology and detection. Br J Pharmacol 2019, 176 (4), 
616-627. 
 
191. Licht, S.; Davis, J. Disproportionation of Aqueous Sulfur and Sulfide: Kinetics of 
Polysulfide Decomposition. The Journal of Physical Chemistry B 1997, 101 (14), 2540- 
2545. 
 
192. Xu, S.; Wang, Y.; Radford, M. N.; Ferrell, A. J.; Xian, M. Synthesis of 
Unsymmetric Trisulfides from 9-Fluorenylmethyl Disulfides. Org Lett 2018, 20 (2), 465- 
468. 
 
193. Zysman-Colman, E.; Harpp, D. N. Optimization of the synthesis of symmetric 
aromatic tri- and tetrasulfides. Journal of Organic Chemistry 2003, 68 (6), 2487-2489. 
 
194. Harpp, D. N.; Granata, A. ORGANIC SULFUR CHEMISTRY .21. TRISULFIDE 
FORMATION BY ALKOXIDE DECOMPOSITION OF 
SULFENYLTHIOCARBONATES. Tetrahedron Letters 1976, (35), 3001-3004. 
 
195. Bailey, T. S.; Pluth, M. D. Reactions of isolated persulfides provide insights into 
the interplay between H2S and persulfide reactivity. Free Radical Biology and Medicine 
2015, 89, 662-667. 
243  
196. Ahrika, A.; Robert, J.; Anouti, M.; Paris, J.; Jiang, Z.-H.; Yan, S.-P.; Wang, G.-L.; 
Yao, X.-K.; Wang, H.-G.; Tuchagues, J. P.; Ögren, M. Nucleophilic Substitution of Alkyl 
Halides by Electrogenerated Polysulfide Ions in N,N-dimethylacetamide. Acta Chemica 
Scandinavica 1999, 53 (7), 513-520. 
 
197. Coletta, C.; Papapetropoulos, A.; Erdelyi, K.; Olah, G.; Modis, K.; Panopoulos, P.; 
Asimakopoulou, A.; Gero, D.; Sharina, I.; Martin, E.; Szabo, C. Hydrogen sulfide and nitric 
oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent 
vasorelaxation. Proc Natl Acad Sci U S A 2012, 109 (23), 9161-6. 
 
198. Szczesny, B.; Modis, K.; Yanagi, K.; Coletta, C.; Le Trionnaire, S.; Perry, A.; 
Wood, M. E.; Whiteman, M.; Szabo, C. AP39, a novel mitochondria-targeted hydrogen 
sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects 
against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in 
vitro. Nitric Oxide 2014, 41, 120-30. 
 
199. Yuan, S.; Shen, X.; Kevil, C. G. Beyond a Gasotransmitter: Hydrogen Sulfide and 
Polysulfide in Cardiovascular Health and Immune Response. Antioxid Redox Signal 2017, 
27 (10), 634-653. 
 
200. Malone Rubright, S. L.; Pearce, L. L.; Peterson, J. Environmental toxicology of 
hydrogen sulfide. Nitric Oxide 2017, 71, 1-13. 
 
201. Zhao, W.; Zhang, J.; Lu, Y.; Wang, R. The vasorelaxant effect of H2S as a novel 
endogenous gaseous KATP channel opener. EMBO J 2001, 20 (21), 6008-16. 
 
202. Abe, K.; Kimura, H. The possible role of hydrogen sulfide as an endogenous 
neuromodulator. The Journal of Neuroscience 1996, 16 (3), 1066-1071. 
 
203. Levinn, C. M.; Cerda, M. M.; Pluth, M. D. Activatable Small-Molecule Hydrogen 
Sulfide Donors. Antioxid Redox Signal 2020, 32 (2), 96-109. 
 
204. Levinn, C. M.; Cerda, M. M.; Pluth, M. D. Development and Application of 
Carbonyl Sulfide-Based Donors for H2S Delivery. Acc Chem Res 2019, 52 (9), 2723-2731. 
 
205. Haritos, V. S.; Dojchinov, G. Carbonic anhydrase metabolism is a key factor in the 
toxicity of CO2 and COS but not CS2 toward the flour beetle Tribolium castaneum 
[Coleoptera: Tenebrionidae]. Comp Biochem Physiol C Toxicol Pharmacol 2005, 140 (1), 
139-47. 
 
206. Roth, M. E.; Green, O.; Gnaim, S.; Shabat, D. Dendritic, Oligomeric, and 
Polymeric Self-Immolative Molecular Amplification. Chem Rev 2016, 116 (3), 1309-52. 
 
207. Chauhan, P.; Bora, P.; Ravikumar, G.; Jos, S.; Chakrapani, H. Esterase Activated 






208. (a) Zhao, Y.; Henthorn, H. A.; Pluth, M. D. Kinetic Insights into Hydrogen Sulfide 
Delivery from Caged-Carbonyl Sulfide Isomeric Donor Platforms. Journal of 
theAmerican Chemical Society 2017, 139 (45), 16365-16376; (b) Chauhan, P.; Jos, S.; 
Chakrapani, H. Reactive Oxygen Species-Triggered Tunable Hydrogen Sulfide Release. 
Organic Letters 2018, 20 (13), 3766-3770. 
 
209. Powell, C. R.; Foster, J. C.; Swilley, S. N.; Kaur, K.; Scannelli, S. J.; Troya, D.; 
Matson, J. B. Self-Amplified Depolymerization of Oligo(thiourethanes) for the Release of 
COS/H2S. Polym Chem 2019, 10 (23), 2991-2995. 
 
210. Monks, T. J.; Jones, D. C. The metabolism and toxicity of quinones, quinonimines, 
quinone methides, and quinone-thioethers. Curr Drug Metab 2002, 3 (4), 425-38. 
 
211. Bolton, J. L.; Turnipseed, S. B.; Thompson, J. A. Influence of quinone methide 
reactivity on the alkylation of thiol and amino groups in proteins: studies utilizing amino 
acid and peptide models. Chem Biol Interact 1997, 107 (3), 185-200. 
 
212. Barany, G.; Merrifield, R. B. A new amino protecting group removable by 
reduction. Chemistry of the dithiasuccinoyl (Dts) function. J Am Chem Soc 1977, 99 (22), 
7363-5. 
 
213. Barany, G.; Merrifield, R. B. Kinetics and mechanism of the thiolytic removal of 
the dithiasuccinoyl (Dts) amino protecting group. Journal of the American Chemical 
Society 1980, 102 (9), 3084-3095. 
 
214. Siegel, L. M. A direct microdetermination for sulfide. Analytical Biochemistry 
1965, 11 (1), 126-132. 
 
215. Elliott, S.; Lu, E.; Rowland, F. S. Rates and mechanisms for the hydrolysis of 
carbonyl sulfide in natural waters. Environmental Science & Technology 1989, 23 (4), 458- 
461. 
 
216. Poole, L. B. The basics of thiols and cysteines in redox biology and chemistry. Free 
Radic Biol Med 2015, 80, 148-57. 
 
217. Saito, R.; Sato, T.; Ikai, A.; Tanaka, N. Structure of bovine carbonic anhydrase II 
at 1.95 A resolution. Acta Crystallogr D Biol Crystallogr 2004, 60 (Pt 4), 792-5. 
 
218. Ponomarov, O.; Padělková, Z.; Hanusek, J. Mechanism of sulfur transfer from 
1,2,4-dithiazolidine-3,5-diones to triphenylphosphines. Journal of Physical Organic 
Chemistry 2013, 26 (7), 560-564. 
 
219. Hill, S. V.; Thea, S.; Williams, A. Degradation in aqueous solution of O-aryl N- 
arylthioncarbamates to aryloxide ions and isothiocyanates. A study of Leffler's assumption. 
Journal of the Chemical Society, Perkin Transactions 2 1983, (4), 437-446. 
 
220. Lavis, L. D.; Raines, R. T. Bright ideas for chemical biology. ACS Chem Biol 2008, 
3 (3), 142-55. 
245  
221. Fiorucci, S.; Orlandi, S.; Mencarelli, A.; Caliendo, G.; Santagada, V.; Distrutti, E.; 
Santucci, L.; Cirino, G.; Wallace, J. L. Enhanced activity of a hydrogen sulphide-releasing 
derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 2007, 
150 (8), 996-1002. 
 
222. Hanwell, M. D.; Curtis, D. E.; Lonie, D. C.; Vandermeersch, T.; Zurek, E.; 
Hutchison, G. R. Avogadro: an advanced semantic chemical editor, visualization, and 
analysis platform. J Cheminform 2012, 4 (1), 17. 
 
223. Frisch, M. J. T., G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, 
J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, 
M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; 
Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; 
Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, 
F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, 
R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; 
Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; 
Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; 
Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. 
G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; 
Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. . Gaussian 09 Rev. D.02, 
Wallingford, CT, 2009. 
 
224. Lee, C.-L.; Brimblecombe, P. Anthropogenic contributions to global carbonyl 
sulfide, carbon disulfide and organosulfides fluxes. Earth-Science Reviews 2016, 160, 1- 
18. 
 
225. (a) Andreae, M. O.; Merlet, P. Emission of trace gases and aerosols from biomass 
burning. Global Biogeochemical Cycles 2001, 15 (4), 955-966; (b) Andreae, M. O. 
Emission of trace gases and aerosols from biomass burning – an updated assessment. 
Atmospheric Chemistry and Physics 2019, 19 (13), 8523-8546. 
 
226. Campbell, J. E.; Whelan, M. E.; Seibt, U.; Smith, S. J.; Berry, J. A.; Hilton, T. W. 
Atmospheric carbonyl sulfide sources from anthropogenic activity: Implications for carbon 
cycle constraints. Geophysical Research Letters 2015, 42 (8), 3004-3010. 
 
227. Vainio, E.; Brink, A.; Demartini, N.; Hupa, M.; Vesala, H.; Tormonen, K.; 
Kajolinna, T. In-Furnace Measurement of Sulphur and Nitrogen Species in a Recovery 
Boiler. J. Pulp Pap. Sci. 2010, 36 (3-4), 135-142. 
 
228. Watts, S. F. The mass budgets of carbonyl sulfide, dimethyl sulfide, carbon 
disulfide and hydrogen sulfide. Atmospheric Environment 2000, 34 (5), 761-779. 
 
229. Ferm, R. J. The Chemistry Of Carbonyl Sulfide. Chemical Reviews 1957, 57 (4), 
621-640. 
 
230. Leman, L.; Orgel, L.; Ghadiri, M. R. Carbonyl sulfide-mediated prebiotic 
formation of peptides. Science 2004, 306 (5694), 283-6. 
246  
231. Balazy, M.; Abu-Yousef, I. A.; Harpp, D. N.; Park, J. Identification of carbonyl 
sulfide and sulfur dioxide in porcine coronary artery by gas chromatography/mass 
spectrometry, possible relevance to EDHF. Biochem Biophys Res Commun 2003, 311 (3), 
728-34. 
 
232. Kamboures, M. A.; Blake, D. R.; Cooper, D. M.; Newcomb, R. L.; Barker, M.; 
Larson, J. K.; Meinardi, S.; Nussbaum, E.; Rowland, F. S. Breath sulfides and pulmonary 
function in cystic fibrosis. Proc Natl Acad Sci U S A 2005, 102 (44), 15762-7. 
 
233. (a) Zhou, J.; Ma, H. Design principles of spectroscopic probes for biological 
applications. Chem Sci 2016, 7 (10), 6309-6315; (b) Jiao, X.; Li, Y.; Niu, J.; Xie, X.; Wang, 
X.; Tang, B. Small-Molecule Fluorescent Probes for Imaging and Detection of Reactive 
Oxygen, Nitrogen, and Sulfur Species in Biological Systems. Anal Chem 2018, 90 (1), 533- 
555. 
 
234. Tudose, A.; Demonceau, A.; Delaude, L. Imidazol(in)ium-2-carboxylates as N- 
heterocyclic carbene precursors in ruthenium–arene catalysts for olefin metathesis and 
cyclopropanation. Journal of Organometallic Chemistry 2006, 691 (24-25), 5356-5365. 
 
235. Delaude, L.; Demonceau, A.; Wouters, J. Assessing the Potential of Zwitterionic 
NHC·CS2Adducts for Probing the Stereoelectronic Parameters of N-Heterocyclic 
Carbenes. European Journal of Inorganic Chemistry 2009, 2009 (13), 1882-1891. 
 
236. Hans, M.; Wouters, J.; Demonceau, A.; Delaude, L. Synthesis and Organocatalytic 
Applications of Imidazol(in)ium-2-thiocarboxylates. European Journal of Organic 
Chemistry 2011, 2011 (35), 7083-7091. 
 
237. Zhou, X.; Lee, S.; Xu, Z.; Yoon, J. Recent Progress on the Development of 
Chemosensors for Gases. Chem Rev 2015, 115 (15), 7944-8000. 
 
238. Neethirajan, S.; Jayas, D. S.; Sadistap, S. Carbon Dioxide (CO2) Sensors for the 
Agri-food Industry—A Review. Food and Bioprocess Technology 2008, 2 (2), 115-121. 
 
239. Guo, Z.; Song, N. R.; Moon, J. H.; Kim, M.; Jun, E. J.; Choi, J.; Lee, J. Y.; 
Bielawski, C. W.; Sessler, J. L.; Yoon, J. A benzobisimidazolium-based fluorescent and 
colorimetric chemosensor for CO2. J Am Chem Soc 2012, 134 (43), 17846-9. 
 
240. Hopkinson, M. N.; Richter, C.; Schedler, M.; Glorius, F. An overview of N- 
heterocyclic carbenes. Nature 2014, 510 (7506), 485-96. 
 
241. Svoronos, P. D. N.; Bruno, T. J. Carbonyl Sulfide: A Review of Its Chemistry and 
Properties. Industrial & Engineering Chemistry Research 2002, 41 (22), 5321-5336. 
 
242. Zhang, C.-J.; Zhang, X.-H. Chemoselective Coupling of CS2 and Epoxides for 
Producing Poly(thioether)s and COS via Oxygen/Sulfur Atom Exchange. Macromolecules 
2019, 53 (1), 233-239. 
